GWAS
Diversity Monitor
Additional Information
Metric
By
Participants
Stage
Discovery
GWAS
Diversity Monitor
Additional Information
Privacy Policy
NHGRI-EBI Catalog
GitHub
How to cite this
Global Initiative
Q&As
Loader
Total GWAS participants diversity
Version 1.0.0. Last check for data: 2022-01-18 09:34:08 .
95.82%
European
3.05%
Asian
0.09%
African
0.18%
African American or Afro-Caribbean
0.23%
Hispanic or Latin American
0.63%
Other/Mixed
Ancestry over time by parent term
Discovery
Stage
All parent terms
Immune system disorder
Other trait
Response to drug
Other measurement
Neurological disorder
Cancer
Metabolic disorder
Biological process
Other disease
Hematological measurement
Lipid or lipoprotein measurement
Cardiovascular disease
Liver enzyme measurement
Body measurement
Digestive system disorder
Inflammatory measurement
Cardiovascular measurement
OR
Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia
Bone mineral density (Ward's triangle area)
Urinary electrolytes (magnesium/calcium ratio)
Tonsillectomy
Arthritis (juvenile idiopathic)
Neuroticism
Oropharynx cancer
Oral cavity cancer
Oral cavity and pharyngeal cancer
Diastolic blood pressure
Systolic blood pressure
Gout
Renal underexcretion gout
Renal overload gout
Suicide behavior
Suicide ideation score in major depressive disorder
Suicide
Suicide attempts in major depressive disorder
Mucinous ovarian carcinoma
Joint damage progression in ACPA-negative rheumatoid arthritis
Pelvic organ prolapse
Pelvic organ prolapse (moderate/severe)
Fibrinogen levels
Pancreatic cancer
LDL peak particle diameter (total fat intake interaction)
Platelet count
Sense of smell
Response to interferon beta in multiple sclerosis
Bipolar disorder
middle facial morphology traits (ordinal measurement)
lower facial morphology traits (ordinal measurement)
middle facial morphology traits (quantitative measurement)
lower facial morphology traits (quantitative measurement)
facial morphology traits (multivariate analysis)
upper facial morphology traits (ordinal measurement)
Memory performance
Verbal-numerical reasoning
Educational attainment
Reaction time
Bone mineral density (hip)
Metabolite levels (lipid measures)
Metabolite levels (small molecules and protein measures)
Metabolite levels (lipoprotein measures)
Coronary artery disease
Myocardial infarction
Neuroendocrine tumor
Small intestine neuroendocrine tumor
Pancreatic neuroendocrine tumor
Bronchial neuroendocrine tumor
Chronotype
Sleep duration
Morning vs. evening chronotype
Sleep duration (oversleepers vs undersleepers)
Sleep duration (oversleepers)
Sleep duration (undersleepers)
Pneumococcal bacteremia
Bacteremia
Celiac disease
Clinical laboratory measurements
Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)
Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder
Bipolar disorder or attention deficit hyperactivity disorder
Maximal oxygen uptake response
knee peak torque response
Polycystic ovary syndrome
Adiponectin levels
Adiponectin levels (BMI-adjusted)
Acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
Juvenile osteochondritis dissecans
Asthma exacerbations
Acylcarnitine levels
Amino acid levels
Glycerophospholipid levels
Sphingolipid levels
Hexose levels
Ischemic stroke
Stroke
Schizophrenia
Multiple system atrophy
"Cholesterol, total"
LDL cholesterol
HDL cholesterol
Triglycerides
Response to lithium treatment in bipolar disorder (dichotomous phenotype)
Response to lithium treatment in bipolar disorder (continuous phenotype)
Triptolide cytotoxicity
"Parkinson's disease (non-familial, age at onset)"
Parkinson's disease (age of onset)
"Parkinson's disease (familial, age at onset)"
Breast cancer
S-phenylmercapturic acid levels in smokers
Body mass index
Breslow thickness in cutaneous melanoma
Spherical equivalent (joint analysis main effects and education interaction)
Thyroid-associated orbitopathy in graves' disease
Systemic lupus erythematosus
Lung cancer
Smoking status (current vs former)
Smoking behaviour (cigarettes smoked per day)
Lung adenocarcinoma
Squamous cell lung carcinoma
Prostate cancer
Aggressive prostate cancer
Endometrial cancer
Response to selective serotonin reuptake inhibitors in depression
Response to citalopram or escitalopram in depression
Response to antidepressants in depression
Non-response to bupropion and depression
Response to bupropion and depression
Response to selective serotonin reuptake inhibitors and depression
Non-response to citalopram or escitalopram and depression
Response to citalopram or escitalopram and depression
Non-response to antidepressants and depression
Non-response to selective serotonin reuptake inhibitors and depression
Response to antidepressants and depression
Response to bupropion in depression
Glaucoma (primary open-angle)
Midgestational circulating levels of organochlorine pesticides
Midgestational circulating levels of PCBs (fetal genetic effect)
Midgestational circulating levels of PBDEs
Midgestational circulating levels of PBDEs (fetal genetic effect)
Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)
Midgestational circulating levels of PCBs
Antipsychotic drug-induced weight gain in schizophrenia
Diabetic kidney disease
Nicotine dependence
Bone mineral density (spine) and age at menarche
Bone mineral density (hip) and age at menarche
Antipsychotic drug-induced weight gain
Antipsychotic drug-induced weight gain (time interaction)
Soluble interleukin-2 receptor subunit alpha
Alzheimer's disease (late onset)
Lung disease severity in cystic fibrosis
Coronary artery aneurysm in Kawasaki disease
Response to Pazopanib in cancer (hepatotoxicity)
Platinum-induced hepatotoxicity in non-small cell lung cancer
Response to montelukast in asthma (change in FEV1)
Thionamide-induced agranulocytosis in Graves' disease
Colorectal cancer
Frontotemporal dementia
Dysphagia
Major depressive disorder (stressful life events interaction)
Cannabis dependence symptom count
High fetal hemoglobin in sickle cell disease
Ischemic stroke (cardioembolic)
Ischemic stroke (non-cardioembolic)
Collagenous colitis
Agreeableness
Conscientiousness
Extraversion
Openness
Abdominal aortic aneurysm
Bone mineral density (femoral neck)
Bone mineral density (total hip)
Bone mineral density (spine)
Serum parathyroid hormone levels
QT interval (sulfonylurea treatment interaction)
JT interval (sulfonylurea treatment interaction)
QRS interval (sulfonylurea treatment interaction)
Excessive daytime sleepiness
Sleep traits (multi-trait analysis)
Insomnia
Macular telangiectasia type 2
Monocyte-lymphocyte ratio
Monocyte count
Skin fluorescence in type 1 diabetes
Autism spectrum disorder
Advanced glycation end-product levels
Setpoint viral load in HIV-1 infection
Response to fenofibrate (HDL cholesterol levels)
Response to fenofibrate (LDL cholesterol levels)
Response to fenofibrate (total cholesterol levels)
Response to fenofibrate (triglyceride levels)
Ideal cardiovascular health (clinical and behavioural)
Ideal cardiovascular health (clinical)
Gestational age at birth (maternal effect)
Gestational age at birth in labor-initiated deliveries (child effect)
Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)
Gestational age at birth in labor-initiated deliveries (maternal effect)
Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)
Gestational age at birth (child effect)
Sjögren's syndrome
Nicotine metabolite ratio in current smokers
Pathological gambling
Multiple sclerosis
Endometrial endometrioid carcinoma
Alcohol consumption
Alcohol consumption (heavy vs. light/non-drinkers)
Asthma (SNP x SNP interaction)
Peanut allergy
Cancer (pleiotropy)
Cancer
Eating disorder in bipolar disorder
Bipolar disorder and eating disorder
Severe malaria
Staphylococcus aureus infection
Skin and soft tissue Staphylococcus aureus infection
Cingulate cortical amyloid beta load
Cardiovascular disease in hypertension (ACE inhibitor interaction)
Cardiovascular disease in hypertension (calcium channel blocker interaction)
Myocardial infarction in hypertension (calcium channel blocker interaction)
Cardiovascular disease in hypertension (diuretic interaction)
Cardiovascular disease in hypertension (beta blocker interaction)
Myocardial infarction in hypertension (ACE inhibitor interaction)
Myocardial infarction in hypertension (beta blocker interaction)
Myocardial infarction in hypertension (diuretic interaction)
Ear protrusion
Tragus size
Antitragus size
Crus helix expression
Superior crus of antihelix expression
Darwin's tubercle
Ear morphology
Lobe size
Lobe attachment
Helix rolling
Folding of antihelix
Late-onset myasthenia gravis
Acute kidney injury in coronary artery bypass surgery (creatinine rise)
Childhood body mass index
Asthma
Prostate cancer (survival)
Liver fibrosis severity in HIV/hepatitis C co-infection
Anti-thyroid drug induced agranulocytosis
Non-chemotherapy drug induced agranulocytosis
Cervical cancer
Celiac disease and Rheumatoid arthritis
Diastolic blood pressure response to hydrochlorothiazide in hypertension
Systolic blood pressure response to hydrochlorothiazide in hypertension
Membranous nephropathy
Estrogen receptor status in HER2 positive breast cancer
Estrogen receptor status in HER2 negative breast cancer
Estrogen receptor status in breast cancer
Subcutaneous adipose tissue
Visceral adipose tissue
Pericardial adipose tissue adjusted for height and weight
Visceral adipose tissue adjusted for BMI
Pericardial fat
Subcutaneous adipose tissue attenuation (Hounsfield unit scale)
Visceral adipose tissue attenuation (Hounslow unit scale)
Visceral adipose tissue/subcutaneous adipose tissue ratio
Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI
Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)
Subjective well-being
Life satisfaction
Positive affect
Depression
Breast cancer (estrogen-receptor negative)
Nonsyndromic cleft lip with cleft palate
Sciatica caused by lumbar disc herniation (treated with microdiscectomy)
Carotid intima media thickness
White matter lesion progression
White matter lesion progression (adjusted for white matter lesion burden at baseline)
Response to serotonin reuptake inhibitors in non-psychotic unipolar depression
Plasma lactate levels
Gastric cancer
Gastric adenocarcinoma (histologically verified)
Metastasis at diagnosis in osteosarcoma
Arterial stiffness (pulse-wave velocity)
Post-traumatic stress disorder
Cardia gastric cancer
Non-cardia gastric cancer
Hearing loss in noise exposure
Plasma homocysteine levels
Survival in colorectal cancer
Survival in colorectal cancer (non-distant metastatic)
Survival in colorectal cancer (distant metastatic)
Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)
Cardiomyopathy in childhood cancer survivors
Tuberculosis
Rheumatoid factor seropositivity in rheumatoid arthritis
Body mass index variance
Parental longevity (father's age at death)
Parental longevity (mother's age at death)
Parental longevity (combined parental age at death)
Parental extreme longevity (95 years and older)
Aggressiveness in attention deficit hyperactivity disorder
Cannabis use
Cognitive impairment (brain beta-amyloid deposition interaction)
Migraine
Migraine without aura
Migraine with aura
Hypertension
Hirschsprung disease
EGFR mutation-positive lung adenocarcinoma
Severity of facial solar lentigines
Depressive symptoms measurement (somatic complaints domain)
Depressive symptoms measurement (lack of negative affect domain)
Depressive symptoms measurement (lack of positive affect domain)
Heroin dependence
Bortezomib-induced peripheral neuropathy in multiple myeloma
Cluster headache
Number of children ever born
Age at first birth
Mathematical ability
Paclitaxel disposition in epithelial ovarian cancer
Carboplatin disposition in epthelial ovarian cancer
Type 2 diabetes
"Allergic disease (asthma, hay fever or eczema)"
Extrinsic epigenetic age acceleration
Intrinsic epigenetic age acceleration
Tooth agenesis
Tooth agenesis (mandibular second premolars)
Tooth agenesis (maxillary lateral incisors)
Tooth agenesis (maxillary second premolars)
Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel
Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin
Smoking status (daily vs non-daily)
Smoking status (heavy vs light)
Smoking status (ever vs never smokers)
Facial emotion recognition
Facial emotion recognition (happy faces)
Facial emotion recognition (sad faces)
Facial emotion recognition (angry faces)
Facial emotion recognition (fearful faces)
Severe malaria (adjusted for sickle cell variant rs334)
Glomerular filtration rate (cystatin C)
Glomerular filtration rate (creatinine)
Blood protein levels
Vaso-occlusive pain in sickle-cell anemia
Atrial fibrillation
Incident atrial fibrillation
Prevalent atrial fibrillation
Colorectal adenoma (advanced)
Colonoscopy-negative controls vs population controls
Pulse pressure (dietary potassium intake interaction)
Systolic blood pressure (dietary potassium intake interaction)
Diastolic blood pressure (dietary potassium intake interaction)
Mean arterial pressure (dietary potassium intake interaction)
Late-onset Alzheimer's disease
Nodular sclerosis Hodgkin lymphoma
Mixed cellularity Hodgkin lymphoma
Hodgkin's lymphoma
White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)
Total mean fractional anisotropy measurement in first episode schizophrenia
White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)
White matter microstructure in first episode schizophrenia (left inferior parietal cortex)
Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)
White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)
White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)
Neuroblastoma (11q deletion)
Neuroblastoma (11q deletion vs 11q undeleted and MYCN amplification)
Neuroblastoma (1p deletion)
Neuroblastoma (MYCN amplification)
Fear of severe pain
Fear of minor pain
Fear of medical pain (dental)
Fear of pain
Pediatric non-alcoholic fatty liver disease activity score
Liver fibrosis in pediatric non-alcoholic fatty acid liver disease
Pediatric nonalcoholic steatohepatitis
Femoral neck bone geometry
Lumbar spine bone mineral density
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)
Waist circumference adjusted for body mass index
Waist-to-hip ratio adjusted for body mass index
Body mass index (physical activity interaction)
Waist circumference adjusted for BMI (physical activity interaction)
Waist-to-hip ratio adjusted for BMI (physical activity interaction)
Body mass index (joint analysis main effects and physical activity interaction)
Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)
Body mass index in physically active individuals
Body mass index in physically inactive individuals
Waist circumference adjusted for BMI in active individuals
Waist circumference adjusted for BMI in inactive individuals
Waist-to-hip ratio adjusted for BMI in active individuals
Waist-to-hip ratio adjusted for BMI in inactive individuals
BMI (smoking interaction)
Waist circumference adjusted for BMI (adjusted for smoking behaviour)
Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)
Waist-to-hip ratio adjusted for BMI (smoking interaction)
Waist circumference adjusted for BMI (smoking interaction)
Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)
Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)
BMI (adjusted for smoking behaviour)
Body mass index (joint analysis main effects and smoking interaction)
Waist circumference adjusted for BMI in non-smokers
Waist-to-hip ratio adjusted for BMI in smokers
BMI in non-smokers
Waist circumference adjusted for BMI in smokers
BMI in smokers
Waist-to-hip ratio adjusted for BMI in non-smokers
Atopy
Heart rate variability traits (SDNN)
Heart rate variability traits (RMSSD)
Heart rate variability traits (pvRSA/HF)
Testicular germ cell tumor
Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms
Lipoprotein (a) levels
Cerebrospinal fluid t-tau levels
Cerebrospinal fluid AB1-42 levels
Cerebrospinal fluid t-tau:AB1-42 ratio
"1,5-anhydroglucitol levels"
Nonalcoholic steatohepatitis-derived hepatocellular carcinoma
Brunt stage in nonalcoholic fatty liver disease
Brunt grade in nonalcoholic fatty liver disease
Hepatocyte fat droplet content in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease
Alcohol consumption in current drinkers
Cerebral blood flow
Post bronchodilator FEV1 in COPD
Post bronchodilator FEV1/FVC ratio
Post bronchodilator FEV1
Post bronchodilator FEV1/FVC ratio in COPD
Pre bronchodilator FEV1
Pre bronchodilator FEV1/FVC ratio
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
Primary biliary cirrhosis
Borderline personality disorder
Rate of cognitive decline in mild cognitive impairment (time interaction)
Craniofacial microsomia
Telomere length
Small cell lung carcinoma
Lung cancer in ever smokers
Lung cancer in never smokers
Activities of daily living score
Short physical performance battery score
Mid-arm muscle circumference
Four meter walk test score
Cognitive performance
Calf circumference
Hand grip strength
Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer
Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer
Plasma estrone levels in resected estrogen-receptor positive breast cancer
Plasma androstenedione levels in resected early stage-receptor positive breast cancer
Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer
Breast cancer (survival)
Motor development (prenatal lead exposure interaction)
Mental development (prenatal lead exposure interaction)
Advanced age-related macular degeneration
Age-related macular degeneration (SNP x mitochondrial T5004C interaction)
Age-related macular degeneration (SNP x mitochondrial A4917G interaction)
Age-related macular degeneration (SNP x mitochondrial G12771A interaction)
Age-related macular degeneration (SNP x mitochondrial C16069T interaction)
Menopause (age at onset)
Depressive symptoms (MTAG)
Subjective well-being (MTAG)
Neuroticism (MTAG)
Depressive symptoms
Heart rate
Intelligence
Left ventricular function change in anthracycline treatment
Peak insulin response
Acute insulin response
Insulin secretion rate
Insulin disposition index
Insulin disposition index (BMI adjusted)
Peak insulin response (BMI and insulin secretion adjusted)
Peak insulin response (insulin secretion adjusted)
Acute insulin response (insulin secretion and BMI adjusted)
Acute insulin response (insulin secretion adjusted)
insulin secretion rate (BMI adjusted)
Bone ultrasound measurement (velocity of sound)
Bone ultrasound measurement (broadband ultrasound attenuation)
Bone erosion in rheumatoid arthritis
Anorexia nervosa
Parental longevity (at least one long-lived parent)
Mean arterial pressure
Pulse pressure
Preterm birth (maternal effect)
Coronary artery disease severity measurement
Ankylosing spondylitis
Ankylosing spondylitis (SNP x SNP interaction)
Hypertriglyceridemia
Peripheral arterial disease (traffic-related air pollution interaction)
Attention deficit hyperactivity disorder and obsessive compulsive disorder
"Facial morphology (factor 1, breadth of lateral portion of upper face)"
"Facial morphology (factor 10, width of nasal floor)"
"Facial morphology (factor 3, length of philtrum)"
"Facial morphology (factor 15, philtrum width)"
Facial morphology (factor 16)
"Facial morphology (factor 17, height of vermillion upper lip)"
Facial morphology (factor 18)
Facial morphology (factor 19)
Facial morphology (factor 20)
"Facial morphology (factor 2, vertical position of orbits relative to midface)"
"Facial morphology (factor 4, facial height related to vertical position of gnathion)"
"Facial morphology (factor 5, width of mouth relative to central midface)"
"Facial morphology (factor 6, height of vermillion lower lip)"
"Facial morphology (factor 7, width of cartilaginous portion of nose)"
"Facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion)"
"Facial morphology (factor 9, facial height related to vertical position of nasion)"
"Facial morphology (factor 11, projection of the nose)"
"Facial morphology (factor 12, vertical position of sublabial sulcus relative to central midface)"
"Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)"
"Facial morphology (factor 14, intercanthal width)"
"Facial morphology (factor 21, depth of nasal alae)"
Facial morphology (factor 22)
Facial morphology (factor 23)
Primary biliary cholangitis
Neurocognitive impairment in HIV-1 infection (continuous)
HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)
HIV-associated neurocognitive disorder (mild neurocognitive disorder)
HIV-associated neurocognitive disorder
Neurocognitive impairment in HIV-1 infection (dichotomous)
HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)
Alcohol consumption (drinks per week)
Alcohol consumption (drinkers vs non-drinkers)
Amyotrophic lateral sclerosis or schizophrenia (pleiotropy)
Body mass index (adult)
Endometriosis
Itch intensity from mosquito bite
Itch intensity from mosquito bite adjusted by bite size
Mosquito bite size
Perceived unattractiveness to mosquitoes
Energy expenditure (24h)
Resting metabolic rate
Rheumatic heart disease
Dehydroepiandrosterone sulphate levels
Glycated hemoglobin levels
Alanine transaminase levels
Serum albumin levels
Serum alkaline phosphatase levels
Aspartate aminotransferase levels
Creatinine levels
Gamma glutamyl transferase levels
Hemoglobin levels
C-reactive protein levels
Insulin-like growth factor 1 levels
Ferritin levels
Testosterone levels
Triglyceride levels
Urea levels
Glomerular filtration rate
Atrial fibrillation (SNPxSNP interaction)
Psychosis proneness (hypomanic personality scale)
Psychosis proneness (perceptual aberration scale)
Psychosis proneness (revised physical anhedonia scale)
Psychosis proneness (revised social anhedonia scale)
Psychosis proneness (hypomanic personality scale and perceptual aberration scale)
Psychosis proneness (schizoidia scale)
Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)
Psychosis proneness (hypomanic personality scale and revised social anhedonia scale)
Psychosis proneness (perceptual aberration scale and revised physical anhedonia scale)
Psychosis proneness (perceptual aberration scale and revised social anhedonia scale)
Psychosis proneness (revised physical anhedonia scale and revised social anhedonia scale)
"DDT metabolite (p,p'-DDE levels)"
Restricted and repetitive behaviours in autism spectrum disorder
Chronic periodontitis (mean interproximal clinical attachment level)
Breast cancer (estrogen-receptor positive)
Antisocial behavior
Graves' disease
Hashimoto thyroiditis
Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)
Anorexia nervosa (excluding migration to or from binge-eating disorder or bulimia nervosa)
Hepatocellular carcinoma in hepatitis C infection
Verbal memory performance (delayed recall level)
Verbal memory performance (residualized delayed recall change)
Verbal memory performance (immediate recall change)
Verbal memory performance (residualized delayed recall level)
Verbal memory performance (immediate recall level)
Verbal memory performance (delayed recall change)
Amyotrophic lateral sclerosis (sporadic)
IgG sialylation phenotypes (multivariate analysis)
IgG disialylation phenotypes (multivariate analysis)
IgG monosialylation phenotypes (multivariate analysis)
IgG fucosylation phenotypes (multivariate analysis)
IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)
IgG galactosylation phenotypes (multivariate analysis)
IgG monogalactosylation phenotypes (multivariate analysis)
IgG digalactosylation phenotypes (multivariate analysis)
IgG N-glycosylation phenotypes (multivariate analysis)
Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)
Spontaneous preterm birth (maternal effect)
BMI x dairy intake interaction (1df interaction test)
Insomnia complaints
Insomnia complaints (sex interaction)
Insomnia complaints (continuous)
Insomnia complaints (dichotomous)
Ease of getting up in the morning
Daytime nap
Snoring
Daytime sleepiness
Renal cell carcinoma
Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia
Knee osteoarthritis
Aggressive periodontitis
Hematocrit
Mean corpuscular hemoglobin concentration
Red blood cell count
Hemoglobin
Red cell distribution width
Mean corpuscular hemoglobin
Mean corpuscular volume
Prevalent type 2 diabetes
Obstetric antiphospholipid syndrome
Alcohol dependence
Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis
Chronic alcoholic pancreatitis or alcohol-related cirrhosis
Systemic sclerosis
White blood cell count
White blood cell count (basophil)
White blood cell count (eosinophil)
White blood cell count (lymphocyte)
White blood cell count (monocyte)
White blood cell count (neutrophil)
Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)
Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)
Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)
Nevirapine-induced hypersensitivity in HIV (rash)
Nevirapine-induced hypersensitivity in HIV
Sarcoidosis
Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)
Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 12 weeks)
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)
Autism spectrum disorder or schizophrenia
Elevated serum prostate-specific antigen levels in healthy men
Birth weight
Cannabis dependence
Tacrolimus trough concentration in kidney transplant patients
Chickenpox
Shingles
Cold sores
Mumps
Plantar warts
Bacterial meningitis
Yeast infection
Myringotomy
Measles
Hepatitis A
Rheumatic fever
Number of common colds
Chronic sinus infection
Urinary tract infection frequency
Childhood ear infection
Rubella
Mononucleosis
Hepatitis B
Strep throat
Scarlet fever
Pneumonia
Residual cognition
6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)
Tenofovir clearance in HIV infection (concomitant antiretroviral treatment interaction)
Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)
6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)
Tenofovir clearance in HIV infection
Bilirubin levels in tenofovir-treated HIV infection
Blood pressure traits (multi-trait analysis)
Subcutaneous adipose tissue adjusted for BMI
Total adipose tissue adjusted for BMI
Total adipose tissue
Psoriasis
Tissue factor pathway inhibitor levels
Barrett's esophagus
Esophageal adenocarcinoma
Barrett's esophagus or Esophageal adenocarcinoma
Acute graft versus host disease in bone marrow transplantation (recipient effect)
Acute graft versus host disease in bone marrow transplantation (donor effect)
Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy
Plasma trimethylamine N-oxide levels
HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes
Nasopharyngeal carcinoma
Schizophrenia (age at onset)
QT interval (ambient particulate matter interaction)
Alopecia areata
"Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)"
Serum sulfate level
Waist circumference
Weight
Lean body mass
Trunk fat mass
Waist-hip ratio
Hip circumference adjusted for BMI
Height
Body fat mass
Waist-to-hip ratio adjusted for BMI
Hip circumference
Resistance to antipsychotic treatment in schizophrenia
Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)
Severe gingival inflammation
Achilles tendinopathy
Anterior cruciate ligament rupture
Early onset atrial fibrillation
Type 1 diabetes
Appendicular lean mass
Blood pressure (parental or offspring effect)
Primary sclerosing cholangitis
"Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)"
QRS duration
Response to statins (HDL cholesterol change)
Neuropathy in taxane-treated breast cancer
Conotruncal heart defects (inherited effects)
Left ventricular obstructive tract defect (inherited effect)
Conotruncal heart defects (maternal effects)
Left ventricular obstructive tract defect (maternal effect)
Congenital heart disease (inherited effect)
Congenital heart disease (maternal effect)
Survival in pancreatic cancer
Alcoholic chronic pancreatitis
"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"
Bronchial hyperresponsiveness in asthma
Bone fracture in osteoporosis
Apolipoprotein A-IV levels
Modified Stumvoll Insulin Sensitivity Index (BMI interaction)
Modified Stumvoll Insulin Sensitivity Index
Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)
Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)
Methotrexate-induced interstitial lung disease in rheumatoid arthritis
Language performance in older adults (adjusted for episodic memory)
Spontaneous dizygotic twinning
Sporadic neuroblastoma
Cutaneous squamous cell carcinoma
Petaloid toenail
Iris color (b* coordinate)
Iris heterochromicity
Skin pigmentation
Iris color (L* coordinate)
Iris color (a* coordinate)
Change in LVEF in response to paclitaxel in HER2+ breast cancer
Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer
Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer
Alloimmunization response to pregnancy (HLA class I and II)
Alloimmunization response to pregnancy (HLA class I)
Alloimmunization response to pregnancy (HLA class II)
Alloimmunization response to pregnancy
Mood instability
Lobe attachment (rater-scored or self-reported)
Lobe attachment (rater scored)
Caudate volume in trauma-exposed individuals
Nucleus accumbens volume in trauma-exposed individuals
Pallidum volume in trauma-exposed individuals
Amygdala volume in trauma-exposed individuals
Hippocampal volume in trauma-exposed individuals
Putamen volume in trauma-exposed individuals
Lateral ventricle volume in trauma-exposed individuals
Thalamus volume in trauma-exposed individuals
P wave terminal force
P wave duration
Major depressive disorder
Low density lipoprotein cholesterol levels
High density lipoprotein cholesterol levels
Total cholesterol levels
Cardiometabolic and hematological traits
High altitude adaptation
Common carotid intima-media thickness in HIV negative individuals
Common carotid intima-media thickness in HIV infection
Common carotid intima-media thickness
Rubella-specific interferon-gamma secretion
Rubella-specific interleukin-6 secretion
Tanning
Atopic dermatitis
Peripheral artery disease
Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes
Coronary artery calcified atherosclerotic plaque score in type 2 diabetes
Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes
Cirrhosis (alcohol related)
Benign prostatic hyperplasia and/or lower urinary tract symptoms
Familial hepatitis B virus-related hepatocellular carcinoma
Foot ulcer in diabetes and neuropathy
Foot ulcer and neuropathy in diabetes
Blood metabolite levels
Early gestational weight gain (fetal effect)
Gestational weight gain (fetal effect)
Late gestational weight gain (fetal effect)
Early gestation weight gain (maternal effect)
Late gestational weight gain (maternal effect)
Gestational weight gain (maternal effect)
Lumbar spine bone mineral density or breast cancer (pleiotropy)
Femoral neck bone mineral density or breast cancer (pleiotropy)
Visceral adipose tissue (sex interaction)
Subcutaneous adipose tissue (sex interaction)
Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)
Visceral adipose tissue adjusted for BMI (sex interaction)
Cognitive ability
Cognitive ability (MTAG)
Duloxetine response in major depressive disorder (remitter/non-remitter status)
Duloxetine response in major depressive disorder (responder/non-responder status)
Placebo response in major depressive disorder (remitter/non-remitter status)
Placebo response in major depressive disorder (responder/non-responder status)
Duloxetine response in major depressive disorder (% change in symptom score)
Placebo response in major depressive disorder (% change in symptom score)
Progranulin levels
Core binding factor acute myeloid leukemia
Vitiligo
Thyroid stimulating hormone levels
Free thyroxine concentration
Branched-chain amino acid levels (Isoleucine)
Branched-chain amino acid levels (Leucine)
Branched-chain amino acid levels (Valine)
B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio
Midregional pro atrial natriuretic peptide levels
N-terminal pro B-type natriuretic peptide levels
B-type natriuretic peptide levels
Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy
Estradiol levels
Estrone levels
Spontaneous preterm birth (preterm birth)
Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)
Low vWF levels
Response to exercise (triglyceride level interaction)
Subjective response to lithium treatment
Subjective response to lithium treatment in bipolar disorder
Objective response to lithium treatment
Objective response to lithium treatment in bipolar disorder
"Response to radiotherapy in prostate cancer (toxicity, urinary frequency)"
Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)
Response to radiotherapy in prostate cancer (overall toxicity)
"Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)"
Parkinson's disease
Cleft palate
Interleukin-10 levels
Interleukin-6 levels
Interleukin-1-receptor antagonist levels
Response to ranibizumab in age-related macular degeneration (visual acuity)
Response to ranibizumab in age-related macular degeneration (additional treatment requirement)
Response to ranibizumab in age-related macular degeneration (dry maculae)
Kawasaki disease
Dupuytren's disease
Plasma kynurenine levels in major depressive disorder
Plasma kynurenine to tryptophan ratio in major depressive disorder
Recurrent major depressive disorder
Idiopathic inflammatory myopathy
Polymyositis
Dermatomyositis
Clinically amyopathic dermatomyositis
Insulin sensitivity index
Insulin levels
Insulin levels adjusted for BMI
Ratio of the area under the curve for insulin and the area under the curve for glucose
Area under the curve of insulin levels
Incremental insulin
Corrected insulin response
Corrected insulin response adjusted for insulin sensitivity index
Serum 25-Hydroxyvitamin D levels
Coffee consumption
Atazanavir levels
Luteinizing hormone levels in polycystic ovary syndrome
Follicle stimulating hormone levels in polycystic ovary syndrome
Sex hormone-binding globulin levels in polycystic ovary syndrome
Testosterone levels in polycystic ovary syndrome
DHEAS levels in polycystic ovary syndrome
Vitamin D levels (dietary vitamin D intake interaction)
Vitamin D levels
Taxane-induced peripheral neuropathy in breast cancer
B cell acute lymphoblastic leukaemia (normal cytogenetics)
B cell acute lymphoblastic leukaemia (hyperdiploid negative)
B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)
B cell acute lymphoblastic leukaemia (abnormal cytogenetics)
Acute lymphoblastic leukemia in childhood (B cell precursor)
B cell acute lymphoblastic leukaemia in young adulthood
B cell acute lymphoblastic leukaemia in adulthood
Acute lymphoblastic leukemia (B-cell precursor)
Acute lymphoblastic leukemia (childhood)
Thrombin-activatable fibrinolysis inhibitor levels
Thrombin-activatable fibrinolysis inhibitor activation peptide
Lumbar spondylosis (disc space narrowing)
Lumbar spondylosis (presence and severity of osteophytes)
Lumbar spondylosis (Kellgren-Lawrence grade)
Disease progression in age-related macular degeneration
Disease progression to geographic atrophy form in age-related macular degeneration
Disease progression to choroidal neovascularization form in age-related macular degeneration
Disease progression in age-related macular degeneration (adjusted for baseline)
Epstein-Barr virus copy number in lymphoblastoid cell lines
Circulating chemerin levels
Sarcoidosis (non-Lofgren's syndrome)
Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)
Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
Sarcoidosis (Lofgren's syndrome)
Obsessive-compulsive disorder or autism spectrum disorder
Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)
Drug-induced torsades de pointes
Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)
Personality traits in bipolar disorder
Intracranial aneurysm
Hyperopia
Myopia
Interferon alpha levels in systemic lupus erythematosus
Iron status biomarkers
Bipolar disorder (body mass index interaction)
Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)
Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)
Response to diuretic therapy in hypertension
Bone mineral density
Thyroid peroxidase antibody positivity
Plasma thyroid-stimulating hormone levels
Cervical artery dissection
Airway responsiveness in chronic obstructive pulmonary disease
IgA nephropathy
Asthma (childhood onset)
Pulmonary emphysema
Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)
Heparin-induced thrombocytopenia
Generalized epilepsy
Response to antipsychotic treatment
General cognitive ability
Breast cancer (menopausal hormone therapy interaction)
Lobular breast cancer (menopausal hormone therapy interaction)
PCA3 expression level
Cardiovascular event reduction in the elderly at risk for vascular disease (statin therapy interaction)
PR interval
Delayed encephalopathy in acute carbon monoxide poisoning
Chronic lymphocytic leukemia
Parent of origin effect on language impairment (paternal)
Parent of origin effect on language impairment (maternal)
Serum uric acid levels
Blood pressure
Blood pressure (age interaction)
Resting heart rate
Lung function (forced vital capacity)
Idiopathic pulmonary fibrosis
Fasting plasma glucose
Blood pressure (response to antihypertensive medication)
Blood pressure variability
Mammographic density (dense area)
Mammographic density (non-dense area)
Percent mammographic density
Epithelial ovarian cancer
Exudative age-related macular degeneration
Trans fatty acid levels
Motion sickness
Leprosy
Cognitive function
Lung cancer and family history of lung cancer
Behavioral disinhibition
Chronic obstructive pulmonary disease
Chronic bronchitis and chronic obstructive pulmonary disease
Chronic bronchitis in chronic obstructive pulmonary disease
Subcortical brain region volumes
Optic disc area
Optic cup area
Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)
Myeloid white cell count
Lymphocyte counts
Immature fraction of reticulocytes
Neutrophil count
Basophil percentage of white cells
Lymphocyte percentage of white cells
Neutrophil percentage of white cells
Basophil percentage of granulocytes
Mean platelet volume
Heart rate increase in response to exercise
Heart rate response to recovery post exercise (30 sec)
Heart rate response to recovery post exercise (40 sec)
Heart rate response to recovery post exercise (50 sec)
Heart rate response to recovery post exercise (10 sec)
Heart rate response to recovery post exercise (20 sec)
Open-angle glaucoma and optic cup area
Open-angle glaucoma and optic disc area
Open-angle glaucoma and vertical cup-disc ratio
Open-angle glaucoma and intra-ocular pressure
Femoral neck bone mineral density
Idiopathic dilated cardiomyopathy
Diffuse cutaneous systemic sclerosis
Limited cutaneous systemic scleroderma
Food allergy (parent-of-origin effect)
Peanut allergy (parent-of-origin effect)
Milk allergy (parent-of-origin effect)
Egg allergy (parent-of-origin effect)
Food allergy (maternal genetic effects)
Peanut allergy (maternal genetic effects)
Milk allergy (maternal genetic effects)
Egg allergy (maternal genetic effects)
Temporomandibular joint disorder
ACPA-negative rheumatoid arthritis (smoking interaction)
ACPA-positive rheumatoid arthritis (smoking interaction)
Alzheimer's disease
Alzheimer's disease (APOE e4 interaction)
Alzheimer's disease in APOE e4+ carriers
Alzheimer's disease in APOE e4- carriers
Gout vs. Hyperuricemia
Hyperuricemia
Sperm motility
Rheumatoid arthritis
Multiple keratinocyte cancers
Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)
Gallstone disease
Idiopathic osteonecrosis of the femoral head
Adverse response to chemotherapy (congestive heart failure) in breast cancer
Circulating chromogranin peptide levels
Trans-epidermal water loss
beta-nerve growth factor levels
Vascular endothelial growth factor levels
CTACK levels
Eotaxin levels
Fibroblast growth factor basic levels
Granulocyte-colony stimulating factor levels
Growth-regulated protein alpha levels
Hepatocyte growth factor levels
Interferon gamma levels
Interleukin-1-beta levels
Interleukin-2 levels
Interleukin-2 receptor antagonist levels
Interleukin-4 levels
Interleukin-5 levels
Interleukin-7 levels
Interleukin-8 levels
Interleukin-9 levels
Interleukin-13 levels
Interleukin-17 levels
Interleukin-18 levels
Macrophage Migration Inhibitory Factor levels
Interferon gamma-induced protein 10 levels
Interleukin-12p70 levels
Interleukin-16 levels
Monocyte chemoattractant protein-1 levels
Monocyte chemoattractant protein-3 levels
Macrophage colony stimulating factor levels
Monokine induced by gamma interferon levels
Macrophage inflammatory protein 1a levels
Macrophage inflammatory protein 1b levels
Platelet-derived growth factor BB levels
RANTES levels
Stem cell factor levels
Stem cell growth factor beta levels
Stromal-cell-derived factor 1 alpha levels
Tumor necrosis factor alpha levels
Tumor necrosis factor beta levels
TRAIL levels
Multiple system atrophy (pathologically confirmed)
Ovarian disease with few adhesions
Deep ovarian and/or rectovaginal disease with dense adhesions
Alcohol dependence symptom count
Alcohol consumption (max-drinks)
Response to alcohol consumption (flushing response)
Theory of mind score in adolescence (Emotional Triangles Task)
Fasting blood insulin
Fasting blood glucose
Fasting blood insulin adjusted for BMI
Very low density lipoprotein cholesterol levels
Homeostasis model assessment of insulin resistance
Homeostasis model assessment of insulin resistance adjusted for BMI
Drug-induced liver injury (terbinafine)
Drug-induced hepatocellular liver injury
Drug-induced liver injury (statins)
Drug-induced cholestatic/mixed liver injury
Drug-induced liver injury (nitrofurantoin)
Drug-induced liver injury (diclofenac)
Drug-induced liver injury (anti-tuberculosis drugs)
Drug-induced liver injury (fluoroquinolones)
Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)
Drug-induced liver injury
Vertical cup-disc ratio
Intraocular pressure
Melanoma
"Caffeine metabolism (plasma 1,3,7-trimethyluric acid level)"
"Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)"
"Caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level)"
"Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)"
"Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)"
"Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)"
Thiopurine S-methyltransferase activity
Venous thromboembolism adjusted for sickle cell variant rs77121243-T
Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes
Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes
Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes
Kidney disease (early and late stages) in type 1 diabetes
Kidney disease (early stage) in type 1 diabetes
Kidney disease (late stage) in type 1 diabetes
Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes
Hepatitis B (viral clearance)
Central corneal thickness
Otitis media
Otitis media (chronic)
Otitis media (recurrent)
L-arginine levels
QRS complex (12-leadsum)
QRS complex (Cornell)
QRS complex (Sokolow-Lyon)
Carotenoid levels (cryptoxanthin)
Carotenoid levels (alpha-carotene)
Vitamin E levels (alpha-tocopherol)
Carotenoid levels (beta-carotene)
Carotenoid levels (lutein)
Carotenoid levels (zeaxanthin)
Vitamin E levels (gamma-tocopherol)
Retinol levels
Hepcidin/transferrin saturation ratio
Hepcidin/ferritin ratio
Hepcidin levels
Acute-on-chronic liver failure in hepatitis B
Thyroid cancer
Self-reported tiredness
Hippocampal volume
Response to platinum-based neoadjuvant chemotherapy in cervical cancer
Agoraphobic traits
Essential tremor
Brain activation in response to working memory task
Resistin levels
Attention function
Emotional dysregulation
Lung function (FEV1)
Lung function (FVC)
Lung function (FEV1/FVC)
Nonsyndromic cleft lip with or without cleft palate
HIV progression (CD4 and viral load)
Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative)
Protein C levels
Bronchiolitis
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications
Basal cell carcinoma
Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)
Emphysema distribution in smoking
Urinary albumin-to-creatinine ratio
Daytime sleep phenotypes
Night sleep phenotypes
Methadone dose in opioid dependence
Survival in breast cancer (TP53 expression interaction)
Survival in TP53 positive breast cancer
Plasma t-tau levels
Takotsubo syndrome
Pediatric areal bone mineral density (radius)
Pediatric bone mineral density (spine)
Pediatric bone mineral content (femoral neck)
Pediatric bone mineral density (femoral neck)
Pediatric bone mineral density (hip)
Pediatric bone mineral content (radius)
Pediatric bone mineral content (spine)
Pediatric bone mineral content (hip)
Serum galactose-deficient IgA1 levels
Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)
Neuritic plaques or neurofibrillary tangles (pleiotropy)
Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)
Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)
Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)
Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)
Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)
Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)
Systolic blood pressure x smoking status (ever vs never) interaction (2df test)
Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)
Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)
Systolic blood pressure x smoking status (ever vs never) interaction (1df test)
Systolic blood pressure (cigarette smoking interaction)
Diastolic blood pressure (cigarette smoking interaction)
"B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)"
Lung function (maximal voluntary ventilation)
Lung function (forced expiratory volume in 1 second)
Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)
Pulmonary arterial hypertension
Primary vesicoureteric reflux
Insulin levels in response to oral glucose tolerance test (fasting)
Glucagon levels in response to oral glucose tolerance test (fasting)
GIP levels in response to oral glucose tolerance test (fasting)
GLP-1 levels in response to oral glucose tolerance test (fasting)
Insulin levels in response to oral glucose tolerance test (30 minutes)
Insulin levels in response to oral glucose tolerance test (120 minutes)
GLP-1 levels in response to oral glucose tolerance test (120 minutes)
GIP levels in response to oral glucose tolerance test (120 minutes)
Glucagon levels in response to oral glucose tolerance test (120 minutes)
Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)
Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)
Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)
Small vessel stroke
Blood osmolality (transformed sodium)
Fuchs's corneal dystrophy
Urinary magnesium-to-creatinine ratio
Fractional excretion of magnesium
Serum magnesium levels
NHDL cholesterol to HDL cholesterol ratio
LDL cholesterol to HDL cholesterol ratio
Triglyceride to HDL cholesterol ratio
Body mass index x sex interaction
Body mass index x sex x age interaction (4df test)
Body mass index (age>50)
Body mass index (age <50)
Body mass index x age interaction
Body mass index x sex x age interaction
Waist-to-hip ratio adjusted for BMI (age <50)
Waist-to-hip ratio adjusted for BMI (age >50)
Waist-to-hip ratio adjusted for BMI x sex interaction
Waist-to-hip ratio adjusted for BMI x sex x age interaction
Waist-to-hip ratio adjusted for BMI x age interaction
Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease
Major coronary event in placebo-treated cardiovascular disease (time to event)
Diarrhoea in darapladib-treated cardiovascular disease (time to event)
Myocardial infarction in darapladib-treated cardiovascular disease (time to event)
Myocardial infarction in placebo-treated cardiovascular disease (time to event)
Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)
Odor events in darapladib-treated cardiovascular disease (time to event)
Major coronary event in darapladib-treated cardiovascular disease (time to event)
Lipoprotein phospholipase A2 activity in cardiovascular disease
Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)
Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)
Alzheimer's disease (age of onset)
Orofacial clefts (cleft lip vs. cleft lip and palate)
Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy
Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy
Breast cancer in childhood cancer survivors
Complex regional pain syndrome
Frontotemporal dementia (age at onset)
Post traumatic stress disorder symptom count in trauma-exposed individuals
Monoclonal gammopathy of undetermined significance
Adolescent idiopathic scoliosis
Osteoarthritis (with total hip replacement)
"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)"
Body fat percentage
Urate levels
Whole body bone mineral density and alcohol drinking
Hip bone mineral density and alcohol drinking
Spine bone mineral density and alcohol drinking
Gut microbiota (functional units)
Gut microbiota (bacterial taxa)
QT interval (tricyclic/tetracyclic antidepressant use interaction)
RR interval (tricyclic/tetracyclic antidepressant use interaction)
Exhaled nitric oxide output
Exhaled nitric oxide levels
Systolic blood pressure change trajectory
Response to clopidogrel therapy in coronary heart disease
Venous thromboembolism
Early-onset Parkinson's disease
Opioid dependence
Chronic venous disease
Metabolic syndrome
LDL cholesterol levels
Vitamin B12 levels
Low-grade serous and serous borderline ovarian cancer
Ovarian cancer in BRCA2 mutation carriers
Ovarian clear cell cancer
Endometrioid ovarian cancer
Serous invasive ovarian cancer
Serous borderline ovarian cancer
High-grade serous ovarian cancer
Low-grade serous ovarian cancer
Ovarian cancer in BRCA1 mutation carriers
Invasive epithelial ovarian cancer
Type 2 diabetes (age of onset)
Alcohol misuse (trauma interaction)
Adult onset asthma (smoking interaction)
Adult onset asthma in non-smokers
Adult onset asthma in ever-smokers
Childhood onset asthma (traffic air pollution exposure interaction)
Glioma
Non-glioblastoma glioma
Glioblastoma
Iron status biomarkers (ferritin levels)
Iron status biomarkers (iron levels)
Iron status biomarkers (total iron binding capacity)
Iron status biomarkers (transferrin saturation)
Heart rate response to beta blockers (atenolol monotherapy)
Heart rate response to beta blockers (atenolol add-on therapy)
Heart rate response to beta blockers
Subclinical trait of interstitial lung disease (basilar percentage of high attenuation areas on CT scan)
Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan)
Subclinical trait of interstitial lung disease (percentage of high attenuation areas on CT scan)
Rheumatoid arthritis (ACPA-positive)
Hip bone size
Hip bone size adjusted for BMI
Fasting blood glucose adjusted for BMI
Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)
Attention deficit hyperactivity disorder (sex interaction)
Sex difference in attention deficit hyperactivity disorder
Attention deficit hyperactivity disorder
Crohn's disease
Ulcerative colitis
Inflammatory bowel disease
Large artery stroke
Response to dendritic cell-based immunotherapy in HIV infection
Vasculitis associated with antineutrophil cytoplasmic antibody reactive to myeloperoxidase
Vasculitis associated with antineutrophil cytoplasmic antibody reactive to proteinase-3
Antineutrophil cytoplasmic antibody-associated vasculitis
Adiponectin levels in pregnancy
Response to paliperidone in schizophrenia (positive Marder score)
Response to paliperidone in schizophrenia (negative Marder score)
Response to paliperidone in schizophrenia (PANSS score)
Response to paliperidone in schizophrenia (Multivariate)
Response to paliperidone in schizophrenia (CGI-S score)
"Urinary 1,3-butadiene metabolite levels in smokers"
Breast size
Hypothyroidism
Chin dimples
Allergy
Photic sneeze reflex
Menarche (age at onset)
Age at voice drop
Monobrow
Joint mobility (Beighton score)
Nose size
Male-pattern baldness
Educational attainment (years of education)
Educational attainment (college completion)
Glomerular load of uric acid
Uric acid clearance
Fractional excretion of uric acid
Creatinine clearance
Urinary uric acid to urinary creatinine ratio
Resistance to antihypertensive treatment in hypertension
Phlegm
Dyspnea
Cough
Age-related diseases and mortality
"Age-related diseases, mortality and associated endophenotypes"
Age-related disease endophenotypes
Carotid plaque burden
Sepsis in extremely premature infants
Prostate-specific antigen levels
Prostate-specific antigen levels (conditioned on lead SNPs)
Gut microbiota (beta diversity)
Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)
Lung function (FEV1) in asthma (dust mite allergen exposure interaction)
Depressive symptoms (stressful life events interaction)
Immune response to measles vaccine (measles-specific neutralising antibody titre)
Immune response to measles vaccine (measles-induced IFN gamma)
Orofacial clefts
Cleft lip with or without cleft palate
Liver injury in anti-retroviral drug treated HIV
Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis
Paneth cell defects in Crohn's disease
Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib
Nicotine metabolite ratio
Pre-treatment pain in head and neck squamous cell carcinoma
HDL cholesterol levels
Liver injury in anti-tuberculosis drug treatment
Antithyroid drug-induced agranulocytosis
Clopidogrel active metabolite levels
Response to clopidogrel therapy
Gallbladder cancer
Rectal cancer
Colon cancer
Systolic blood pressure (long-term average)
Diastolic blood pressure (long-term average)
Pulse pressure (long-term average)
Mean arterial pressure (long-term average)
High-altitude pulmonary edema
Loneliness (multivariate analysis)
Loneliness
Loneliness (linear analysis)
Presence of antiphospholipid antibodies
Palmitoleic acid (16:1n-7) levels
Vaccenic acid (18:1n-7) levels
Oleic acid (18:1n-9) levels
Gondoic acid (20:1n-9) levels
Erucic acid (22:1n-9) levels
Nervonic acid (24:1n-9) levels
Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder
Peak velocity of the mitral E-wave
Isovolumetric relaxation time
Peak velocity of excursion of lateral mitral annulus in early diastolic phase
Peak velocity of the mitral A-wave
Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.
Deceleration time of the mitral E-wave
Ratio of the peak velocity of the excursion of the lateral mitral annulus in the early diastolic phase and the peak velocity of the mitral E-wave
Diastolic dysfunction with preserved ejection pressure
Heart failure with preserved ejection fraction
Aortic root size
Left atrial antero-posterior diameter
Left ventricle diastolic internal dimension
Left ventricle wall thickness
Left ventricular mass
Left ventricular fractional shortening
Left ventricle systolic dysfunction
Smoking interaction in non-small cell lung cancer (1df test)
Smoking interaction in lung adenocarcinoma (1df test)
Smoking interaction in squamous cell lung cancer (1df test)
Cow's milk allergy
Food allergy
Hen's egg allergy
Major depression and alcohol dependence
Eosinophil percentage of white cells
Eosinophil counts
Plateletcrit
Granulocyte percentage of myeloid white cells
Monocyte percentage of white cells
High light scatter reticulocyte count
Sum neutrophil eosinophil counts
Granulocyte count
High light scatter reticulocyte percentage of red cells
Hemoglobin concentration
Platelet distribution width
Eosinophil percentage of granulocytes
Reticulocyte fraction of red cells
Sum basophil neutrophil counts
Reticulocyte count
Neutrophil percentage of granulocytes
Sum eosinophil basophil counts
Breast Cancer in BRCA1 mutation carriers
Obstructive sleep apnea trait (apnea hypopnea index)
Obstructive sleep apnea during non-REM sleep (apnea hypopnea index)
Obstructive sleep apnea during REM sleep (apnea hypopnea index)
Problematic alcohol use in trauma-exposed individuals
Alcohol consumption over the past year
Pursuit maintenance gain in psychotic disorders
Initial pursuit acceleration
Pursuit maintenance gain
Anti-saccade response
Initial pursuit acceleration in psychotic disorders
Anti-saccade error rate in psychotic disorders
White coat effect (clinic systolic blood pressure minus home systolic blood pressure)
White coat effect (clinic diastolic blood pressure minus home diastolic blood pressure)
Diastolic blood pressure x sodium interaction (1df test)
Systolic blood pressure x sodium interaction (2df test)
Diastolic blood pressure x sodium interaction (2df test)
Mean arterial pressure x sodium interaction (2df test)
Systolic blood pressure x sodium interaction (1df test)
Mean arterial pressure x sodium interaction (1df test)
Pulse pressure x sodium interaction (1df test)
Pulse pressure x sodium interaction (2df test)
Schizophrenia (MTAG)
Osteoporosis-related phenotypes (MTAG)
Reading disability
Leukocyte telomere length
Behcet's disease
Allergic rhinitis
Eczema
Hay fever and/or eczema
Nicotine dependence symptom count
Lean mass index
Urinary calcium excretion
Urinary magnesium excretion
Urinary uric acid excretion
Urinary volume
Conjunctival UV autofluorescence (CUVAF)
Serum metabolite levels
Schizophrenia or schizoaffective disorder
Serum alpha-fetoprotein levels
Serum carcinoembryonic antigen levels
Serum cancer antigen 15.3 levels
Serum cancer antigen 19.9 levels
Serum cancer antigen 125 levels
Opioid dependence in opioid exposure
Opioid exposure
Basophil count
Follicle stimulating hormone levels
Follicle stimulating hormone in healthy women
Luteinizing hormone levels in healthy women
Luteinizing hormone levels
Spontaneous adipocyte lipolysis
Stimulated adipocyte lipolysis
Aortic valve stenosis
Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia
DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia
DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia
Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia
Modic changes
Thiopurine-induced myelosuppression in inflammatory bowel disease
Cortical thickness
Cortical surface area
Autism and major depressive disorder (MTAG)
Autism and schizophrenia (MTAG)
Autism and educational attainment (MTAG)
Attention deficit hyperactivity disorder or hippocampal volume (pleiotropy)
Attention deficit hyperactivity disorder or nucleus accumbens volume (pleiotropy)
Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)
Intracranial volume
Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)
Attention deficit hyperactivity disorder or putamen volume (pleiotropy)
Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)
Attention deficit hyperactivity disorder or pallidum volume (pleiotropy)
Attention deficit hyperactivity disorder or thalamus volume (pleiotropy)
Serum urea levels
Thyroxine levels
Triiodothyronine levels
Triiodothyronine/thyroxine ratio
Estimated glomerular filtration rate in coronary artery disease and impaired kidney function
Circulating odd-numbered chain saturated fatty acid levels (C15:0)
Circulating odd-numbered chain saturated fatty acid levels (C17:0)
Circulating odd-numbered chain saturated fatty acid levels (C15:0+C17:0)
Circulating odd-numbered chain saturated fatty acid levels (C19:0)
Circulating odd-numbered chain saturated fatty acid levels (C23:0)
Cerebrospinal fluid beta-site APP cleaving enzyme levels
White matter integrity (fractional anisotropy)
White matter integrity (mean diffusivity)
White matter hyperintensity volume
Meningioma
Executive function in ADHD
Rosacea symptom severity
"Obstructive sleep apnea trait (apnea hypopnea index, change over time)"
Thyroid autoantibody positivity (anti-thyroglobulin (TgAb) and/or anti-thyroid peroxidase (TPOAb) levels)
Spherical equivalent
Myopia (age of diagnosis)
Spherical equivalent or myopia (age of diagnosis)
Dietary macronutrient intake
Nephrolithiasis
Elevated fasting plasma glucose
Ewing sarcoma
Alzheimer's disease (onset at age over 80)
Alzheimer's disease (onset between ages 58 and 79)
Huntington's disease (age at onset)
Plasma neurofilament light levels
Current cigarettes per day in chronic obstructive pulmonary disease
Lactose tolerance test
Behavioural changes in frontotemporal lobe dementia
Frontotemporal dementia with GRN mutation
Frontotemporal dementia with GRN mutation (age at onset)
Memory dysfunction in frontotemporal lobe dementia
Language impairment in frontotemporal lobe dementia
Parkinsonism in frontotemporal lobe dementia
End stage renal disease x APOL1 genotype interaction
End stage renal disease in APOL1 risk genotype-negative individuals
End stage renal disease in APOL1 risk genotype-positive individuals
End-stage renal disease
High bone mineral density
Coronary artery disease in diabetes
Cannabis use (age at onset)
Lung cancer x radon exposure interaction (1df)
Hepatitis B surface antigen seroclearance in chronic hepatitis B infection
Anti-chlamydia trachomatis IgG seropositivity
Type 1 diabetes in high risk HLA genotype individuals (time to event)
Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)
Serum folate levels
Cleft lip with or without cleft palate x maternal periconceptional alcohol use interaction (parent of origin effect)
Cleft lip with or without cleft palate x maternal periconceptional smoking interaction (parent of origin effect)
Cleft lip with or without cleft palate x maternal periconceptional vitamin use interaction (parent of origin effect)
Self-reported risk-taking behaviour
Nucleus accumbens volume
Amygdala volume
Brainstem volume
Caudate nucleus volume
Pallidum volume
Putamen volume
Thalamus volume
Circulating leptin levels or fasting insulin levels
Circulating leptin levels or HOMA-B
Circulating leptin levels or HOMA-IR
Circulating leptin levels or type 2 diabetes
Trunk fat mass adjusted for trunk lean mass
Femoral neck bone mineral density and trunk fat mass adjusted by trunk lean mass
Narcolepsy with cataplexy
Levodopa wearing off effect (time symptoms uncontrolled) in Parkinson's disease (response to zonisamide)
Levodopa wearing off effect (motor symptom score change) in Parkinson's disease (response to zonisamide)
Vascular endothelial growth factor levels in major depressive disorder
COVID-19 (critical illness vs population)
QT interval
JT interval
Lifetime anxiety disorder
Anxiety symptoms
Non-del(5q) myelodysplastic syndromes
Stroke and BMI (pleiotropy)
Blood protein levels in cardiovascular risk
Parkinson's disease in GBA mutation carriers
Parkinson's disease in GBA mutation carriers (age at onset)
Low tan response
Neuromyelitis optica
Neuromyelitis optica (AQP4-IgG-positive)
Neuromyelitis optica (AQP4-IgG-negative)
Opioid dependence x sex interaction
Optic nerve head parameters (multi-trait analysis)
Intraocular pressure and central corneal thickness (multi-trait analysis)
Optic disc size
Cognitive decline (age-related)
Depressed affect
Worry
Dysmenorrheic pain severity
Menstruation quality of life impact (dysmenorrhea)
Pain medicine use during menstruation
Menstruation quality of life impact (fever)
Heavy vaginal discharge
Menstruation quality of life impact (acne)
Menstruation quality of life impact (aggressiveness)
Menstruation quality of life impact (increased appetite)
Menstruation quality of life impact (bowel movement)
Menstruation quality of life impact (depression)
Menstruation quality of life impact (edema)
Menstruation quality of life impact (headache)
Menstruation quality of life impact (joint pain)
Menstruation quality of life impact (loss of concentration)
Menstruation quality of life impact (nervousness)
Menstruation quality of life impact (pressure in breast)
Menstruation quality of life impact (sleepiness)
Menstruation quality of life impact (stiff neck)
Vaginal discharge (itching)
Vaginal discharge (metrorrhagia)
Vaginal discharge (smell)
Exacerbations requiring hospitalisation in asthma
Café-au-lait macule number in neurofibromatosis type1
Mucinous adenocarcinoma in colorectal cancer
Cerebrospinal fluid α-synuclein levels
Prostate cancer aggressiveness (high vs low)
Prostate cancer aggressiveness (high vs low/intermediate)
Prostate cancer (advanced vs non-advanced)
Prostate cancer (advanced)
Prostate cancer (early onset)
Prostate cancer (Gleason score)
Non-small cell lung cancer in heavy smokers
Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease
Chronic pain or major depressive disorder (pleiotropy)
Uric acid levels
Blood urea nitrogen levels
Disease free survival in colon cancer
Survival in colon cancer
Anhedonia
Systolic blood pressure night-to-day ratio in hypertension
Diastolic blood pressure night-to-day ratio in hypertension
Penicillin allergy
Freckles
Double-edged eyelids
Thick vs thin eyebrows
Straight vs curly hair
Excessive hairiness
Excessive sweating
Age spots
Childhood onset systemic lupus erythematosus
Longitudinal brain connectivity change (Louvain modularity)
Longitudinal brain connectivity change (transitivity)
Longitudinal brain connectivity change (global efficiency)
Longitudinal brain connectivity change (characteristic path length)
Blood pressure x alcohol consumption interaction
Refractory celiac disease type II
Clinical remission in asthma
Complete remission in asthma
Spontaneous coronary artery dissection
Glycemic traits (multi-trait analysis)
Short-term memory (digit-span task)
Short-term memory (visuospatial task)
Short-term memory (shared component of digit-span and visuospatial tasks)
Long-term memory (delayed word recall task)
Uterine fibroids
Uterine fibroids (MTAG)
Endometriosis (MTAG)
Ovarian cancer
Ovarian cancer (MTAG)
Endometrial cancer (MTAG)
Gynecologic disease
Cervical cancer (MTAG)
Gynecologic disease (multivariate analysis)
Maximum cranial length
Cephalic index
Maximum cranial width
Drug-induced liver injury in interferon-beta-treated multiple sclerosis
Diabetic macular edema in type 2 diabetes
Proliferative diabetic retinopathy in type 2 diabetes
Apolipoprotein B levels
Apolipoprotein A1 levels
Leisure sedentary behaviour (television watching)
Leisure sedentary behaviour (computer use)
Driving (hours per day)
Head and neck squamous cell carcinoma
Eye color (saturation)
Eye color
Hair color
Eye color (brightness)
Eye color (hue)
"Skin, hair and eye pigmentation (multivariate analysis)"
Nonunion in individuals with fractures
Inflammatory biomarkers
Severe aplastic anemia
Acute respiratory distress syndrome in sepsis
Midgestational total 25-hydroxyvitamin D levels (maternal genetic effect)
Neonatal total 25-hydroxyvitamin D levels (maternal genetic effect)
Midgestational total 25-hydroxyvitamin D levels (fetal genetic effect)
Neonatal total 25-hydroxyvitamin D levels (fetal genetic effect)
Non-small cell lung cancer
Hepatocellular carcinoma in hepatitis B infection
Chronic kidney disease
Infective endocarditis in Staphylococcus aureus infection
Blood glucose levels
Bipolar disorder or major depressive disorder
Serum total polyunsaturated fatty acid concentration in metabolic syndrome
Serum omega-3 polyunsaturated fatty acid concentration in metabolic syndrome
Serum omega-6 polyunsaturated fatty acid concentration in metabolic syndrome
Serum docosahexaenoic fatty acid concentration in metabolic syndrome
Serum linoleic acid concentration in metabolic syndrome
Serum omega-6 to omega-3 polyunsaturated fatty acid ratio in metabolic syndrome
Serum polyunsaturated fatty acid concentration x sex interaction in metabolic syndrome
Serum polyunsaturated fatty acid concentration x Mediterranean diet adherence interaction in metabolic syndrome
Multiple myeloma
Renal complication in type 2 diabetes
Cerebrospinal fluid neurofilament light levels
Opioid use disorder
Green tea consumption
Milk consumption
Yoghurt consumption
Cheese consumption
Natto consumption
Tofu consumption
Fish intake frequency
Small whole fish consumption
Vegetable consumption
Meat consumption
Estimated glomerular filtration rate
Serum creatinine levels
Basal ganglia growth
White matter growth
Cerebellum growth
Cerebral cortical growth
Right lateral prefrontal cortical growth
Cryptosporidiosis
Memory decline
Response to statins (LDL cholesterol percent change)
Low density lipoprotein cholesterol levels (on statin treatment)
Response to statins (LDL cholesterol change)
Airflow obstruction in ever smokers
Age at loss of ambulation in Duchenne muscular dystrophy
Childhood steroid-sensitive nephrotic syndrome
Dermatomyositis or juvenile dermatomyositis
Red blood cell traits (multivariate analysis)
Death
Coronary heart disease
Diabetes mellitus
Heart failure
Cortical surface area (visual PC2)
Cortical thickness (PC1)
Cortical thickness (PC2)
Cortical surface area (global PC1)
Bone mineral density (hip) and hip bone size
Buruli ulcer
Buruli ulcer (age at onset)
Retinal detachment
Retinal detachment or retinal break
Retinal detachment with retinal break
High myopia
Cataracts (operation)
COVID-19 (very severe respiratory confirmed vs not hospitalized) RELEASE 4
COVID-19 (RELEASE 5)
COVID-19 (very severe respiratory confirmed vs population) RELEASE 3
COVID-19 (hospitalized vs not hospitalized) RELEASE 3
COVID-19 (hospitalized vs population) RELEASE 3
COVID-19 (covid vs lab/self reported negative) RELEASE 3
COVID-19 (RELEASE 3)
COVID-19 (predicted from self-reported symptoms vs predicted or self-reported non-covid) RELEASE 3
COVID-19 (very severe respiratory confirmed vs population) RELEASE 5
COVID-19 (hospitalized vs not hospitalized) RELEASE 5
COVID-19 (hospitalized vs population) RELEASE 5
COVID-19 (RELEASE 4)
COVID-19 (very severe respiratory confirmed vs population) RELEASE 4
COVID-19 (hospitalized covid vs not hospitalized) RELEASE 4
COVID-19 (predicted covid from self-reported symptoms vs predicted or self-reported non-covid) RELEASE 4
Cotinine and 3'-hydroxycotinine levels in current smokers
Cotinine levels in current smokers
Smoking behaviour (cigarette pack-years)
Smoking intensity (cotinine levels/cigarettes per day)
Neuritic plaque
Neurofibrillary tangles
Diffuse plaques
Cerebral amyloid angiopathy
Microscopic brain infarct
Macroscopic brain infarct
Dementia with Lewy bodies
Neuropathologic traits (pleiotropy)
Lung function (FVC) in asthma
Lung function (FEV1/FVC) in asthma
Post-bronchodilator lung function in asthma (FEV1)
Post-bronchodilator lung function in asthma (FVC)
Post-bronchodilator lung function in asthma (FEV1/FVC)
Lung function (FEV1) in asthma
Central retinal vein equivalent
Central retinal arteriolar equivalent
Hallucinations in long-term cannabis use
Severe malarial anemia in Plasmodium falciparum infection
C-peptide levels
NASH resolution in nonalcoholic steatohepatitis
Pruritus in nonalcoholic steatohepatitis
Fibrosis improvement in nonalcoholic steatohepatitis
Uric acid elevation in response to thiazide-like diuretic in hypertension
Brain region volumes
Serum sclerostin levels
Serum metabolite levels (CMS)
Change in serum metabolite levels
Change in serum metabolite levels (CMS)
Testosterone levels x fluid intelligence interaction
Testosterone levels x alcohol consumption (drinks per week) interaction
Testosterone levels x smoking behaviour (cigarettes smoked per day) interaction
Bioavailable testosterone levels x smoking behaviour (cigarettes smoked per day) interaction
Bioavailable testosterone levels x alcohol consumption (drinks per week) interaction
Bioavailable testosterone levels x fluid intelligence interaction
Estradiol levels x smoking behaviour (cigarettes smoked per day) interaction
Estradiol levels x alcohol consumption (drinks per week) interaction
Estradiol levels x fluid intelligence interaction
Sex hormone-binding globulin levels x smoking behaviour (cigarettes smoked per day) interaction
Sex hormone-binding globulin levels x alcohol consumption (drinks per week) interaction
Sex hormone-binding globulin levels x fluid intelligence interaction
Nucleoside diphosphate kinase A levels in hepatocellular carcinoma
Bipolar disorder or intelligence (pleiotropy)
Schizophrenia or intelligence (pleiotropy)
Asthma x air pollution interaction (2df)
Asthma x Hispanic interaction (2df)
LDL cholesterol levels x loop diuretics use interaction
Triglyceride levels x loop diuretics use interaction
HDL cholesterol levels x thiazide or thiazide-like diuretics use interaction
LDL cholesterol levels x thiazide or thiazide-like diuretics use interaction
Triglyceride levels x thiazide or thiazide-like diuretics use interaction
HDL cholesterol levels x loop diuretics use interaction
Impaired insulin sensitivity in response to n-3 PUFA supplementation
Protein level change in low calorie diet obesity intervention
Protein levels in obesity
Complement factor H binding to malondialdehyde
Cutaneous malignant melanoma
Cutaneous melanoma or hair colour
Nevus count or cutaneous melanoma
Youthful appearance (self-reported)
Neuroblastoma or malignant cutaneous melanoma
COVID-19 (hospitalized vs population) RELEASE 4
COVID-19 (covid vs lab/self reported negative) RELEASE 4
Scavenger receptor cysteine-rich type 1 protein M130 levels
Complement component C1q receptor levels
Cadherin-5 levels
Chitinase-3-like protein 1 levels
Chitotriosidase-1 levels
Contactin-1 levels
Collagen alpha-1 (I) chain levels
Carboxypeptidase A1 levels
Carboxypeptidase B levels
Cystatin-B levels
Cathepsin D levels
Cathepsin Z levels
C-X-C motif chemokine 16 levels
Protein delta homolog 1 levels
Epidermal growth factor levels
epithelial cell adhesion molecule levels
Ephrin type-B receptor 4 levels
"Fatty acid-binding protein, adipocyte levels"
Tumor necrosis factor receptor superfamily member 6 levels
Galectin-3 levels
Galectin-4 levels
Granulins levels
Intercellular adhesion molecule 2 levels
Insulin-like growth factor-binding protein 1 levels
Insulin-like growth factor-binding protein 2 levels
Insulin-like growth factor-binding protein 7 levels
Interleukin-17 receptor A levels
Interleukin-18-binding protein levels
Interleukin-1 receptor type 1 levels
Interleukin-1 receptor type 2 levels
Interleukin-2 receptor subunit alpha levels
Interleukin-6 receptor subunit alpha levels
Integrin beta-2 levels
Junctional adhesion molecule A levels
Kallikrein-6 levels
Low-density lipoprotein receptor levels
Lymphotoxin-beta receptor levels
Myoglobin levels
Matrix extracellular phosphoglycoprotein levels
Matrix metalloproteinase-2 levels
Matrix metalloproteinase-3 levels
Matrix metalloproteinase-9 levels
Myeloperoxidase levels
Neurogenic locus notch homolog protein 3 levels
Osteoprotegerin levels
Osteopontin levels
Plasminogen activator inhibitor-1 (PAI-1) levels
Proprotein convertase subtilisin/kexin type 9 levels
Platelet-derived growth factor subunit A levels
Glucagon levels in response to oral glucose tolerance test (decremental area under the curve for 0-30 minutes)
Glucagon levels in response to oral glucose tolerance test (decremental area under the curve for 0-120 minutes)
Glucagon levels in response to oral glucose tolerance test (30 minutes)
C-type lectin domain family 5 member A levels
CXADR-like membrane protein levels
Calsyntenin-2 levels
Clusterin-like protein 1 levels
Catechol O-methyltransferase levels
Crk-like protein levels
Pro-cathepsin H levels
Cathepsin O levels
Aromatic-L-amino-acid decarboxylase levels
Dipeptidyl peptidase 2 levels
Gamma-enolase levels
Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 levels
Ectonucleoside triphosphate diphosphohydrolase 5 levels
Protein FAM3C levels
"Fructose-1,6-bisphosphatase 1 levels"
Fc receptor-like protein 1 levels
Peptidyl-prolyl cis-trans isomerase FKBP4 levels
Galanin peptide levels
Glutaredoxin-1 levels
GRB2-related adapter protein 2 levels
Insulin-like growth factor-binding protein-like 1 levels
Integrin beta-7 levels
Kallikrein-10 levels
Kynurenine-oxoglutarate transaminase 1 levels
Leukocyte immunoglobulin-like receptor subfamily A member 5 levels
Leucine-rich repeats and immunoglobulin-like domains protein 1 levels
Low-density lipoprotein receptor-related protein 11 levels
Multiple coagulation factor deficiency protein 2 levels
Meprin A subunit beta levels
Meteorin-like protein levels
NAD kinase levels
Nectin-2 levels
Nodal modulator 1 levels
Neural proliferation differentiation and control protein 1 levels
Neuronal pentraxin receptor levels
Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 levels
Paired immunoglobulin-like type 2 receptor beta levels
Protein phosphatase inhibitor 2 levels
Dihydropteridine reductase levels
Regenerating islet-derived protein 4 levels
Eosinophil cationic protein levels
Inactive tyrosine-protein kinase transmembrane receptor ROR1 levels
Reticulon-4 receptor levels
Protein S100-A12 levels
Syndecan-4 levels
Semaphorin-3F levels
Serpin B6 levels
Serpin B8 levels
Sialic acid-binding Ig-like lectin 7 levels
Synaptosomal-associated protein 23 levels
Tartrate-resistant acid phosphatase type 5 levels
Urokinase-type plasminogen activator levels
Urokinase plasminogen activator surface receptor levels
vWF levels
Lysophosphatidic acid phosphatase type 6 levels
Adhesion G protein-coupled receptor E2 levels
Adhesion G-protein coupled receptor G2 levels
Retinal dehydrogenase 1 levels
Angiopoietin-2 levels
Angiopoietin-related protein 1 levels
Angiopoietin-related protein 7 levels
DNA-(apurinic or apyrimidinic site) lyase levels
Amyloid-like protein 1 levels
Arginase-1 levels
Large proline-rich protein BAG6 levels
Carbonic anhydrase 13 levels
Soluble calcium-activated nucleotidase 1 levels
Coiled-coil domain-containing protein 80 levels
Sialomucin core protein 24 levels
T-cell surface glycoprotein CD1c levels
CD2-associated protein levels
B-cell antigen receptor complex-associated protein beta chain levels
Cadherin-2 levels
Cadherin-related family member 5 levels
Chordin-like protein 2 levels
Leptin levels
Spondin-2 levels
Macrophage receptor MARCO levels
Tyrosine-protein kinase Mer levels
Protein-glutamine gamma-glutamyltransferase 2 levels
Matrix metalloproteinase-7 levels
Thrombopoietin levels
Pappalysin-1 levels
Thrombomodulin levels
Poly [ADP-ribose] polymerase 1 levels
Platelet-derived growth factor subunit B levels
Programmed cell death 1 ligand 2 levels
Placenta growth factor levels
Polymeric immunoglobulin receptor levels
Prolargin levels
V-set and immunoglobulin domain-containing protein 2 levels
Prostasin levels
P-selectin glycoprotein ligand 1 levels
Pentraxin-related protein PTX3 levels
Tyrosine-protein kinase receptor UFO levels
Renin levels
Bleomycin hydrolase levels
Serpin A12 levels
C-C motif chemokine 15 levels
"Superoxide dismutase [Mn],mitochondrial levels"
Sortilin levels
Lipoprotein lipase levels
Serine/threonine-protein kinase 4 levels
Tissue factor levels
Matrix metalloproteinase-12 levels
Thrombospondin-2 levels
NF-kappa-B essential modulator levels
Angiopoietin-1 receptor levels
Proteinase-activated receptor 1 levels
Tumor necrosis factor receptor superfamily member 10A levels
Tumor necrosis factor receptor superfamily member 11A levels
Tumor necrosis factor receptor superfamily member 13B levels
TNF-related apoptosis-inducing ligand receptor 2 levels
vascular endothelial growth factor D levels
Serine protease 27 levels
XCL1 levels
CD166 antigen levels
Aminopeptidase N levels
Receptor for advanced glycosylation end products levels
Azurocidin levels
Caspase-3 levels
SLAM family member 7 levels
C-C motif chemokine 16 levels
C-C motif chemokine 24 levels
Platelet endothelial cell adhesion molecule levels
Peptidoglycan recognition protein 1 levels
Elafin levels
Perlecan levels
Paraoxonase activity
Myeloblastin levels
Pulmonary surfactant-associated protein D levels
Retinoic acid receptor responder protein 2 levels
Secretoglobin family 3A member 2 levels
E-selectin levels
P-selectin levels
Tyrosine-protein phosphatase non-receptor type substrate 1 levels
Spondin-1 levels
ST2 protein levels
Metalloproteinase inhibitor 4 levels
Trem-like transcript 2 protein levels
Tumor necrosis factor receptor 1 levels
Tumor necrosis factor receptor 2 levels
Tumor necrosis factor receptor superfamily member 10C levels
Tumor necrosis factor receptor superfamily member 14 levels
Tumor necrosis factor ligand superfamily member 13B levels
Tissue-type plasminogen activator levels
Transferrin receptor protein 1 levels
Chymotrypsin C levels
Cathepsin L1 levels
C-X-C motif chemokine 1 levels
Decorin levels
"2,4-dienoyl-CoA reductase,mitochondrial levels"
Dickkopf-related protein 1 levels
"Fatty acid-binding protein,intestinal levels"
Fibroblast growth factor 21 levels
Fibroblast growth factor 23 levels
Follistatin levels
Galectin-9 levels
Growth/differentiation factor 2 levels
Growth hormone levels
Gastric intrinsic factor levels
Lactoylglutathione lyase levels
Gastrotropin levels
Hydroxyacid oxidase 1 levels
Proheparin-binding EGF-like growth factor levels
Heme oxygenase 1 levels
Osteoclast-associated immunoglobulin-like receptor levels
Heat shock 27 kDa protein levels
Alpha-L-iduronidase levels
Low affinity immunoglobulin gamma Fc region receptor II-b levels
Pro-interleukin-16 levels
Interleukin-17D levels
Sclerostin levels
Scavenger receptor cysteine-rich domain-containing group B protein levels
Sulfatase-modifying factor 2 levels
Trefoil factor 2 levels
Thimet oligopeptidase levels
Thyrotropin subunit beta levels
Thioredoxin domain-containing protein 5 levels
Thymidine phosphorylase levels
Tyrosine-protein kinase receptor TYRO3 levels
Ubiquitin carboxyl-terminal hydrolase 8 levels
Versican core protein levels
Angiotensin-converting enzyme 2 levels
A disintegrin and metalloproteinase with thrombospondin motifs 13 levels
Agouti-related protein levels
Protein AMBP levels
Angiopoietin-1 levels
Bone morphogenetic protein 6 levels
Brother of CDO levels
"Carbonic anhydrase 5A,mitochondrial levels"
C-C motif chemokine 17 levels
C-C motif chemokine 3 levels
T-cell surface glycoprotein CD4 levels
CD40 ligand levels
SLAM family member 5 levels
Carcinoembryonic antigenrelated cell adhesion molecule 8 levels
Interleukin-1 receptor-like 2 levels
Interleukin-27 levels
Interleukin-4 receptor subunit alpha levels
Kidney Injury Molecule levels
Opioid use cessation
Heel bone mineral density
Fractures
Response to antiepileptic drugs in genetic generalized epilepsy
Response to valproic acid in genetic generalized epilepsy
Response to lamotrigine in genetic generalized epilepsy
Response to levetiracetam in genetic generalized epilepsy
Response to lamotrigine and valproic acid in genetic generalized epilepsy
BMI in adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation
BMI in adult survivors of childhood acute lymphoblastic leukemia not treated with cranial radiation
BMI in adult survivors of childhood acute lymphoblastic leukemia
Mastocytosis (KIT D816V positive)
Response to serotonin-norepinephrine reuptake inhibitors (responders vs non-responders)
Response to norepinephrine-dopamine reuptake inhibitors (responders vs non-responders)
Response to antidepressants (non-treatment-resistant vs treatment-resistant depression)
Response to SSRI (responders vs non-responders)
Chronic rhinosinusitis
HDL cholesterol x physical activity interaction (2df test)
LDL cholesterol x physical activity interaction (2df test)
Triglycerides x physical activity interaction (2df test)
LDL cholesterol x physical activity interaction (1df test)
HDL cholesterol x physical activity interaction (1df test)
Triglycerides x physical activity interaction (1df test)
Corneal astigmatism
Refractive astigmatism
Plasma free amino acid levels (adjusted for twenty other PFAAs)
Plasma free amino acid levels (adjusted for one other PFAA)
Plasma free proline levels
Plasma free asparagine levels
Plasma free amino acid levels
Body fat distribution (arm fat ratio)
Body fat distribution (leg fat ratio)
Body fat distribution (trunk fat ratio)
HDL cholesterol levels x long total sleep time interaction (2df test)
Triglyceride levels x long total sleep time interaction (1df test)
HDL cholesterol levels x short total sleep time interaction (2df test)
LDL cholesterol levels x long total sleep time interaction (2df test)
LDL cholesterol levels x short total sleep time interaction (2df test)
Triglyceride levels x long total sleep time interaction (2df test)
Triglyceride levels x short total sleep time interaction (2df test)
HDL cholesterol levels x long total sleep time interaction (1df test)
Triglyceride levels x short total sleep time interaction (1df test)
HDL cholesterol levels x short total sleep time interaction (1df test)
LDL cholesterol levels x long total sleep time interaction (1df test)
LDL cholesterol levels x short total sleep time interaction (1df test)
B-cell acute lymphoblastic leukaemia
B-cell acute lymphoblastic leukaemia (high-hyperdiploidy)
B-cell acute lymphoblastic leukaemia (ETV6-RUNX1 positive)
Circulating leptin levels in high cardiovascular risk
Circulating leptin levels x sex interaction in high cardiovascular risk
Facial morphology
Hippocampal atrophy rate
"19,155 disease classifications in UK Biobank (pleiotropy)"
Refractive error
White matter hyperintensities
Colorectal cancer x BMI interaction (2df)
Inhibin B levels
Semen volume
Sperm concentration
Testis size
Fasting glucose
Fasting insulin
Maternal nondisjunction of chromosome 21 (mothers vs fathers)
Maternal nondisjunction of chromosome 21 (MI error vs fathers)
Maternal nondisjunction of chromosome 21 (MII error vs fathers)
Maternal nondisjunction of chromosome 21 (MI error vs MII error)
Bone mineral content
T-cell acute lymphoblastic leukaemia
Cirrhosis
Insomnia symptoms (never/rarely vs. sometimes/usually)
Insomnia symptoms (never/rarely vs. usually)
Arsenic metabolism
Anthracycline-induced cardiotoxicity
Thyroid volume in Hashimoto’s thyroiditis
Calcific aortic valve stenosis
Bladder cancer
Creativity
treatment failure in response to intravesical BCG therapy in non-muscle invasive bladder cancer
Weight gain in amisulpride-treated first-episode psychosis
Adverse response to inhaled corticosteroid treatment x age interaction in asthma
Acute cholecystitis
Cholelithiasis
Crohn's disease or systemic sclerosis
Tourette syndrome
Left ventricular mass x antihypertensive treatment interaction
Relative wall thickness x antihypertensive treatment interaction
Erosive esophagitis
Carotid intima media thickness x smoking interaction
Attention deficit hyperactivity disorder (persistent)
Attention deficit hyperactivity disorder (childhood)
Endometriosis or migraine
Lactate dehydrogenase levels
Creatine kinase levels
Creatine kinase levels in statin users
Creatine kinase levels in off-statin users
Lactate dehydrogenase levels in statin users
Lactate dehydrogenase levels in off-statin users
Total triglycerides levels
Household income
Ocular sarcoidosis
Ocular sarcoidosis in sarcoidosis
Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)
Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)
Anemia in mycophenolic acid treated kidney transplant patients (time to event)
Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)
New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)
Crohn's disease (time to progression)
Crohn's disease (time to first abdominal surgery)
Crohn's disease (indolent vs progressive)
Meconium ileus in cystic fibrosis
Osteoarthritis of the hand
Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)
Alzheimer's disease or fasting glucose levels (pleiotropy)
Alzheimer's disease or fasting insulin levels (pleiotropy)
Alzheimer's disease or HDL levels (pleiotropy)
Emotional recognition
Systolic blood pressure x educational attainment (some college) interaction (2df)
Systolic blood pressure x educational attainment (graduated college) interaction (2df)
Diastolic blood pressure x educational attainment (some college) interaction (2df)
Diastolic blood pressure x educational attainment (graduated college) interaction (2df)
Mean arterial pressure x educational attainment (some college) interaction (2df)
Mean arterial pressure x educational attainment (graduated college) interaction (2df)
Pulse pressure x educational attainment (some college) interaction (2df)
Pulse pressure x educational attainment (graduated college) interaction (2df)
Left ventricular end-diastolic volume
Left ventricular end-systolic volume
Left ventricular stroke volume
Body surface area-indexed left ventricular end-diastolic volume
Body surface area-indexed left ventricular end-systolic volume
Body surface area-indexed left ventricular stroke volume
Left ventricular ejection fraction
Anthracycline-induced cardiotoxicity in early breast cancer
Recurrence of Clostridium difficile infection x bezlotuxumab treatment interaction (2df test)
FEV1
Peak expiratory flow
Major depressive disorder in trauma exposed individuals
Major depressive disorder in trauma-unexposed individuals
Trauma exposure
Trauma exposure in major depressive disorder
Trauma exposure in major depressive disorder-negative individuals
Drug-induced liver injury (flucloxacillin)
Drug-induced liver injury (isoxazolyl penicillins)
Drug-induced liver injury (amoxicillin)
Glycated hemoglobin levels in type 1 diabetes
Nasal polyps
Obese vs. thin
Obesity (extreme)
Normal body mass index vs. thin
Morningness
Sweet taste preference
Depressive symptoms x herpes simplex 1 infection interaction
Depression x herpes simplex 1 infection interaction
Opioid requirements during laparoscopic-assisted colectomy
Response to metformin (IC50)
Coenzyme Q10 levels
Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer
Response to cognitive-behavioural therapy in anxiety disorder
Sleep latency
Bipolar disorder (early onset)
Breast cancer-free interval (treatment with aromatase inhibitor)
Psoriasis vulgaris
Stimulated C-peptide levels in type I diabetes
Fasting C-peptide levels in type I diabetes
Random C-peptide levels in type I diabetes
C-peptide levels in type I diabetes
Premature menopause in childhood cancer survivors
Hepatitis B virus-related hepatocellular carcinoma
Calcium levels
Phosphorus levels
Total bilirubin levels
Left ventricular internal dimension in diastole
Left ventricular internal dimension in systole
Relative wall thickness
Fractional shortening
Ejection fraction
Interventricular septum thickness
Posterior wall thickness
Left ventricular mass index
E/A ratio
Blood sugar levels
Hemoglobin A1c levels
Immunoglobulin measurement (zinc sulfate turbidity test)
Suicide attempts
Coronary artery disease and/or body mass index (pleiotropy)
Anti-Toxoplasma gondii IgG seropositivity
Predicted suicide risk
Remission after antidepressant treatment in major depression
Bitter taste perception (multivariate analysis)
Bitter taste perception
Pyridoxal levels
4-pyridoxic acid levels
Pyridoxal 5'-phosphate levels
Attention deficit hyperactivity disorder or cannabis use
Response to beta blocker use in hypertension (diastolic blood pressure)
Maximum habitual alcohol consumption
Dentate gyrus volume x schizophrenia interaction
Dentate gyrus volume
Subscapular skin fold thickness
Bicuspid aortic valve without aortic dilation
Bicuspid aortic valve
Nonsyndromic cleft lip
Nonsyndromic cleft palate
Perceived sweetness of sucrose
Sucrose liking
Intake of sweets
Perceived intensity of fructose
Perceived intensity of neohesperidin dihydrochalcone
Perceived intensity of aspartame
Perceived intensity of sweet substances
Perceived intensity of sucrose
Intake of total sugars
Perceived intensity of glucose
Depressive symptom (depressed mood) (binary trait)
Depressive symptom (sleep problems) (binary trait)
Depressive symptom (fatigue) (binary trait)
Depressive symptom (appetite changes) (binary trait)
Depressive symptom (low self-esteem) (binary trait)
Depressive symptom (concentration problems) (binary trait)
Depressive symptom (psychomotor changes) (binary trait)
Depressive symptom (suicidal ideation) (binary trait)
Depressive symptoms (binary sum-score)
Depressive symptoms (sum-score)
Depressive symptom (sleep problems) (ordinal trait)
Depressive symptom (fatigue) (ordinal trait)
Depressive symptom (appetite changes) (ordinal trait)
Depressive symptom (low self-esteem) (ordinal trait)
Depressive symptom (concentration problems) (ordinal trait)
Depressive symptom (psychomotor changes) (ordinal trait)
Depressive symptom (suicidal ideation) (ordinal trait)
Depressive symptom (anhedonia) (ordinal trait)
Depressive symptom (depressed mood) (ordinal trait)
Depressive symptom (anhedonia) (binary trait)
Adverse response to drug
Psychotic experience
Psychotic experience (multiple occurrences)
Psychotic experience (distressing)
Alzheimer’s disease (clinical subgroup AD+)
Alzheimer’s disease (clinical subgroup AD++)
Alzheimer’s disease (clinical subgroup AD+++)
Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD++)
Pneumococcal meningitis
Left ventricular mass to end-diastolic volume ratio
Colorectal cancer or advanced adenoma
Handedness (non-right-handed vs right-handed)
Handedness (Left-handed vs. non-left-handed)
Handedness (left-handed vs. right-handed)
Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
Response to placebo treatment in childhood asthma (FVC change)
BMI-adjusted waist-hip ratio variance
Body fat percentage variance
Basal metabolic rate variance
Waist circumference variance
Hip circumference variance
Waist-hip ratio variance
Height variance
Lung function (forced vital capacity) variance
Lung function (FEV1) variance
Lung function (FEV1/FVC) variance
Heel bone mineral density variance
Birth weight variance
Predicted visceral adipose tissue
Recurrence of malaria infection (mild or asymptomatic)
Recurrence of mild malaria attacks
FEV1 decline rate x corticosteroid treatment interaction in chronic obstructive pulmonary disease
Joint damage in rheumatoid arthritis
Early onset periodontitis x smoking status interaction
Retinal arteriolar tortuosity
Maximum retinal arteriolar tortuosity
Retinal venular tortuosity
Maximum retinal venular tortuosity
Retinal arteriole-to-venule ratio
Optic disc radius
Leukocyte count in ischemic stroke
Trastuzumab-induced cardiotoxicity in cancer
Immunogenicity to anti-TNF therapy in Crohn's disease
Longitudinal cocaine use
Urinary albumin-to-creatinine ratio in diabetes
Microalbuminuria
Ischemic heart disease
Bilirubin levels
Minimum ankle–brachial index
White coat effect (clinic systolic blood pressure minus ambulatory systolic blood pressure)
White coat effect (clinic diastolic blood pressure minus ambulatory diastolic blood pressure)
Early cardiac repolarization
Glucose homeostasis traits
Hematology traits
Hormone measurements
Lipid traits
Liver disease biomarker
Anthropometric traits
Asthma (adult onset)
Asthma and attention deficit hyperactivity disorder
Asthma and anxiety disorder
Asthma and major depressive disorder
Early spontaneous preterm birth
Moderate-to-late spontaneous preterm birth
Spontaneous preterm birth with premature rupture of membranes
Spontaneous preterm birth without premature rupture of membranes
Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease
Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease
Diabetic nephropathy in type 1 diabetes
Macroalbuminuria in type 1 diabetes
End-stage renal disease in Type 1 diabetics
Kidney disease (end stage renal disease vs macroalbuminuria) in type 1 diabetes
Microalbuminuria in type 1 diabetes
Chronic kidney disease (reduced eGFR or end stage renal disease) in type 1 diabetes
Chronic kidney disease (end stage renal disease vs. normal eGFR) in type 1 diabetes
Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in type 1 diabetes
Kidney disease (end stage renal disease or albuminuria) in type 1 diabetes
Esotropia
Accommodative esotropia
Amblyopia
Non-accommodative esotropia
Infection persistence (>18 months) in genital human papillomavirus 16 infection
"Number of decayed, missing and filled tooth surfaces or use of dentures"
"Number of decayed, missing and filled tooth surfaces"
Number of decayed and filled tooth surfaces per available tooth surface
Periodontitis
Bleeding gums
Painful gums
Response to adalimumab in hidradenitis suppurativa (abscess and inflammatory nodule count increase)
Dentures
Toothache
Mouth ulcers
Number of natural teeth
Loose teeth
Periodontitis or loose teeth
Antipsychotic drug-induced weight gain in schizophrenia or autism
"Dental caries (decayed, missing and filled tooth surfaces)"
"Dental caries (decayed, missing and filled teeth)"
Dental caries (decayed and filled deciduous teeth)
Dental caries (decayed and filled deciduous tooth surfaces)
Metabolite levels
Ankle-brachial index
Peripheral artery disease (borderline)
Verbal cognitive ability
Numerical cognitive ability
Figural/spatial cognitive ability
Tendinopathy
Change in neurofilament light levels
Serum platinum levels after completion of cisplatin chemotherapy
Hydrolysed wheat protein allergy
Response to allopurinol in gout (change in serum uric acid levels)
Age at suicide
Skin aging measurement
Basal metabolic rate
Uveal melanoma
Uveal melanoma with any chromosomal aberration
Choroidal melanoma
Uveal melanoma with chromosome 3 loss
Uveal melanoma with epithelioid cells
Presence of epithelioid cells in uveal melanoma
Uveal melanoma (TNM stage 1 or 2)
Uveal melanoma (TNM stage 3 or 4)
Disease severity in uveal melanoma (TNM stage 3 or 4 vs TNM stage 1 or 2)
T wave morphology restitution during exercise (MTAG)
T wave morphology restitution during exercise
T wave morphology restitution during recovery from exercise
T wave morphology restitution during recovery from exercise (MTAG)
Fagerstrӧm test for nicotine dependence
Time to smoke first cigarette in the morning
Resistant hypertension
Mosaic loss of chromosome Y (Y chromosome dosage)
LDL cholesterol levels in current drinkers
HDL cholesterol levels in current drinkers
Triglyceride levels in current drinkers
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)
Mental disorder
Psychiatric disorder without cannabis use disorder
Cannabis use disorder vs schizophrenia
Cannabis use disorder
Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease
Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease
Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease
Alcohol dependence or heroin dependence or methamphetamine dependence
Epigenetic age acceleration in alcohol use disorder
Corneal resistance factor
Corneal hysteresis
Cerebral microbleed progression
Cerebral microbleeds
Uterine fibroids and heavy menstrual bleeding
Heavy menstrual bleeding
Left planum temporale grey matter volume
Right planum temporale grey matter volume
Planum temporale asymmetry index
Erectile dysfunction
Voxel-wise structural brain imaging measurements in Alzheimer’s disease
Factor VIII levels
vWF and FVIII levels
Cognitive performance (language ability)
Cognitive performance (processing speed) x major depressive disorder status interaction
Cognitive performance (language ability) x major depressive disorder status interaction
Cognitive performance (processing speed) x major depressive disorder type interaction
Cognitive performance (processing speed) in major depressive disorder
Cognitive performance (processing speed)
Anti-helicobacter pylori IgG seropositivity
Severe gastric atrophy
Pepsinogen-I levels
Pepsinogen I/II ratio
Gastric atrophy
Response to ketamine in bipolar disorder or major depression (antidepressant effects)
Response to ketamine in bipolar disorder or major depression (dissociation effects)
B6 vitamer levels (multivariate analysis)
Cerebrospinal fluid pyridoxal phosphate levels
Plasma pyridoxal phosphate levels
Cerebrospinal fluid pyridoxal phosphate to pyridoxal ratio
Plasma pyridoxal phosphate to pyridoxal ratio
Plasma pyridoxic acid to pyridoxal phosphate ratio
Alloimmunization response to red blood cell transfusion in sickle cell anemia
Red vs. brown/black hair color
Blond vs. brown/black hair color
Brown vs. black hair color
Nonischemic cardiomyopathy
Childhood obesity
Thoracic aortic calcification levels
Abdominal aortic calcification levels
Amyotrophic lateral sclerosis
Latent naming speed
Rapid automised naming and rapid alternating stimulus test performance
Rapid automised naming of objects
Rapid automised naming of letters
Rapid alternating stimulus test for letters/numbers
Cocaine use disorder
Cocaine use disorder x non-traditional parental care interaction
Cocaine use disorder x change in residence interaction
Cocaine use disorder x traumatic experience interaction
Cocaine use disorder x household drinking and illicit drug use interaction
Cocaine use disorder x household tobacco use interaction
Hypotension and cognitive impairment
Eosinophilic esophagitis
Proliferative diabetic retinopathy
Knee pain
Bipolar I disorder
Bipolar II disorder
Schizoaffective disorder-bipolar type
Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)
Eosinophilic granulomatosis with polyangiitis (ANCA negative)
Eosinophilic granulomatosis with polyangiitis
HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)
Midline nonsyndromic craniosynostosis
Metopic nonsyndromic craniosynostosis
fetal weight (maternal genotype effect)
Vertical cup-disc ratio (adjusted for vertical disc diameter)
Vertical cup-disc ratio (multi-trait analysis)
Glaucoma
Glaucoma (multi-trait analysis)
Intracerebral hemorrhage
HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)
HDL cholesterol levels in current smokers
HDL cholesterol levels in non smokers
HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)
HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)
HDL cholesterol levels in ever smokers
HDL cholesterol levels in never smokers
LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)
LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)
LDL cholesterol levels in current smokers
LDL cholesterol levels in non smokers
LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)
LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)
LDL cholesterol levels in ever smokers
LDL cholesterol levels in never smokers
Triglyceride levels x smoking (current vs non smokers) interaction (1df test)
Triglyceride levels x smoking (current vs non smokers) interaction (2df test)
Triglyceride levels in current smokers
Triglyceride levels in non smokers
Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)
Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)
Triglyceride levels in ever smokers
Triglyceride levels in never smokers
TPE interval (resting)
TPE interval (response to exercise)
TPE interval (recovery after exercise)
Bone mineral density or trunk lean mass (pleiotropy)
Trunk lean mass
Bipolar disorder or body mass index
Bipolar disorder or type 2 diabetes
Peak weight velocity
Age at adiposity peak
BMI at adiposity peak
Age at adiposity rebound
BMI at adiposity rebound
Peak height velocity
Suicidal or self-harm ideation
Chronic postoperative pain
Smoking initiation (ever regular vs never regular)
Smoking cessation (former vs current smokers)
Age of smoking initiation
Lifetime smoking index
Carotid intima media thickness (mean)
Carotid intima media thickness (maximum)
Carotid intima media thickness (mean-maximum)
Fat-free mass
Polycystic ovary syndrome (reproductive subtype)
Polycystic ovary syndrome (metabolic subtype)
Polycystic ovary syndrome (indeterminate subtype)
Anxiety
Anxiety disorders
Low HDL-cholesterol levels
High fasting blood glucose
OTU97_16 (Faecalibacterium) abundance
O_Coriobacteriales abundance
OTU97_165 (Porphyromonadaceae) abundance
OTU97_17 (Parabacteroides) abundance
OTU97_173 (Bacteroides) abundance
OTU97_1 (Bacteroides) abundance
OTU97_2 (Bacteroides) abundance
OTU97_101 (Sutterella) abundance
OTU97_23 (Faecalibacterium) abundance
OTU97_105 (Ruminococcaceae) abundance
OTU97_24 (Prevotella) abundance
OTU97_108 (Phascolarctobacterium) abundance
OTU97_109 (Paraprevotella) abundance
OTU97_11 (Parabacteroides) abundance
OTU97_113 (Bacteroidales) abundance
OTU97_117 (Ruminococcus) abundance
OTU97_119 (Desulfovibrio) abundance
OTU97_12 (Bacteroides) abundance
OTU97_34 (Ruminococcus) abundance
OTU97_38 (Alphaproteobacteria) abundance
OTU97_130 (Butyrivibrio) abundance
OTU97_4 (Alistipes) abundance
OTU97_138 (Oscillibacter) abundance
OTU97_140 (Bacteroides) abundance
OTU97_15 (Parasutterella) abundance
OTU97_150 (Bacteroides) abundance
OTU99_12 (Bacteroides) abundance
OTU97_50 (Aestuariispira) abundance
OTU99_121 (Ruminococcaceae) abundance
OTU97_56 (Ruminococcaceae) abundance
OTU99_124 (Paraprevotella) abundance
OTU99_13 (Subdoligranulum) abundance
OTU99_132 (Bacteroidales) abundance
OTU99_137 (Ruminococcus) abundance
OTU99_140 (Desulfovibrio) abundance
OTU99_150 (Prevotella) abundance
OTU99_155 (Butyrivibrio) abundance
OTU99_157 (Barnesiella) abundance
OTU99_16 (Faecalibacterium) abundance
OTU99_166 (Prevotella) abundance
OTU99_17 (Parabacteroides) abundance
OTU99_171 (Bacteroides) abundance
OTU99_19 (Bacteria) abundance
OTU99_197 (Bacteroides) abundance
OTU99_2 (Bacteroides) abundance
OTU97_9 (Alistipes) abundance
OTU97_95 (Cytophagales) abundance
OTU99_23 (Faecalibacterium) abundance
P_Actinobacteria abundance
OTU99_24 (Prevotella) abundance
OTU99_26 (Parasutterella) abundance
O_Clostridiales abundance
OTU97_163 (Bacteroides) abundance
O_Erysipelotrichales abundance
O_Selenomonadales abundance
OTU97_19 (Bacteria) abundance
OTU97_100 (Ruminococcaceae) abundance
OTU97_21 (Parasutterella) abundance
OTU97_102 (Prevotella) abundance
OTU97_235 (Phascolarctobacterium) abundance
OTU97_106 (Ruminococcaceae) abundance
OTU97_257 (Mitsuokella) abundance
OTU97_26 (Parasutterella) abundance
OTU97_27 (Bacteroides) abundance
OTU97_277 (Prevotella) abundance
OTU97_3 (Bacteroides) abundance
OTU97_30 (Roseburia) abundance
OTU97_31 (Prevotella) abundance
OTU97_33 (Holdemanella) abundance
OTU97_126 (Prevotella) abundance
OTU97_354 (Alloprevotella) abundance
OTU97_13 (Subdoligranulum) abundance
OTU97_39 (Proteobacteria) abundance
OTU97_137 (Catenibacterium) abundance
OTU97_46 (Lachnospiraceae) abundance
OTU97_5 (Sutterella) abundance
OTU99_120 (Ruminococcaceae) abundance
OTU97_51 (Barnesiella) abundance
OTU97_53 (Bacteroides) abundance
OTU99_123 (Phascolarctobacterium) abundance
OTU97_58 (Sutterellaceae) abundance
OTU97_6 (Sutterella) abundance
OTU97_65 (Parabacteroides) abundance
OTU97_69 (Clostridiales) abundance
OTU97_7 (Lachnospiraceae) abundance
OTU97_73 (Prevotella) abundance
OTU97_74 (Alistipes) abundance
OTU97_8 (Ruminococcaceae) abundance
OTU97_80 (Ruminococcus) abundance
OTU97_82 (Bacteroides) abundance
OTU97_86 (Phascolarctobacterium) abundance
OTU99_21 (Parasutterella) abundance
OTU99_211 (Bacteroides) abundance
OTU97_97 (Clostridiales) abundance
OTU99_1 (Bacteroides) abundance
OTU99_106 (Barnesiella) abundance
OTU99_108 (Cytophagales) abundance
OTU99_11 (Parabacteroides) abundance
OTU99_110 (Clostridiales) abundance
OTU99_116 (Sutterella) abundance
G_Prevotella prevalence
G_Prevotellaceae prevalence
G_Ruminococcus prevalence
G_Sutterella prevalence
O_Selenomonadales prevalence
OTU97_1 (Bacteroides) prevalence
OTU97_100 (Ruminococcaceae) prevalence
OTU97_101 (Sutterella) prevalence
OTU97_102 (Prevotella) prevalence
OTU97_105 (Ruminococcaceae) prevalence
OTU97_106 (Ruminococcaceae) prevalence
OTU97_108 (Phascolarctobacterium) prevalence
OTU97_109 (Paraprevotella) prevalence
OTU97_11 (Parabacteroides) prevalence
OTU97_113 (Bacteroidales) prevalence
OTU97_117 (Ruminococcus) prevalence
OTU97_119 (Desulfovibrio) prevalence
OTU97_12 (Bacteroides) prevalence
OTU97_126 (Prevotella) prevalence
OTU97_13 (Subdoligranulum) prevalence
OTU97_130 (Butyrivibrio) prevalence
OTU97_137 (Catenibacterium) prevalence
OTU97_138 (Oscillibacter) prevalence
OTU97_140 (Bacteroides) prevalence
OTU99_30 (Parasutterella) prevalence
OTU99_8 (Ruminococcaceae) abundance
OTU99_84 (Prevotella) abundance
OTU99_85 (Alistipes) abundance
OTU99_9 (Alistipes) abundance
OTU99_92 (Ruminococcus) abundance
OTU99_94 (Bacteroides) abundance
OTU99_98 (Phascolarctobacterium) abundance
P_Bacteroidetes abundance
P_Firmicutes abundance
P_Proteobacteria abundance
TestASV_1 (Bacteroides) abundance
TestASV_10 (Parabacteroides) abundance
TestASV_11 (Lachnospiraceae) abundance
TestASV_12 (Bacteroides) abundance
TestASV_13 (Bacteroides) abundance
TestASV_14 (Lachnospiraceae) abundance
TestASV_15 (Bacteroides) abundance
TestASV_16 (Bacteroides) abundance
TestASV_17 (Bacteroides) abundance
TestASV_18 (Prevotella) abundance
TestASV_19 (Prevotella) abundance
TestASV_2 (Bacteroides) abundance
TestASV_20 (Phascolarctobacterium) abundance
TestASV_21 (Ruminococcaceae) abundance
TestASV_22 (Sutterella) abundance
OTU99_271 (Prevotella) abundance
OTU99_298 (Phascolarctobacterium) abundance
OTU99_3 (Bacteroides) abundance
OTU99_30 (Parasutterella) abundance
OTU99_32 (Prevotella) abundance
OTU99_34 (Holdemanella) abundance
OTU99_35 (Ruminococcus) abundance
OTU99_39 (Alphaproteobacteria) abundance
OTU99_4 (Alistipes) abundance
OTU99_40 (Proteobacteria) abundance
OTU99_45 (Faecalibacterium) abundance
OTU99_47 (Prevotella) abundance
OTU99_5 (Sutterella) abundance
OTU99_53 (Aestuariispira) abundance
OTU99_54 (Holdemanella) abundance
OTU99_55 (Barnesiella) abundance
OTU99_558 (Bacteroidales) abundance
OTU99_58 (Bacteroides) abundance
OTU99_59 (Prevotella) abundance
OTU99_6 (Sutterella) abundance
OTU99_62 (Ruminococcaceae) abundance
OTU99_65 (Sutterellaceae) abundance
OTU99_7 (Lachnospiraceae) abundance
OTU99_72 (Parabacteroides) abundance
OTU99_78 (Clostridiales) abundance
TestASV_47 (Parasutterella) abundance
TestASV_48 (Sutterella) abundance
TestASV_49 (Parasutterella) abundance
TestASV_5 (Bacteroides) abundance
TestASV_6 (Subdoligranulum) abundance
TestASV_7 (Bacteroides) abundance
TestASV_8 (Bacteroides) abundance
TestASV_9 (Alistipes) abundance
C_Alphaproteobacteria prevalence
C_Negativicutes prevalence
F_Acidaminococcaceae prevalence
F_Prevotellaceae prevalence
G_Alloprevotella prevalence
G_Alphaproteobacteria prevalence
G_Bacteroidales prevalence
G_Bacteroidetes prevalence
G_Barnesiella prevalence
G_Catenibacterium prevalence
G_Coprococcus prevalence
G_Holdemanella prevalence
G_Parabacteroides prevalence
G_Paraprevotella prevalence
G_Parasutterella prevalence
G_Phascolarctobacterium prevalence
G_Porphyromonadaceae prevalence
OTU97_15 (Parasutterella) prevalence
OTU97_150 (Bacteroides) prevalence
OTU97_16 (Faecalibacterium) prevalence
OTU97_163 (Bacteroides) prevalence
OTU97_165 (Porphyromonadaceae) prevalence
OTU97_17 (Parabacteroides) prevalence
OTU97_173 (Bacteroides) prevalence
OTU97_19 (Bacteria) prevalence
OTU97_2 (Bacteroides) prevalence
OTU97_21 (Parasutterella) prevalence
OTU97_23 (Faecalibacterium) prevalence
OTU97_235 (Phascolarctobacterium) prevalence
OTU97_24 (Prevotella) prevalence
OTU97_257 (Mitsuokella) prevalence
OTU97_26 (Parasutterella) prevalence
OTU97_27 (Bacteroides) prevalence
OTU97_277 (Prevotella) prevalence
OTU97_3 (Bacteroides) prevalence
OTU97_30 (Roseburia) prevalence
OTU97_31 (Prevotella) prevalence
OTU97_33 (Holdemanella) prevalence
OTU97_34 (Ruminococcus) prevalence
OTU97_354 (Alloprevotella) prevalence
OTU97_38 (Alphaproteobacteria) prevalence
OTU97_39 (Proteobacteria) prevalence
Cytokine levels
Cytokine network levels (multivariate analysis)
Pancreatic ductal adenocarcinoma
Acne (severe)
Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
Subpleural-predominant interstitial lung abnormalities
Interstitial lung abnormalities
Epilepsy
Childhood absence epilepsy
Juvenile absence epilepsy
Juvenile myoclonic epilepsy
"Epilepsy (generalized, with tonic-clonic seizures alone)"
Focal epilepsy (lesion negative)
Focal epilepsy (with hippocampal sclerosis)
Focal epilepsy (with lesion other than hippocampal sclerosis)
Focal epilepsy
Response to beta blocker use in hypertension (systolic blood pressure)
Plasma anti-thyroid peroxidase levels
Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)
Plasma anti-thyroglobulin levels
Post-term birth
Phenylephrine infusion rate during anesthesia
Age-related cognitive decline (global cognition) (slope of z-scores)
Age-related cognitive decline (executive function) (slope of z-scores)
Age-related cognitive decline (language) (slope of z-scores)
Age-related cognitive decline (memory) (slope of z-scores)
Age-related cognitive decline (visuospatial skill) (slope of z-scores)
Age-related cognitive decline (attention/processing speed) (slope of z-scores)
Rate of ventricular enlargement
Adult asthma
Hepatitis C (spontaneous viral clearance)
3-month functional outcome in ischaemic stroke (modified Rankin score)
Age-related hearing impairment (high minus low frequency)
Age-related hearing impairment
Age-related hearing impairment (low/mid frequency)
Age-related hearing impairment (high frequency)
Physiological dysregulation (Mahalanobis distance)
Hand grip strength (Mahalanobis distance)
Neck pain or shoulder pain
"Multiple traits (2,148)"
"Multiple traits (2,173)"
Externalizing behaviour score
Exfoliation syndrome
Alanine aminotransferase levels
Birth weight (MTAG)
Birth length (MTAG)
Infant head circumference (MTAG)
Parkinson's disease or first degree relation to individual with Parkinson's disease
Systolic blood pressure response to thiazide and thiazide-like diuretics in hypertension
Diastolic blood pressure response to thiazide and thiazide-like diuretics in hypertension
Systolic blood pressure response to chlorthalidone in hypertension
Diastolic blood pressure response to chlorthalidone in hypertension
Parkinson's disease or schizophrenia
Relative fat intake
Relative protein intake
Relative carbohydrate intake
Relative sugar intake
Substance uses or psychiatric disorders (pleiotropy)
Aortic valve area
Adventurousness
Automobile speeding propensity
Number of sexual partners
General risk tolerance (MTAG)
Risk-taking tendency (4-domain principal component model)
General risk tolerance
Ebbinghaus illusion (underestimation)
Ebbinghaus illusion (overestimation)
OTU99_8 (Ruminococcaceae) prevalence
OTU99_84 (Prevotella) prevalence
OTU99_85 (Alistipes) prevalence
OTU99_9 (Alistipes) prevalence
OTU99_92 (Ruminococcus) prevalence
OTU99_94 (Bacteroides) prevalence
OTU99_98 (Phascolarctobacterium) prevalence
TestASV_1 (Bacteroides) prevalence
TestASV_10 (Parabacteroides) prevalence
TestASV_11 (Lachnospiraceae) prevalence
TestASV_12 (Bacteroides) prevalence
TestASV_13 (Bacteroides) prevalence
TestASV_14 (Lachnospiraceae) prevalence
TestASV_15 (Bacteroides) prevalence
TestASV_16 (Bacteroides) prevalence
TestASV_17 (Bacteroides) prevalence
TestASV_18 (Prevotella) prevalence
TestASV_19 (Prevotella) prevalence
TestASV_2 (Bacteroides) prevalence
C_Actinobacteria abundance
C_Alphaproteobacteria abundance
C_Bacteroidia abundance
C_Betaproteobacteria abundance
C_Clostridia abundance
C_Erysipelotrichia abundance
OTU99_26 (Parasutterella) prevalence
OTU99_271 (Prevotella) prevalence
OTU99_298 (Phascolarctobacterium) prevalence
OTU99_3 (Bacteroides) prevalence
OTU99_32 (Prevotella) prevalence
OTU99_34 (Holdemanella) prevalence
OTU99_35 (Ruminococcus) prevalence
OTU99_39 (Alphaproteobacteria) prevalence
OTU99_4 (Alistipes) prevalence
OTU99_40 (Proteobacteria) prevalence
OTU99_45 (Faecalibacterium) prevalence
OTU99_47 (Prevotella) prevalence
OTU99_5 (Sutterella) prevalence
OTU99_53 (Aestuariispira) prevalence
OTU99_54 (Holdemanella) prevalence
OTU99_55 (Barnesiella) prevalence
OTU99_558 (Bacteroidales) prevalence
OTU99_58 (Bacteroides) prevalence
OTU99_59 (Prevotella) prevalence
OTU99_6 (Sutterella) prevalence
OTU99_62 (Ruminococcaceae) prevalence
OTU99_65 (Sutterellaceae) prevalence
OTU99_7 (Lachnospiraceae) prevalence
OTU99_72 (Parabacteroides) prevalence
OTU99_78 (Clostridiales) prevalence
G_Holdemanella abundance
G_Lachnospiraceae abundance
G_Oscillibacter abundance
G_Parabacteroides abundance
G_Paraprevotella abundance
G_Parasutterella abundance
G_Phascolarctobacterium abundance
G_Porphyromonadaceae abundance
G_Prevotella abundance
G_Prevotellaceae abundance
G_Roseburia abundance
G_Ruminococcaceae abundance
G_Ruminococcus abundance
G_Ruminococcus2 abundance
G_Subdoligranulum abundance
G_Sutterella abundance
O_Bacteroidales abundance
O_Burkholderiales abundance
TestASV_20 (Phascolarctobacterium) prevalence
TestASV_21 (Ruminococcaceae) prevalence
TestASV_22 (Sutterella) prevalence
TestASV_23 (Barnesiella) prevalence
TestASV_24 (Bacteroides) prevalence
TestASV_25 (Sutterella) prevalence
TestASV_26 (Phascolarctobacterium) prevalence
OTU97_4 (Alistipes) prevalence
OTU97_46 (Lachnospiraceae) prevalence
OTU97_5 (Sutterella) prevalence
OTU97_50 (Aestuariispira) prevalence
OTU97_51 (Barnesiella) prevalence
OTU97_53 (Bacteroides) prevalence
OTU97_56 (Ruminococcaceae) prevalence
OTU97_58 (Sutterellaceae) prevalence
OTU97_6 (Sutterella) prevalence
OTU97_65 (Parabacteroides) prevalence
OTU97_69 (Clostridiales) prevalence
OTU97_7 (Lachnospiraceae) prevalence
OTU97_73 (Prevotella) prevalence
OTU97_74 (Alistipes) prevalence
OTU97_8 (Ruminococcaceae) prevalence
OTU97_80 (Ruminococcus) prevalence
OTU97_82 (Bacteroides) prevalence
OTU97_86 (Phascolarctobacterium) prevalence
OTU97_9 (Alistipes) prevalence
OTU97_95 (Cytophagales) prevalence
OTU97_97 (Clostridiales) prevalence
OTU99_1 (Bacteroides) prevalence
OTU99_106 (Barnesiella) prevalence
OTU99_108 (Cytophagales) prevalence
OTU99_11 (Parabacteroides) prevalence
OTU99_110 (Clostridiales) prevalence
OTU99_116 (Sutterella) prevalence
OTU99_12 (Bacteroides) prevalence
OTU99_120 (Ruminococcaceae) prevalence
OTU99_121 (Ruminococcaceae) prevalence
OTU99_123 (Phascolarctobacterium) prevalence
OTU99_124 (Paraprevotella) prevalence
OTU99_13 (Subdoligranulum) prevalence
OTU99_132 (Bacteroidales) prevalence
OTU99_137 (Ruminococcus) prevalence
OTU99_140 (Desulfovibrio) prevalence
OTU99_150 (Prevotella) prevalence
OTU99_155 (Butyrivibrio) prevalence
OTU99_157 (Barnesiella) prevalence
OTU99_16 (Faecalibacterium) prevalence
OTU99_166 (Prevotella) prevalence
OTU99_17 (Parabacteroides) prevalence
OTU99_171 (Bacteroides) prevalence
OTU99_19 (Bacteria) prevalence
OTU99_197 (Bacteroides) prevalence
OTU99_2 (Bacteroides) prevalence
OTU99_21 (Parasutterella) prevalence
OTU99_211 (Bacteroides) prevalence
OTU99_23 (Faecalibacterium) prevalence
OTU99_24 (Prevotella) prevalence
TestASV_23 (Barnesiella) abundance
TestASV_24 (Bacteroides) abundance
TestASV_25 (Sutterella) abundance
TestASV_26 (Phascolarctobacterium) abundance
TestASV_27 (Ruminococcaceae) abundance
TestASV_28 (Holdemanella) abundance
TestASV_29 (Barnesiella) abundance
TestASV_3 (Bacteroides) abundance
TestASV_30 (Paraprevotella) abundance
TestASV_31 (Ruminococcus) abundance
TestASV_32 (Ruminococcaceae) abundance
TestASV_33 (Paraprevotella) abundance
TestASV_34 (Phascolarctobacterium) abundance
TestASV_35 (Alphaproteobacteria) abundance
TestASV_36 (Aestuariispira) abundance
TestASV_37 (Ruminococcaceae) abundance
TestASV_38 (Ruminococcus) abundance
TestASV_39 (Bacteroides) abundance
TestASV_4 (Alistipes) abundance
TestASV_41 (Barnesiella) abundance
TestASV_42 (Alphaproteobacteria) abundance
TestASV_43 (Parasutterella) abundance
TestASV_44 (Parasutterella) abundance
TestASV_45 (Clostridiales) abundance
TestASV_46 (Sutterella) abundance
TestASV_27 (Ruminococcaceae) prevalence
TestASV_28 (Holdemanella) prevalence
TestASV_29 (Barnesiella) prevalence
TestASV_3 (Bacteroides) prevalence
TestASV_30 (Paraprevotella) prevalence
TestASV_31 (Ruminococcus) prevalence
TestASV_32 (Ruminococcaceae) prevalence
TestASV_33 (Paraprevotella) prevalence
TestASV_34 (Phascolarctobacterium) prevalence
TestASV_35 (Alphaproteobacteria) prevalence
TestASV_36 (Aestuariispira) prevalence
TestASV_37 (Ruminococcaceae) prevalence
TestASV_38 (Ruminococcus) prevalence
TestASV_39 (Bacteroides) prevalence
TestASV_4 (Alistipes) prevalence
TestASV_40 (Barnesiella) prevalence
TestASV_41 (Barnesiella) prevalence
TestASV_42 (Alphaproteobacteria) prevalence
TestASV_43 (Parasutterella) prevalence
TestASV_44 (Parasutterella) prevalence
TestASV_45 (Clostridiales) prevalence
TestASV_46 (Sutterella) prevalence
TestASV_47 (Parasutterella) prevalence
TestASV_48 (Sutterella) prevalence
TestASV_49 (Parasutterella) prevalence
C_Gammaproteobacteria abundance
C_Negativicutes abundance
F_Acidaminococcaceae abundance
F_Bacteroidaceae abundance
F_Coriobacteriaceae abundance
F_Erysipelotrichaceae abundance
F_Lachnospiraceae abundance
F_Porphyromonadaceae abundance
F_Prevotellaceae abundance
F_Rikenellaceae abundance
F_Ruminococcaceae abundance
F_Sutterellaceae abundance
G_Alistipes abundance
G_Alloprevotella abundance
G_Alphaproteobacteria abundance
G_Bacteroidales abundance
G_Bacteroides abundance
G_Bacteroidetes abundance
G_Barnesiella abundance
G_Catenibacterium abundance
G_Clostridiales abundance
G_Clostridium_XlVa abundance
G_Coprococcus abundance
G_Faecalibacterium abundance
G_Firmicutes abundance
TestASV_5 (Bacteroides) prevalence
TestASV_6 (Subdoligranulum) prevalence
TestASV_7 (Bacteroides) prevalence
TestASV_8 (Bacteroides) prevalence
TestASV_9 (Alistipes) prevalence
Refractive error (age-at-onset of spectacle wearing-inferred)
Refractive error (autorefraction measured)
Hematological and biochemical traits
Lung function
Cholesterol
Physiological traits
Obsessive compulsive disorder severity
Compulsion score in obsessive compulsive disorder
Obsession score in obsessive compulsive disorder
Graft survival time in renal transplantation (donor effect)
Graft survival time in renal transplantation (donor effect) x APOL1 genotype interaction
Cardioembolic stroke (CCSp classification)
Cardioembolic stroke (TOAST classification)
Cardioembolic stroke (CCS and TOAST classification)
Cardioembolic stroke (CCS or TOAST classification)
Large artery stroke (CCSc classification)
Large artery stroke (CCSp classification)j
Large artery stroke (TOAST classification)
Large artery stroke (CCS and TOAST classification)
Large artery stroke (CCS or TOAST classification)
Small vessel stroke (CCSc classification)
Small vessel stroke (CCSp classification)
Small vessel stroke (TOAST classification)
Small vessel stroke (CCS and TOAST classification)
Small vessel stroke (CCS or TOAST classification)
Cardioembolic stroke (CCSc classification)
LDL cholesterol change in response to niacin in statin-treated individuals
Triglycerides levels in response to niacin in statin-treated individuals
Total cholesterol change in response to niacin in statin-treated individuals
Lipoprotein (a) levels in response to niacin in statin-treated individuals
HDL cholesterol change in response to niacin in statin-treated individuals
Gastrointestinal infection
Diastolic blood pressure x quantitative lifestyle risk score interaction (1df test)
Diastolic blood pressure x quantitative lifestyle risk score interaction (2df test)
Diastolic blood pressure x dichotomous lifestyle risk score interaction (1df test)
Diastolic blood pressure x dichotomous lifestyle risk score interaction (2df test)
Systolic blood pressure x quantitative lifestyle risk score interaction (1df test)
Systolic blood pressure x quantitative lifestyle risk score interaction (2df test)
Systolic blood pressure x dichotomous lifestyle risk score interaction (1df test)
Systolic blood pressure x dichotomous lifestyle risk score interaction (2df test)
Brain imaging measurements (variance)
Brain imaging measurements (mean)
Salivary metabolite levels
Childhood maltreatment
Survival in breast cancer (estrogen-receptor positive)
Type 2 diabetes (adjusted for BMI)
Angioedema in response to angiotensin-converting enzyme inhibitor and/or angiotensin receptor blocker
Serum immune biomarker levels
Cerebrospinal fluid immune biomarker levels
Adult onset Still's disease
Idiopathic downbeat nystagmus
Gout (combined type)
Gout (normal type)
Meat-related diet
Pork consumption
Poultry consumption
Raw vegetable consumption
Cooked vegetable consumption
Fruit consumption
Oily fish consumption
Non-oily fish consumption
Lamb consumption
Processed meat consumption
Fish- and plant-related diet
Beef consumption
Diabetic retinopathy (all NPDR and PDR)
Proliferative diabetic retinopathy (vs NPDR and no DR)
Diabetic retinopathy (moderate NPDR and PDR)
Proliferative diabetic retinopathy (vs no DR)
Lung function in heavy smokers (low FEV1 vs high FEV1)
Lung function in never smokers (high FEV1 vs average FEV1)
Lung function in heavy smokers (high FEV1 vs average FEV1)
Lung function in never smokers (low FEV1 vs average FEV1)
Lung function in heavy smokers (low FEV1 vs average FEV1)
Smoking status (heavy vs never)
Lung function (low FEV1 vs high FEV1) x smoking interaction
Lung function (low FEV1 vs high FEV1)
Lung function in never smokers (low FEV1 vs high FEV1)
Occipital lobe volume
Parietal lobe volume
Temporal lobe volume
Frontal lobe volume
Urinary incontinence
Stress urinary incontinence
Urgency urinary incontinence
Stress urinary incontinence and urgency urinary incontinence
Fecal incontinence
Skin pigmentation (conditioned on rs1426654 and rs35397)
Kidney stones
Panic disorder
Hospital contact for infections
Disability (impaired activities of daily living)
Hallux valgus
Brain age (difference between predicted and chronological age)
Severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis
Moderate or severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis
Brain volume in infants (white matter)
Brain volume in infants (cerebrospinal fluid)
Brain volume in infants (grey matter)
Brain volume in infants (intracranial brain volume)
Forced expiratory volume in 1 second (environmental tobacco smoke interaction)
Restless legs syndrome
Glaucoma (primary angle closure)
Depression in response to interferon-based therapy in chronic hepatitis C
Delayed reward discounting
Food addiction
Response to mepolizumab in severe asthma
Parental lifespan
Moyamoya disease
Alcoholic hepatitis
Thiazide-induced hyponatremia
Lumbar spinal stenosis
Differentiated thyroid cancer
Papillary thyroid cancer
Follicular thyroid cancer
Neovascular age-related macular degeneration
Immunoglobulin A vasculitis
Mortality in sepsis
Drug abuse
Sciatica
Bipolar disorder lithium response (continuous) or schizophrenia
Bipolar disorder lithium response (categorical) or schizophrenia
Male sexual orientation
Giant cell arteritis
Offspring birth weight
GLP-1-stimulated insulin secretion
Cortisol levels (saliva)
Serum bilirubin levels in metabolic syndrome
Serum bilirubin levels x sex interaction in metabolic syndrome
Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome
Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)
Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)
Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)
IgG glycosylation patterns
Atopic march
Cisplatin-induced ototoxicity
Fast beta electroencephalogram
Gait speed in old age
Lichen planus in hepatitis C
Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities)
Moderate to vigorous physical activity levels
Vigorous physical activity
Strenuous sports or other exercises
Accelerometer-based physical activity measurement (average acceleration)
Depressive symptom measurement or major depressive disorder
Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)
Palmar length-width ratio in Kashin-Beck disease
Nevus count
Osteoarthritis (hip)
Nonobstructive coronary artery disease
Angiotensin-converting enzyme inhibitor intolerance
Cough in response to angiotensin-converting enzyme inhibitor drugs
Poor prognosis in Crohn's disease
Cerebrospinal fluid biomarker levels
Surgical necrotising enterocolitis in extremely premature birth
Hematoma volume in lobar spontaneous intracerebral hemorrhage
Hematoma volume in non-lobar spontaneous intracerebral hemorrhage
Hyperthyroidism
Asthma or allergic disease (pleiotropy)
Intelligence (MTAG)
Response to metformin in type 2 diabetes (HbA1c reduction)
Family history of upper gastrointestinal cancer in esophageal squamous cell carcinoma
HER2 status in breast cancer
Antiepileptic drug-induced maculopapular exanthema
Carbamazepine-induced maculopapular exanthema
Lamotrigine-induced maculopapular exanthema
Phenytoin-induced maculopapular exanthema
Sulfasalazine-induced agranulocytosis
Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia
Pseudoexfoliation syndrome
ADAMTS13 levels
Epstein Barr virus nuclear antigen 1 IgG levels
Epstein Barr virus nuclear antigen 1 IgG seropositivity
Viral capsid antigen IgG levels
Viral capsid antigen IgG seropositivity
Epstein-Barr virus immune response (multivariate analysis)
Rheumatoid arthritis (ACPA-negative)
Mortality in heart failure
Dysmenorrheic pain
Job-related exhaustion in shift workers
Selective IgA deficiency
Mosaic loss of chromosome Y
Total body bone mineral density
Total body bone mineral density (age 45-60)
Survival in endocrine treated breast cancer (estrogen-receptor positive)
Bronchopulmonary dysplasia in preterm infants
Sotalol-induced IKr potassium channel inhibition (T wave peak and end interval change)
Sotalol-induced IKr potassium channel inhibition (T wave maximal amplitude change)
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization duration change)
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)
Sotalol-induced IKr potassium channel inhibition (T wave morphology notching)
Overall survival in osteosarcoma
Inhibitory control
Chronic rhinosinusitis with nasal polyps
Early age at menarche
Late age at menarche
Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)
Ankle injury
Alzheimer's disease or type 2 diabetes (pleiotropy)
Narcolepsy
Matrix metalloproteinase-8 levels
Laterality in neovascular age-related macular degeneration
Paternal history of Alzheimer's disease
Family history of Alzheimer's disease
Alzheimer's disease or family history of Alzheimer's disease
Maternal history of Alzheimer's disease
Acute respiratory distress syndrome
Activated partial thromboplastin time
Prothrombin time
Lower body strength
Serum uric acid levels in response to allopurinol in gout
Ratio of apolipoprotein A1 to apolipoprotein B
Esterified cholesterol levels
Free cholesterol levels
Total cholesterol levels in HDL
Total cholesterol levels in LDL
Serum total cholesterol levels
Mean diameter of HDL particles
Mean diameter of LDL particles
Mean diameter of VLDL particles
Very large VLDL particle concentration
Phospholipid levels in very large VLDL
Triglyceride levels in very large VLDL
Phospholipid levels in large VLDL
Total cholesterol levels in large VLDL
Free cholesterol levels in large VLDL
Triglyceride levels in large VLDL
Cholesterol ester levels in large VLDL
Medium VLDL particle concentration
Phospholipid levels in medium VLDL
Total cholesterol levels in medium VLDL
Cholesterol ester levels in medium VLDL
Free cholesterol levels in medium VLDL
Triglyceride levels in medium VLDL
Small VLDL particle concentration
Phospholipid levels in small VLDL
Total cholesterol levels in small VLDL
Free cholesterol levels in small VLDL
Triglyceride levels in small VLDL
Very small VLDL particle concentration
Phospholipid levels in very small VLDL
Triglyceride levels in very small VLDL
IDL particle concentration
Phospholipid levels in IDL
Free cholesterol levels in IDL
Triglyceride levels in IDL
Large LDL particle concentration
Phospholipid levels in large LDL
Total cholesterol levels in large LDL
Cholesterol ester levels in large LDL
Free cholesterol levels in large LDL
Medium LDL particle concentration
Phospholipid levels in medium LDL
Total cholesterol levels in medium LDL
Cholesterol ester levels in medium LDL
Small LDL particle concentration
Total cholesterol levels in small LDL
Very large HDL particle concentration
Phospholipid levels in very large HDL
Total cholesterol levels in very large HDL
Cholesterol ester levels in very large HDL
Free cholesterol levels in very large HDL
Triglyceride levels in very large HDL
Large HDL particle concentration
Phospholipid levels in large HDL
Total cholesterol levels in large HDL
Free cholesterol levels in large HDL
Medium HDL particle concentration
Phospholipid levels in medium HDL
Total cholesterol levels in medium HDL
Cholesterol ester levels in medium HDL
Free cholesterol levels in medium HDL
Small HDL particle concentration
Triglyceride levels in small HDL
Chylomicron and largest VLDL particle concentration
Phospholipid levels in chylomicrons and largest VLDL
Triglyceride levels in chylomicrons and largest VLDL
Survival in head and neck cancer
Risky sexual behaviors (alcohol dependence interaction)
Risky sexual behaviors in alcohol dependence
Hair shape
Heart rate response to exercise
Heart rate response to recovery post exercise
Systemic sclerosis (anti-centromere-positive)
Systemic sclerosis (anti-topoisomerase-positive)
diarrhoeal disease at age 1
diarrhoeal disease at age 1 with doctor diagnosis
diarrhoeal disease at age 2
diarrhoeal disease at age 2 with doctor diagnosis
Curve progression in adolescent idiopathic scoliosis
Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines
Thiopurine-induced leukopenia in inflammatory bowel disease
Cranial base width
Eye morphology
Nose morphology
Lip morphology
Lower facial height
Facial depth
Response to methylphenidate treatment in attention-deficit/hyperactivity disorder
Intracranial haemorrhage in renal transplantation (donors)
End stage renal failure in renal transplantation (recipient effect)
Graft survival time in renal transplantation (recipient effect)
Graft survival time in renal transplantation (donor-recipient interaction)
Acute graft rejection in renal transplantation (recipient effect)
Acute graft rejection in renal transplantation (donor effect)
Acute graft rejection in renal transplantation (donor-recipient interaction)
Forearm bone mineral density
Major depressive disorder (exposed to adversity)
Major depressive disorder (unexposed to adversity)
Osteoarthritis of the hip or knee (with total joint replacement)
Osteoarthritis of the hip or knee
Osteoarthritis of the hip (with total joint replacement)
Osteoarthritis of the knee (with total joint replacement)
Response to antipsychotic treatment in schizophrenia
Response to haloperidol in schizophrenia
Response to perphenazine in schizophrenia
Response to ziprazidone in schizophrenia
Response to quetiapine in schizophrenia
Response to aripiprazole in schizophrenia
Response to risperidone in schizophrenia
Response to olanzapine in schizophrenia
Hip minimal joint space width
Fasting growth hormone levels
Osteoporosis or obesity (pleiotropy)
Survival in sporadic amyotrophic lateral sclerosis
Broad depression or major depressive disorder (self-reported)
Broad depression or major depressive disorder (recurrent)
Broad depression or bipolar disorder
Broad depression or schizophrenia
Smoking initiation
Smoking cessation
Change in glucose in response to thiazide diuretic treatment in hypertension
Non-albumin protein levels
Serum total protein level
Albumin-globulin ratio
Sodium levels
Potassium levels
Chloride levels
Autoimmune hepatitis in primary sclerosing cholangitis
Primary sclerosing cholangitis (small duct vs large duct)
Liver transplant-free survival in primary sclerosing cholangitis (time to event)
Colectomy in primary sclerosing cholangitis
Cholangiocarcinoma in primary sclerosing cholangitis
Cholangiocarcinoma in primary sclerosing cholangitis (time to event)
Colorectal carcinoma in primary sclerosing cholangitis
Gallbladder carcinoma in primary sclerosing cholangitis
Hepatocellular carcinoma in primary sclerosing cholangitis
Headache
Decline in glucose metabolism in posterior cingulate cortex
Dimensional psychopathology (Negative)
Dimensional psychopathology (Positive)
Dimensional psychopathology (Arousal)
Dimensional psychopathology (Social)
Dimensional psychopathology (Cognitive)
N-glycan levels
Systemic lupus erythematosus or rheumatoid arthritis
Left ventricular QRS voltage
Primary spontaneous pneumothorax
Persistent hepatitis B virus infection
Colorectal cancer (alcohol consumption interaction)
Colorectal cancer (smoking interaction)
Severe progression in rheumatoid arthritis
Breast milk fatty acid composition (maternal genotype effect)
Breast milk fatty acid composition (infant genotype effect)
Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)
Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)
Thiopurine-induced severe leukopenia in inflammatory bowel disease
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease
Thiopurine-induced alopecia in inflammatory bowel disease
Thiopurine-induced severe alopecia in inflammatory bowel disease
Thiopurine-induced pancreatitis in inflammatory bowel disease
Thiopurine-induced fever in inflammatory bowel disease
Thiopurine-induced digestive symptoms in inflammatory bowel disease
Thiopurine-induced infection in inflammatory bowel disease
Thiopurine-induced liver dysfunction in inflammatory bowel disease
Thiopurine-induced skin symptoms in inflammatory bowel disease
Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)
Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)
Bone mineral density x blood lead interaction in current smokers (2df test)
Bone mineral density x blood lead interaction in current smokers (1df test)
Empathy quotient
Urinary haptoglobin levels in type 2 diabetes
Plasma haptoglobin levels in type 2 diabetes
Airflow obstruction
Virologic severity in Herpes simplex virus type 2 infection
Plasma trimethyllysine levels
Joint destruction and growth retardation
Acute kidney injury in critical illness
Binge eating behaviour in bipolar disorder
Binge eating behaviour and bipolar disorder
Serum C3d:C3 ratio (systemic complement activation)
Early childhood caries
Excitement-seeking behaviour
Fractures (vertebral)
Platelet-to-lymphocyte ratio
Neutrophil-to-lymphocyte ratio
Neurociticism
Irritable mood
Feeling lonely
Feeling miserable
Experiencing mood swings
Feeling guilty
Worry too long after an embarrassing experience
Feeling fed-up
Feeling nervous
Suffering from nerves
Feeling worry
Feeling hurt
Feeling tense
Mortality
Age at first sexual intercourse
Antipsychotic drug-induced QTc interval change in schizophrenia
Takayasu arteritis
Chronic central serous retinopathy
Frailty index
Alcohol and nicotine co-dependence
Benign prostatic hyperplasia and lower urinary tract symptoms
Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)
Social isolation
Ability to confide in someone
Regular attendance at a gym or sports club
Regular attendance at a pub or social club
Regular attendance at a religious group
Loneliness (MTAG)
Pemphigus foliaceus
Pemphigus
Pemphigus vulgaris
Decreased fine motor function in Charcot-Marie-Tooth disease 1A (eating with utensils)
Hearing loss in Charcot-Marie-Tooth disease 1A
Decreased sensory function in Charcot-Marie-Tooth disease type 1A
Neuropathy in Charcot-Marie-Tooth disease type 1A
Balance difficulty in Charcot-Marie-Tooth disease type 1A
"Decreased fine motor function in Charcot-Marie-Tooth disease 1A (buttons, zippers, fasteners, bottles)"
Walking difficulty in Charcot-Marie-Tooth disease 1A
Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A
First dorsal interosseous strength in Charcot-Marie-Tooth disease 1A
Foot deformity in Charcot-Marie-Tooth disease 1A
Foot plantar flexion strength in Charcot-Marie-Tooth disease 1A
Scoliosis in Charcot-Marie-Tooth disease 1A
Arthritic-like pain in Charcot-Marie-Tooth type 1A
Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A
Working memory
Verbal memory
Visual memory
Reasoning
Information processing speed
Forehead morphology
Upper eyelid morphology
Superior frontal gyrus volume
Superior parietal cortex volume
Superior temporal gyrus volume
Supramarginal gyrus volume
Frontal pole volume
Temporal pole volume
Transverse temporal cortex volume
Insular cortex volume
Ventral diencephalon volume
Choroid plexus volume
Lateral ventricle volume
Lateral ventricle temporal horn volume
Third ventricle volume
Fourth ventricle volume
Corpus callosum posterior volume
Corpus callosum Mid-posterior volume
Corpus callosum central volume
Corpus callosum mid-anterior volume
Caudal anterior-cingulate cortex volume
Caudal middle frontal gyrus volume
Cuneus cortex volume
Entorhinal cortical volume
Fusiform gyrus volume
Inferior parietal cortex volume
Inferior temporal gyrus volume
Isthmus-cingulate cortex volume
Lateral occipital cortex volume
Lateral orbital frontal cortex volume
Lingual gyrus volume
Medial orbital frontal cortex volume
Middle temporal gyrus volume
Parahippocampal gyrus volume
Paracentral lobule volume
Pars opercularis volume
Pars orbitalis volume
Pars triangularis volume
Pericalcarine cortex volume
Postcentral gyrus volume
Posterior-cingulate cortex volume
Precentral gyrus volume
Precuneus cortex volume
Rostral anterior cingulate cortex volume
Rostral middle frontal gyrus volume
Treatment resistant depression
Depressive symptom improvement
Appendicitis
"Cough x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction"
"Dyspnea x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction"
"Phlegm x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction"
Bone mineral density (lumbar spine) in inflammatory bowel disease
Bone mineral density (femoral neck) in inflammatory bowel disease
Cerebrospinal AB1-42 levels in Alzheimer's disease dementia
Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia
Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia
Hippocampal volume in Alzheimer's disease dementia
Logical memory (immediate recall) in Alzheimer's disease dementia
Logical memory (delayed recall) in Alzheimer's disease dementia
Cerebrospinal AB1-42 levels in mild cognitive impairment
Cerebrospinal fluid t-tau levels in mild cognitive impairment
Cerebrospinal fluid p-tau levels in mild cognitive impairment
Hippocampal volume in mild cognitive impairment
Logical memory (immediate recall) in mild cognitive impairment
Logical memory (delayed recall) in mild cognitive impairment
Cerebrospinal AB1-42 levels in normal cognition
Cerebrospinal fluid t-tau levels in normal cognition
Cerebrospinal fluid p-tau levels in normal cognition
Hippocampal volume in normal cognition
Logical memory (immediate recall) in normal cognition
Logical memory (delayed recall) in normal cognition
Cerebrospinal fluid p-tau levels
Logical memory (immediate recall)
Logical memory (delayed recall)
Schizophrenia vs type 2 diabetes
Type 2 diabetes vs schizophrenia and type 2 diabetes
Schizophrenia and type 2 diabetes
Schizophrenia vs schizophrenia and type 2 diabetes
Platelet count and reactivity phenotypes
Response to interferon treatment in hepatitis C virus genotype 3
Response to direct-acting antiviral treatment in hepatitis C virus genotype 3
Pre-treatment viral load in hepatitis C virus genotype 3
Esophageal adenocarcinoma x BMI interaction
Esophageal adenocarcinoma x smoking interaction
Esophageal adenocarcinoma x pack-years of smoking exposure interaction
Esophageal adenocarcinoma x gastroesophageal reflux disease interaction
Barrett's esophagus x BMI interaction
Barrett's esophagus x pack-years of smoking exposure interaction
Barrett's esophagus x smoking interaction
Barrett's esophagus x gastroesophageal reflux disease interaction
Smoking behaviour (maximum cigarettes in a 24 hour period)
Nicotine withdrawal symptom count
Nicotine withdrawal
Response to inhaled corticosteroid treatment in asthma (change in FEV1)
Normal facial asymmetry (angle of surface orientation score)
Normal facial asymmetry (angle of deformation score)
Normal facial asymmetry (deformation magnitude)
Serum metabolite concentrations in chronic kidney disease
Urinary metabolite ratios in chronic kidney disease
Serum metabolite ratios in chronic kidney disease
Urinary metabolite levels in chronic kidney disease
Fractional excretion of metabolites in chronic kidney disease
Liver disease severity in Alagille syndrome
Factor XI
Optic nerve measurement (cup-to-disc ratio)
Erosive tooth wear (severe vs non-severe)
Erosive tooth wear (severe vs none or mild)
Vitiligo (late onset)
Vitiligo (early onset)
Keratinocyte cancer (MTAG)
Squamous cell carcinoma
Ischemic stroke (large artery atherosclerosis)
Ischemic stroke (small-vessel)
Deliberate self-harm
Suicidality (suicidal ideation/attempts)
Suicidality
Brain glucose metabolism (fluorodeoxyglucose uptake)
Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia
Suicide attempts in bipolar disorder
Suicide attempts in schizophrenia
Suicide attempts in major depressive disorder or bipolar disorder
Suicide attempts in bipolar disorder or schizophrenia
Alzheimer's disease in hypertension-negative individuals
Alzheimer's disease in hypertension
Cortisol levels (plasma)
DHEAS levels
Progesterone levels
17-hydroxyprogesterone (17-OHP) levels
Androstenedione levels
Aldosterone levels
Infliximab-induced mucosal healing in Crohn's disease
Smoking behaviour (age at first cigarette)
Triacylglyceride levels
Ceramide levels
Diacylglyceride levels
Lysophosphatidylcholine levels
Lysophosphatidylethanolamine levels
Phosphatidylcholine levels
Phosphatidylcholine-ether levels
Phosphatidylethanolamine levels
Phosphatidylethanolamine-ether levels
Phosphatidylinositol levels
Cholesteryl ester levels
Sphingomyelin levels
Sterol levels
Allergic rhinitis x sex interaction
Diabetes (gestational)
Alcohol withdrawal symptoms
Mental health study participation (provided email address)
Mental health study participation (completed survey)
Platelet reactivity measurement (collagen-ADP)
Platelet reactivity measurement (collagen-epinephrine)
Number of alcoholic drinks required to feel an effect (first five times drinking)
Number of alcoholic drinks required to feel an effect (long-term average)
Lymphangioleiomyomatosis (sporadic)
End-stage kidney disease
Mild to moderate chronic kidney disease
Longevity (age >90th survival percentile)
Longevity (age >99th survival percentile)
Chronic mountain sickness
Urinary sodium excretion
Urinary potassium excretion
Fasting glucose change
Fasting glucose change (long-term)
Fasting glucose change (short-term)
Diabetic maculopathy with decreased visual acuity in type 2 diabetes
Diabetic maculopathy in type 2 diabetes
Plasma factor V levels in venous thrombosis
Plasma factor V levels in venous thrombosis (conditioned on rs6027)
Non-muscle-invasive bladder cancer age at diagnosis
Non-muscle-invasive bladder cancer age at diagnosis (< 70 years vs ≥ 70 years)
Non-muscle-invasive bladder cancer tumour size
Non-muscle-invasive bladder cancer tumour size (< 3 cm vs ≥ 3 cm)
Non-muscle-invasive bladder cancer tumour stage (Tis/T1 vs Ta)
Non-muscle-invasive bladder cancer tumour grade (G3 vs G2/G1)
Non-muscle-invasive bladder cancer EORTC risk category
Diastolic blood pressure x physical activity (least active quartile vs others) interaction (2df)
Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)
Diastolic blood pressure x physical activity (least vs most active quartile) interaction (2df)
Systolic blood pressure x physical activity (least active quartile vs others) interaction (2df)
Systolic blood pressure x physical activity (less vs more active half) interaction (2df)
Systolic blood pressure x physical activity (least vs most active quartile) interaction (2df)
Systolic blood pressure x physical activity interaction (2df)
Diastolic blood pressure x physical activity (least active quartile vs others) interaction (1df)
Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)
Diastolic blood pressure x physical activity (least vs most active quartile) interaction (1df)
Systolic blood pressure x physical activity (least active quartile vs others) interaction (1df)
Systolic blood pressure x physical activity (less vs more active half) interaction (1df)
Systolic blood pressure x physical activity (least vs most active quartile) interaction (1df)
Systolic blood pressure x physical activity interaction (1df)
Diastolic blood pressure x physical activity interaction (1df)
DIastolic blood pressure x physical activity interaction (2df)
Chronic lymphocytic leukemia or multiple sclerosis
Diffuse large B-cell lymphoma or multiple sclerosis
Follicular lymphoma or multiple sclerosis
Marginal zone lymphoma or multiple sclerosis
Chronic lymphocytic leukemia or rheumatoid arthritis
Diffuse large B-cell lymphoma or rheumatoid arthritis
Follicular lymphoma or rheumatoid arthritis
Marginal zone lymphoma or rheumatoid arthritis
Chronic lymphocytic leukemia or systemic lupus erythematosus
Diffuse large B-cell lymphoma or systemic lupus erythematosus
Follicular lymphoma or systemic lupus erythematosus
Marginal zone lymphoma or systemic lupus erythematosus
Estimated glomerular filtration rate in diabetes
Estimated glomerular filtration rate in non-diabetics
Response to SSRI (symptom improvement)
Response to antidepressants (symptom improvement)
Response to SSRI (symptom remission)
Response to antidepressants (symptom remission)
Uveitis (juvenile idiopathic arthritis-associated)
Uveitis in juvenile idiopathic arthritis
Familial lung cancer
Familial lung adenocarcinoma
Familial squamous cell lung carcinoma
Obsessive-compulsive disorder
Obsessive-compulsive disorder x sex interaction
Autistic traits score (Social and Communication Disorders Checklist)
Systemising
Childhood dental caries in primary teeth
Childhood dental caries in permanent teeth
Corpus callosum anterior volume
Cortex volume
Cerebral white matter volume
Sub-cortical grey matter volume
Total grey matter volume
Whole brain grey matter density
Total intracranial volume
Cerebellum white matter volume
Cerebellum cortex volume
Superior temporal sulcus banks volume
"Parental longevity (combined parental attained age, Martingale residuals)"
Parental longevity (both parents in top 10%)
Parental longevity (mother's attained age)
Parental longevity (father's attained age)
Verbal intelligence quotient (cesarean section interaction)
Performance intelligence quotient (cesarean section interaction)
Full scale intelligence quotient (cesarean section interaction)
Fatty acid desaturase activity (serum)
Fatty acid desaturase activity (adipose tissue)
Insulin resistance/response
Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)
Systolic blood pressure x alcohol consumption interaction (2df test)
Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)
Pulse pressure x alcohol consumption interaction (2df test)
Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)
Mean arterial pressure x alcohol consumption interaction (2df test)
Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)
Diastolic blood pressure x alcohol consumption interaction (2df test)
Type 2 diabetes or obesity or coronary artery disease (pleiotropy)
PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia
Silent asparaginase inactivation in childhood acute lymphoblastic leukaemia
PEG-asparaginase hypersensitivity in childhood acute lymphoblastic leukaemia (allergic reaction grade 2 or more)
Gut microbiota (alpha diversity)
Gut microbiota relative abundance (bacterial taxa)
Parental longevity (father's age at death or father's attained age)
Parental longevity (mother's age at death or mother's attained age)
Longevity
Stress sensitivity (neuroticism score x major depressive disorder status interaction)
Estimated glomerular filtration rate reduction (30%)
Incident chronic kidney disease
Asthma (time to onset)
Abstraction and mental flexibility
Face memory
Sensorimotor dexterity
Spatial memory
Spatial processing
California verbal learning test score
Degraded stimulus continuous performance test score
Letter-number span reordering
Prepulse inhibition of the startle response
Antisaccade task score
Non-lobar intracerebral hemorrhage
Lobar intracerebral hemorrhage
Intracerebral hemorrhage (MTAG)
Non-lobar intracerebral hemorrhage (MTAG)
Lobar intracerebral hemorrhage (MTAG)
Glioma (high-grade)
Irritable bowel syndrome
Cocaine dependence
Skin youthfulness
Schizophrenia or bipolar disorder
Narcolepsy (onset before 2009 H1N1 influenza pandemic)
Narcolepsy (age of onset)
"Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)"
Diabetic retinopathy in type 2 diabetes
Crohn's disease-related phenotypes
Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection
Androgen levels
Skin fluorescence
Neuroblastoma
Social autistic-like traits
Response to platinum-based chemotherapy in non-small-cell lung cancer
Adverse response to radiation therapy
Smoking behavior
C-reactive protein
Carotid plaque burden (smoking interaction)
Paclitaxel-induced neuropathy
Lipopolysaccharide induced cytokine levels
IgE levels in asthmatics
IgE levels in asthmatics (D.p. specific)
IgE levels in asthmatics (D.f. specific)
Serum lipase activity
High serum lipase activity
Asthma and hay fever
Chemerin levels
Hepatitis B vaccine response
Allergic dermatitis (nickel)
Lung Cancer (DNA repair capacity)
Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)
Response to abacavir-containing treatment in HIV-1 infection (virologic failure)
Angioedema in response to angiotensin-converting enzyme inhibitor
Bladder cancer (smoking interaction)
Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)
Cytomegalovirus antibody response
Hepatic lipid content in extreme obesity
Bilirubin levels in extreme obesity
Naphthyl-keratin adduct levels
Hypospadias
Amyotrophic lateral sclerosis or frontotemporal dementia
Fractional exhaled nitric oxide (childhood)
Pneumoconiosis in silica exposure
Soluble leptin receptor levels
Apolipoprotein Levels
Cholesterol and Triglycerides
IgG levels
Response to TNF-alpha inhibitors in rheumatoid arthritis
Osteoarthritis
Colorectal cancer (calcium intake interaction)
Acute anterior uveitis (with or without ankylosing spondylitis)
Acute anterior uveitis in ankylosing spondylitis
Political ideology
Height adjusted BMI
Response to cytidine analogues (gemcitabine)
Response to cytadine analogues (cytosine arabinoside)
Electrocardiographic traits
AIDS progression
Pain
Beta-2 microglubulin plasma levels
Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)
Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)
Response to radiotherapy in prostate cancer (toxicity)
Age-related macular degeneration
Chronic mucus hypersecretion in chronic obstructive pulmonary disease
Chronic mucus hypersecretion
Corneal curvature
Confectionary intake
CYP3A4 enzyme activity
Red blood cell traits
Protein biomarker
Sasang constitutional medicine type
Complement C3 and C4 levels
"Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)"
Lung cancer (smoking interaction)
Depression (age of onset)
Blood metabolite ratios
Psoriatic arthritis
Serologic markers in systemic lupus erythematosus
Non-small cell lung cancer (recurrence rate)
Plasma amyloid beta peptide concentrations (ABx-40)
Plasma amyloid beta peptide concentrations (ABx-42)
Serum thyroid-stimulating hormone levels
Thyroid peroxidase antibody levels
Kidney function decline traits
Inflammatory biomarkers in Kawasaki disease
Hypertension (young onset)
Enteric fever
Response to antiplatelet therapy
Lupus nephritis in systemic lupus erythematosus
Exfoliation glaucoma or exfoliation syndrome
IgA levels
Methotrexate clearance (acute lymphoblastic leukemia)
Response to taxane treatment (placlitaxel)
Response to taxane treatment (docetaxel)
Non-alcoholic fatty liver disease histology (other)
Episodic memory
Infantile hypertrophic pyloric stenosis
Reading disability and language impairment
"Bone mineral density (paediatric, upper limb)"
"Bone mineral density (paediatric, total body less head)"
"Bone mineral density (paediatric, lower limb)"
"Bone mineral density (paediatric, skull)"
Otitis media (chronic/recurrent)
Myopia (pathological)
Coronary artery disease-related phenotypes
Response to temozolomide
Ossification of the posterior longitudinal ligament of the spine
Puberty onset (genital enlargement)
Puberty onset (breast development)
Puberty onset
Recombination measurement
Homocysteine levels
Tourette's syndrome or obsessive-compulsive disorder
Conotruncal heart defects
Amyotrophic lateral sclerosis (age of onset)
Cleft plate (environmental tobacco smoke interaction)
Asymmetrical dimethylarginine levels
Symmetrical dimethylarginine levels
Serum dimethylarginine levels (asymmetric/symetric ratio)
Elevated serum carcinoembryonic antigen levels
Personality dimensions
Handedness
Response to methotrexate in juvenile idiopathic arthritis
Cognitive decline
Spine bone size
Antinuclear antibody levels
Amyloid A serum levels
Alcohol dependence (age at onset)
Musical aptitude
Fetal hemoglobin levels in sickle cell anemia
HDL cholesterol (SNP x SNP interaction)
Immune response to measles-mumps-rubella vaccine
Kashin-Beck disease
Methotrexate phramacokinetics (acute lymphoblastic leukemia)
Response to interferon beta therapy
Psychosis (atypical)
Opioid sensitivity
Bronchopulmonary dysplasia
Recombination measurement (females)
Recombination measurement (males)
Chronic hepatitis C infection
Obesity
Body mass index (change over time)
Underweight status
Overweight status
Schizophrenia (treatment resistant)
Rheumatoid factor
Anti-citrullinated peptide antibody
Sleep time
Sleep quality
Sleep depth
Cotinine glucuronidation
Nicotine glucouronidation
Stroke (ischemic)
Thoracic aortic aneurysms and dissections
Serum vitamin D-binding protein levels
Lipid metabolism phenotypes
Allergic sensitization
Mesial temporal lobe epilepsy with hippocampal sclerosis
Myopia (severe)
Serum alpha1-antitrypsin levels
"Functional impairment in major depressive disorder, bipolar disorder and schizophrenia"
Febrile seizures
Febrile seizures (MMR vaccine-unrelated)
Febrile seizures (MMR vaccine-related)
PR segment duration
Parkinson disease and lewy body pathology
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement
Response to Homoharringtonine (cytotoxicity)
Hippocampal atrophy
Plasma plasminogen activator levels
Milk allergy
Egg allergy
Hepatitis
Nasopharyngeal carcinoma (SNP x SNP interaction)
Homoarginine levels
Gastritis
Gene methylation in lung tissue
Blood pressure response to hydrochlorothiazide in hypertension
Facial pigmentation
Verbal declarative memory
Myasthenia gravis
Glomerular filtration rate in non diabetics (creatinine)
Glomerular filtration rate in diabetics (creatinine)
Cognitive decline rate in late mild cognitive impairment
Periodontal disease-related phenotype (Socransky)
Periodontal disease related phenotype (PCT2)
Periodontal disease related phenotype (PCT3)
Periodontal disease related phenotype (PCT4)
Periodontal disease related phenotype (PCT5)
Periodontal disease related phenotype (PCT6)
Alzheimer disease and age of onset
Acute mountain sickness
Congenital left-sided heart lesions
Obstructive sleep apnea (average oxygen saturation during sleep)
Obstructive sleep apnea trait (average respiratory event duration)
Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
Glucocorticoid-induced osteonecrosis (time dependent analysis)
Glucocorticoid-induced osteonecrosis (time independent analysis)
Glucocorticoid-induced osteonecrosis
Serum lycopene concentrations
Early response to risperidone in schizophrenia
Low bone mineral density (spine)
Low bone mineral density (hip)
Manic episodes in bipolar disorder
Depressive episodes in bipolar disorder
Depressive and manic episodes in bipolar disorder
Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)
Progression free survival in metastatic colorectal cancer (chemotherapy interaction)
Survival in breast cancer (estrogen-receptor negative)
Urinary albumin-to-creatinine ratio in non-diabetics
Incident coronary heart disease
Incident myocardial infarction
Longitudinal change in brain amyloid plaque burden
Percentage gas trapping
Airway imaging phenotypes
Emphysema imaging phenotypes
Proteinuria in chronic kidney disease
Proteinuria and chronic kidney disease
Glomerular filtration rate in chronic kidney disease
Colorectal or endometrial cancer
Skin colour saturation
Perceived skin darkness
Skin sensitivity to sun
Magnesium levels
Endophenotypes for schizophrenia in healthy individuals
Response to stavudine in HIV (lipoatrophy)
Perioperative myocardial infarction in coronary artery bypass surgery
3-hydroxypropylmercapturic acid levels in smokers
3-hydroxy-1-methylpropylmercapturic acid levels in smokers
Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis
Asparaginase hypersensitivity in acute lymphoblastic leukemia
Cannabis use (initiation)
Paclitaxel-induced cytotoxicity
Platelet aggregation
Multiple myeloma and monoclonal gammopathy
Classic bladder exstrophy
Response to zileuton treatment in asthma (FEV1 change interaction)
Bone mineral accretion in asthma (oral corticosteroid dose interaction)
Peak creatinine levels in vancomycin therapy
Vancomycin trough in vancomycin therapy
Renal elimination rate in vancomycin therapy
Sporadic pituitary adenoma
Lapatinib-induced hepatotoxicity
HIV-1 viral setpoint
Pyoderma gangrenosum in inflammatory bowel disease
Erythema nodosum in inflammatory bowel disease
Sex hormone levels
Response to simvastatin treatment (PCSK9 protein level change)
Epilepsy and lamotrigine-induced maculopapular eruptions
Yu-Zhi constitution type in type 2 diabetes
Hearing function (high tone)
Hearing function (0.25 kHz)
Hearing function (0.5 kHz)
Hearing function (1 kHz)
Hearing function (2 kHz)
Hearing function (4 kHz)
Hearing function (8 kHz)
Hearing function (low tone)
Hearing function (medium tone)
Hypersomnia during a major depressive episode in bipolar disorder
Lung cancer (asbestos exposure interaction)
Cryptorchidism
Blond vs non-blond hair color
Brown vs. non-brown hair color
Light vs. dark hair color
Red vs non-red hair color
Black vs. non-black hair color
Sight-threatening diabetic retinopathy in type 2 diabetes
Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder
Atrioventricular septal defects in Down syndrome
Asperger syndrome
Trichloroethylene-induced hypersensitivity syndrome
Multiple myeloma (survival)
Postprandial triglyceride response to high fat diet meal
MGMT methylation in smokers
Anthracycline-induced cardiotoxicity in childhood cancer
Ultraviolet-induced skin pigmentation (minimal erythema dose)
Warfarin maintenance dose
Fentanyl consumption in laparoscopic-assisted colectomy (first 24 hours)
Attention function in attention deficit hyperactive disorder
Ischemic stroke (undetermined subtype)
Adenocarcinoma
IgG1 response to Plasmodium falciparum antigen (GLURP)
"IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7)"
IgG1 response to Plasmodium falciparum antigen (MSP1)
IgG3 response to Plasmodium falciparum antigen (MSP2 3D7)
IgG3 response to Plasmodium falciparum antigen (MSP2 FC27)
Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)
Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)
Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)
Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)
Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)
Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)
Delta-5 desaturase activity
Delta-6 desaturase activity
Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)
Nickel levels
Chromium levels
Cobalt levels
Aluminium levels
Manganese levels
Molybdenum levels
Lead levels
Zinc levels
Mercury levels
Cadmium levels
Copper levels
Thrombosis
Alzheimer's disease or small vessel stroke
White matter hyperintensity burden
White matter hyperintensities in ischemic stroke
Thoracic-to-hip circumference ratio
Early childhood aggressive behavior
Middle childhood and early adolescence aggressive behavior
Childhood and early adolescence aggressive behavior
Rapid functional decline in sporadic amyotrophic lateral sclerosis
Moderate functional decline in sporadic amyotrophic lateral sclerosis
Calcaneal bone ultrasound measurement (speed of sound)
Colorectal cancer (menopausal hormone therapy interaction)
Colorectal cancer (oestrogen-progestogen hormone therapy interaction)
Colorectal cancer (oestrogen hormone therapy interaction)
Glaucoma (low intraocular pressure)
Glaucoma (high intraocular pressure)
Phospholipid levels
Anxiety disorder
Anxiety disorder (factor score)
Response to anti-TNF therapy in rheumatoid arthritis
Inguinal hernia
Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis
World class endurance athleticism
Endurance athleticism
Exploratory eye movement dysfunction in schizophrenia (responsive search score)
Exploratory eye movement dysfunction in schizophrenia (total eye scanning length)
Exploratory eye movement dysfunction in schizophrenia (mean eye scanning length)
Exploratory eye movement dysfunction in schizophrenia (number of eye fixations)
Exploratory eye movement dysfunction in schizophrenia (cognitive search score)
Brain arteriovenous malformations (sporadic)
antipsychotic drug dosage in schizophrenia or schizoaffective disorder
Axial length
Platinum-induced myelosuppression in non-small cell lung cancer
Cutaneous psoriasis
Psoriatic arthritis vs Cutaneous psoriasis
C-reactive protein levels in ischemic stroke
Thrombomodulin levels in ischemic stroke
Creatinine levels in ischemic stroke
Thrombin-antithrombin complex levels in ischemic stroke
Fibrinogen levels in ischemic stroke
Prothrombin fragments F1+2 levels in ischemic stroke
circulating leptin levels adjusted for BMI
circulating leptin levels
Gut microbiome composition (summer)
Gut microbiome composition (summer and winter)
Gut microbiome composition (winter)
Low high density lipoprotein cholesterol levels
NT-proBNP levels in acute coronary syndrome
Entorhinal cortical thickness
Whole-brain volume
Entorhinal cortical thickness (Alzheimer's disease interaction)
Total ventricular volume
Entorhinal cortical volume (Alzheimer's disease interaction)
Total ventricular volume (Alzheimer's disease interaction)
Whole-brain volume (Alzheimer's disease interaction)
Hippocampal volume (Alzheimer's disease interaction)
Scalp hair shape
Beard thickness
Eyebrow thickness
Monobrow thickness
Hair greying
Balding
Body mass index (age interaction)
Ischemic stroke (small artery occlusion)
Length of menstrual cycle
Atrophic age-related macular degeneration
Sex ratio
Clozapine-induced cytotoxicity
Cisplatin-induced hearing loss in brain tumor patients
Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia
Oligoclonal band status in multiple sclerosis
Immunoglobulin G index levels in multiple sclerosis
Cardiac Troponin-T levels
Mathematical ability in children with dyslexia
Body mass (lean)
Digit length ratio
Asthma (bronchodilator response)
Coffee consumption (cups per day)
Very long-chain saturated fatty acid levels (fatty acid 20:0)
Very long-chain saturated fatty acid levels (fatty acid 22:0)
Very long-chain saturated fatty acid levels (fatty acid 24:0)
Exhaled carbon monoxide levels
Number of children (6+ vs. 0 or 1)
Number of children
Number of pregnancies
Urate levels in lean individuals
Urate levels (BMI interaction)
Urate levels in overweight individuals
Urate levels in obese individuals
Cutaneous lupus erythematosus
Sasang constitutional medicine type (So-Eum)
Sasang constitutional medicine type (Tae-Eum)
Sasang constitutional medicine type (So-Yang)
Sasang constitutional medicine type (Tae-Yang)
Developmental dysplasia of the hip
Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)
Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)
Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)
Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)
Serum IgE levels
Non-small cell lung cancer (survival)
Dental caries
Cataracts in type 2 diabetes
Leishmaniasis (visceral)
Sagittal craniosynostosis
Food antigen IgG levels
Musician's dystonia
Lung cancer (SNP x SNP interaction)
Brugada syndrome
Obesity (early onset extreme)
Anterior chamber depth
Iron status biomarkers (transferrin levels)
Vogt-Koyanagi-Harada syndrome
Response to chemotherapy in breast cancer (hypertension) (bevacizumab)
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)
Aggressive periodontitis (sex interaction)
Circulating phylloquinone levels
Sickle cell anemia (haemolysis)
Birdshot chorioretinopathy
Hip circumference (psychosocial stress interaction)
Acoustic startle blink response
Heschl's gyrus morphology
Lung cancer (household air pollution interaction)
Response to methotrexate in rheumatoid arthritis
Airway hyperresponsiveness
Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)
Pulmonary function in asthmatics
Fractional exhaled nitric oxide levels
Plasma renin activity levels
Serum VEGFR2 concentration
Follicular lymphoma
Acute lymphoblastic leukemia (adolescents and young adults)
Lipoprotein (a) - cholesterol levels
Schizophrenia (inflammation and infection response interaction)
Bipolar disorder (inflammation and infection response interaction)
Colorectal cancer (SNP x SNP interaction)
Survival in microsatellite instability low/stable colorectal cancer
Survival in rectal cancer
Executive function
Myeloproliferative neoplasms
Cytokine-stimulated IL-6 production
Cytokine and corticosteroid-stimulated IL-6 production
Suicide in bipolar disorder
LDL cholesterol subfractions
Response to statin therapy (LDL cholesterol subfractions)
"Response to anti-TNF treatment (adalimumab, etanercept or infliximab) in rheumatoid arthritis"
Polychlorinated biphenyl levels
Creutzfeldt-Jakob disease (sporadic)
Type 1 diabetes and autoimmune thyroid diseases
Chronic obstructive pulmonary disease-related biomarkers
Serum tamsulosin hydrochloride concentration
Systemic lupus erythematosus and Systemic sclerosis
Acute myeloid leukemia
Asthma or chronic obstructive pulmonary disease
Red wine liking
White wine liking
Age-related nuclear cataracts
Antibody level in response to infection
Colorectal cancer (aspirin and/or NSAID use interaction)
HIV-1 susceptibility
Chronic hepatitis B infection
Spontaneous preterm birth (preterm delivery)
Sitting height ratio
Disease-free survival in breast cancer
Total bilirubin levels in HIV-1 infection
Neutrophil count in HIV-infection
HDL Cholesterol in HIV-infection
Response to serotonin reuptake inhibitors in major depressive disorder
Vein graft stenosis in coronary artery bypass grafting
Carotid artery intima media thickness (sex interaction)
Diisocyanate-induced asthma
Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor
AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor
Recalcitrant atopic dermatitis
Prostate cancer aggressiveness
ADAMTS13 activity
Adult antisocial behavior
Personality disorders
"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)"
Gray matter volume (schizophrenia interaction)
Expressive vocabulary in infants
White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy
Fibromyalgia
Persistent attention-deficit hyperactivity disorder
Plasma plasminogen levels
Diffuse large B cell lymphoma
Neuropathic pain in type 2 diabetes
Iris characteristics
Mammographic density
Thiazide-induced adverse metabolic effects in hypertensive patients
Proinsulin levels
Platelet thrombus formation
Rotator cuff tears
Pediatric autoimmune diseases
Influenza A (H1N1) severity
Influenza A (H1N1) infection
Mild influenza (H1N1) infection
Severe influenza A (H1N1) infection
Postoperative atrial fibrillation in coronary artery bypass grafting surgery
Staphylococcus aureus nasal carriage (persistent)
Staphylococcus aureus nasal carriage (intermittent)
Postburn hypertrophic scarring severity
Myositis
Urinary metabolites
Mitral valve prolapse
Response to metformin in type 2 diabetes (glycemic)
Hoarding
Anti-cyclic Citrullinated Peptide Antibody
Amyotrophic lateral sclerosis (SNP x SNP interaction)
Lp (a) levels
Blue vs. green eyes
Burning and freckling
Blond vs. brown hair color
Red vs. non-red hair color
Type 2 diabetes nephropathy
Homeostasis model assessment of beta-cell function
Phytosterol levels
Idiopathic membranous nephropathy
Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
Lipoprotein-associated phospholipase A2 activity and mass
Response to hepatitis C treatment
Waist circumference and related phenotypes
Progressive supranuclear palsy
Fibrinogen
Obesity-related traits
AIDS
Menarche and menopause (age at onset)
Monocyte early outgrowth colony forming units
HIV-1 control
Pulmonary function
Adiposity
Cutaneous nevi
Cardiac hypertrophy
Glomerulosclerosis
Fat intake
Prion diseases
Vitiligo (non-segmental)
Obesity and osteoporosis
C4b binding protein levels
Urinary bladder cancer
Radiation response
Arterial stiffness
Diabetic retinopathy
Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)
Sudden cardiac arrest
Hepatocellular carcinoma
Ribavirin-induced anemia
Immunoglobulin A
Metabolic traits
Hepatitis C induced liver cirrhosis
Hearing impairment
Response to citalopram treatment
Methamphetamine dependence
Matrix metalloproteinase levels
Response to platinum-based chemotherapy in head and neck cancers
Autism
Speech perception in dyslexia
Major depressive disorder (broad)
Frontotemporal lobar degeneration
Neuroticism (age interaction)
Major mood disorders
Emphysema-related traits
Nephrotic syndrome (acquired)
Myocardial infarction in coronary artery disease
Multiple sclerosis (severity)
Alzheimer's disease biomarkers
Brain cytoarchitecture
Asthma (toluene diisocyanate-induced)
Response to treatment for acute lymphoblastic leukemia
Creutzfeldt-Jakob disease
Two-hour glucose challenge
Otosclerosis
Angiotensin-converting enzyme activity
Testicular cancer
Polyunsaturated fatty acid levels
Lumiracoxib-related liver injury
Inflammatory bowel disease (early onset)
HIV-1 replication
Bitter taste response
Electroencephalogram traits
Coagulation factor levels
Body mass index and fat mass
Type 1 diabetes autoantibodies
Male infertility
Malignant pleural mesothelioma
Helicobacter pylori serologic status
Response to statin therapy
Cardiac structure and function
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
Brachial circumference
Chronic fatigue syndrome
Lentiform nucleus volume
Permanent tooth development
Bipolar disorder and schizophrenia
Malaria
Pit-and-Fissure caries
Smooth-surface caries
Renal function-related traits (BUN)
Renal function-related traits (sCR)
Renal function-related traits (eGRFcrea)
Renal function-related traits (urea)
Aging (facial)
End-stage coagulation
Schizophrenia (negative symptoms)
Circulating vasoactive peptide levels
IgE levels
Response to diuretic therapy
Blood trace element (Se levels)
Blood trace element (Cu levels)
Blood trace element (Zn levels)
Hematological parameters
Brain development
Ovarian reserve
"Schizophrenia, bipolar disorder and depression (combined)"
Leisure-time exercise behaviour
Testicular dysgenesis syndrome
Ileal carcinoids
Adverse response to aromatase inhibitors
IgE grass sensitization
Thyroid function
Protein quantitative trait loci
Pubertal anthropometrics
Response to TNF antagonist treatment
Soluble ICAM-1
Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)
Conduct disorder (maternal expressed emotions interaction)
Life threatening arrhythmia
Keloid
Black vs. blond hair color
Black vs. red hair color
Attention deficit hyperactivity disorder and conduct disorder
Biliary atresia
Crohn's disease and sarcoidosis (combined)
Osteoporosis
Cardiovascular disease risk factors
Scoliosis
Colorectal cancer (environment interaction)
DNA methylation (parent-of-origin)
DNA methylation (variation)
Interstitial lung disease
Pulmonary arterial hypertension (without BMPR2 mutations)
β2-Glycoprotein I (β2-GPI) plasma levels
Relative hand skill in reading disability
Relative hand skill
Coronary artery calcification
Subclinical brain infarct
Response to dabigatran etexilate treatment
Immune response to anthrax vaccine
Response to Vitamin E supplementation
Gamma glutamyl transpeptidase
Electroencephalographic traits in alcoholism
Renal sinus fat
Asthma treatment response
Response to antipsychotic treatment in schizophrenia (working memory)
Response to antipsychotic treatment in schizophrenia (reasoning)
Depression (quantitative trait)
Ulcerative colitis or Crohn's disease
Urinary symptoms in response to radiotherapy in prostate cancer
Clozapine-induced agranulocytosis
Tumor biomarkers
Body mass index in non-asthmatics
Body mass index in asthmatics
Amyotrophic lateral sclerosis (C9orf72 mutation interaction)
Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals
Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals
Response to fenofibrate (adiponectin levels)
Breast cancer (male)
Disc degeneration (lumbar)
Metabolite levels (HVA/5-HIAA ratio)
Metabolite levels (HVA-5-HIAA Factor score)
Metabolite levels (HVA)
Metabolite levels (5-HIAA)
Metabolite levels (MHPG)
Metabolite levels (5-HIAA/ MHPG Ratio)
Metabolite levels (HVA/MHPG ratio)
Bipolar disorder (Negative mood delusions)
Head circumference (infant)
Vitamin E levels
HPV seropositivity
Esophageal cancer and gastric cancer
Non-obstructive azoospermia
Aging
Neonatal lupus
Partial epilepsies
Suicide risk
Response to ximelagatran treatment (increased serum alanine aminotransferase levels)
Type 2 diabetes and 6 quantitative traits
Factor VII
Hemostatic factors and hematological phenotypes
Urinary albumin excretion
Retinal vascular caliber
Intelligence (childhood)
Fetal hemoglobin levels
HIV-1 progression
Osteonecrosis of the jaw
Select biomarker traits
Blue vs. brown eyes
F-cell distribution
Memory (short-term)
Premature ovarian failure
Crohn's disease (time to surgery)
Crohn's disease (need for surgery)
Testicular germ cell cancer
Eye color traits
Brain structure (hippocampal volume)
Brain structure (temporal lobe volume)
Corneal structure
Vaccine-related adverse events
Lung adenocarcinoma (clinical stage)
IgG glycosylation
Metabolic syndrome (bivariate traits)
Waist Circumference - Triglycerides (WC-TG)
HDL Cholesterol - Triglycerides (HDLC-TG)
Triglycerides-Blood Pressure (TG-BP)
Lapatinib-induced hepatotoxicity in breast cancer
Other erythrocyte phenotypes
Prostate cancer (SNP x SNP interaction)
Temperament (bipolar disorder)
Response to tamoxifen in breast cancer
Vascular dementia
RR interval (heart rate)
Response to platinum-based chemotherapy in small-cell lung cancer
Glaucoma (exfoliation)
Iron levels
Non-alcoholic fatty liver disease histology (lobular)
Non-alcoholic fatty liver disease histology (AST)
Rhegmatogenous retinal detachment
Vitamin D insufficiency
Neuranatomic and neurocognitive phenotypes
Stevens-Johnson syndrome
Psychosis (methamphetamine induced)
Alcoholism (heaviness of drinking)
Alcoholism (12-month weekly alcohol consumption)
Alcoholism (alcohol use disorder factor score)
Alcoholism (alcohol dependence factor score)
F-cell distribution in sickle cell anaemia
Freckling
Common traits (Other)
Biomedical quantitative traits
Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)
Quantitative traits
Liver enzyme levels
Vascular constriction
Serum prostate-specific antigen levels
Lupus
Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)
Acute lung injury
Common variable immunodeficiency
Age-related macular degeneration (smoking status interaction)
Age-related macular degeneration (extreme sampling)
Inattentive symptoms
Hyperactive-impulsive symptoms
Neuroblastoma (high-risk)
Cortisol secretion
Optic disc parameters
Suicidal ideation
Aspirin intolerance in asthmatics
Response to antidepressant treatment
Brain structure
Attention deficit hyperactivity disorder (time to onset)
Heart rate variability traits
Brain imaging
Beta thalassemia/hemoglobin E disease
Social and non-social autistic-like traits
Asthma or atopy (farm exposure interaction)
Autism spectrum disorders (language delay)
Acenocoumarol maintenance dosage
Folate pathway vitamin levels
Cerebrospinal T-tau levels
Cerebrospinal P-tau181p levels
Hair morphology
Exercise treadmill test traits
Echocardiographic traits
Endothelial function traits
Volumetric brain MRI
Cognitive test performance
Coronary spasm
Primary tooth development (number of teeth)
Primary tooth development (time to first tooth eruption)
Large B-cell lymphoma
Iron deficiency
Attention deficit hyperactivity disorder motor coordination
5-HTT brain serotonin transporter levels
Functional MRI
Optic nerve measurement (cup area)
Optic nerve measurement (rim area)
Optic nerve measurement (disc area)
Carotenoid and tocopherol levels
Insulin-like growth factors
Cardiac muscle measurement
Response to acetaminophen (hepatotoxicity)
Lymphoma
Iris color
Tardive dyskinesia in schizophrenia
Myocardial infarction (early onset)
Environmental confusion in the home
Multiple sclerosis (age of onset)
Normalized brain volume
Brain lesion load
YKL-40 levels
Parkinson's disease (familial)
Atrial fibrillation/atrial flutter
Natriuretic peptide levels
Bipolar disorder (age of onset and psychotic symptoms)
Carotid atherosclerosis in HIV infection
Heroin addiction
HIV (mother-to-child transmission)
Celiac disease or Rheumatoid arthritis
Beta-trace protein levels
Cardiovascular risk factors (age interaction)
Cardiovascular risk factors
Creutzfeldt-Jakob disease (variant)
Migraine in psychiatric disorder
Esophageal cancer
Electrocardiographic conduction measures
Osteosarcoma
Glycemic control in type 1 diabetes (HbA1c)
Soluble E-selectin levels
Serum selenium levels
Insulin-related traits
Pulmonary function (smoking interaction)
Osteoporosis-related phenotypes
Event-related brain oscillations
Atrioventricular conduction
Erectile dysfunction and prostate cancer treatment
Soluble levels of adhesion molecules
Biochemical measures
Alcohol consumption (transferrin glycosylation)
Orofacial clefts (maternal alcohol consumption interaction)
Congenital heart malformation
Body mass in chronic obstructive pulmonary disease
Response to lithium treatment in bipolar disorder
Liver enzyme levels (alanine transaminase)
Liver enzyme levels (alkaline phosphatase)
Liver enzyme levels (gamma-glutamyl transferase)
Sex hormone-binding globulin levels
Circulating myeloperoxidase levels (serum)
Circulating myeloperoxidase levels (plasma)
Hypersomnia (HLA-DQB1*06:02 negative)
White blood cell types
Brain connectivity
Formal thought disorder in schizophrenia
QT interval (drug interaction)
Psychosis and Alzheimer's disease
Psychosis in Alzheimer's disease
HbA2 levels
Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)
Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)
Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)
Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
Age-related macular degeneration (choroidal neovascularisation)
Age-related macular degeneration (geographic atrophy)
Age-related macular degeneration (CNV vs. GA)
Cardiovascular heart disease in diabetics
Coronary arterial lesions in patients with Kawasaki disease
Sexual dysfunction (SSRI/SNRI-related)
Age-related macular degeneration (wet)
Chronic kidney disease and serum creatinine levels
Influenza (severity)
Self-rated health
Prostate cancer mortality
Sex ratio at birth
Serum ceruloplasmin levels
Aspirin hydrolysis (plasma)
Drinking behavior
Anthropometric traits in newborns
Wilms tumor
LDL (oxidized)
Response to fenofibrate
Stroke (pediatric)
Sunburns
Non-melanoma skin cancer
Periodontal microbiota
Preeclampsia
Response to platinum-based chemotherapy in small cell and non-small cell lung cancers
Erythrocyte sedimentation rate
Dengue shock syndrome
Caffeine consumption
Cholelithiasis-related traits in sickle cell anemia
Venous thromboembolism (SNP x SNP interaction)
Estradiol plasma levels (breast cancer)
IgM levels
Response to amphetamines
Hypertrophic cardiomyopathy
Response to platinum-based agents
Response to gemcitabine in pancreatic cancer
Palmitic acid (16:0) levels
Stearic acid (18:0) levels
Type 2 diabetes (dietary heme iron intake interaction)
Cystic fibrosis (meconium ileus)
Visceral fat
Esophageal cancer (squamous cell)
Esophageal cancer (alcohol interaction)
Oral cancers (chewing tobacco related)
Age at smoking initiation in chronic obstructive pulmonary disease
Smoking cessation in chronic obstructive pulmonary disease
Lifetime average cigarettes per day in chronic obstructive pulmonary disease
Capecitabine sensitivity
Sexual dysfunction (female)
Pulmonary function decline
Hypertension risk in short sleep duration
Response to bleomycin (chromatid breaks)
Bone mineral density (wrist)
Small-cell lung cancer (survival)
Reporting of stressful life event
Body mass index (SNP x SNP interaction)
Epirubicin-induced leukopenia
Adverse response to carbamazepine
Retinopathy in non-diabetics
Response to cholinesterase inhibitors in Alzheimer's disease
Self-employment
Thyroid hormone levels
Podoconiosis
Aspirin exacerbated respiratory disease in asthmatics
Comprehensive strength and appendicular lean mass
Hypertension (SNP x SNP interaction)
Coronary heart disease (SNP X SNP interaction)
Alzheimer's disease (cognitive decline)
Cystic fibrosis severity
Peripartum cardiomyopathy
Esophageal squamous cell cancer (length of survival)
Response to anti-depressant treatment in major depressive disorder
Lean body mass and age at menarche (combined)
Gambling
Odorant perception (isobutyraldehyde)
Odorant perception (β-damascenone)
Odorant perception (β-ionone)
Molar-incisor hypomineralization
Type 1 diabetes nephropathy
Epstein-Barr virus immune response (EBNA-1)
Multiple sclerosis (OCB status)
Anxiety in major depressive disorder
Anxiety and major depressive disorder
"Thyroid cancer (Papillary, radiation-related)"
Platelet reactivity
Periodontitis (DPAL)
Periodontitis (PAL4Q3)
Periodontitis (Mean PAL)
Periodontitis (CDC/AAP)
Response to tocilizumab in rheumatoid arthritis
Body mass index and cholesterol (psychopharmacological treatment)
Glutamate decarboxylase autoantibody levels in type 1 diabetes
Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes
Gastric parietal cell autoantibody levels in type 1 diabetes
Thyroid peroxidase autoantibody levels in type 1 diabetes
"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)"
B cell non-Hodgkin lymphoma
Lipid levels in hepatitis C treatment
Renal transplant outcome
Response to antineoplastic agents
Breast cancer in BRCA2 mutation carriers
Nephropathy
Response to angiotensin II receptor blocker therapy
Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
Crohn's disease and celiac disease
Economic and political preferences
Economic and political preferences (environmentalism)
Economic and political preferences (fairness)
Economic and political preferences (feminism/equality)
Economic and political preferences (immigration/crime)
Economic and political preferences (time)
Male fertility
Response to antidepressants
White matter integrity
Handedness in dyslexia
Bone mineral density (sex interaction)
Haptoglobin levels
Coronary restenosis
Drug-induced liver injury (amoxicillin-clavulanate)
Dialysis-related mortality
Sclerosing cholangitis and ulcerative colitis (combined)
Psychosis
Immune reponse to smallpox (secreted IL-12p40)
Immune reponse to smallpox (secreted IL-2)
Immune reponse to smallpox (secreted IL-10)
Immune reponse to smallpox (secreted IL-1beta)
Immune response to smallpox vaccine (IL-6)
Immune reponse to smallpox (secreted TNF-alpha)
Immune reponse to smallpox (secreted IFN-alpha)
Addiction
Response to mTOR inhibitor (everolimus)
Response to mTOR inhibitor (rapamycin)
Fat distribution (HIV)
Antipsychotic drug-induced QTc interval prolongation
Femoral neck bone geometry and menarche (age at onset)
Cerivastatin-induced rhabdomyolysis
Crohn's disease and psoriasis
Parkinson's disease (motor and cognition)
Phospholipid levels (plasma)
Duodenal ulcer
Coronary heart disease event reduction (statin therapy interaction)
Paget's disease
HIV-associated dementia
IFN-related cytopenia
Adolescent idiopathic scoliosis (severe)
Weight loss (gastric bypass surgery)
Sexual dimorphism in anthropometric traits
Adverse response to chemotherapy in breast cancer (alopecia)
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)
Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
Nevirapine-induced rash
End-stage renal disease (non-diabetic)
Schizophrenia (cytomegalovirus infection interaction)
Post-traumatic stress disorder (asjusted for relatedness)
Response to iloperidone treatment (QT prolongation)
Gaucher disease severity
Homeostasis model assessment of beta-cell function (dietary factor interaction)
Fasting insulin (dietary factor interaction)
Homeostasis model assessment of insulin resistance (dietary factor interaction)
Butyrylcholinesterase levels
Breast cancer (prognosis)
Tardive dyskinesia
Fasting blood insulin (BMI interaction)
Fasting blood glucose (BMI interaction)
Aging (time to death)
Aging (time to event)
Parasitemia in Tripanosoma cruzi seropositivity
QRS duration in Tripanosoma cruzi seropositivity
Chagas cardiomyopathy in Tripanosoma cruzi seropositivity
Antibody status in Tripanosoma cruzi seropositivity
PR interval in Tripanosoma cruzi seropositivity
QT interval in Tripanosoma cruzi seropositivity
Ejection fraction in Tripanosoma cruzi seropositivity
Local histogram emphysema pattern
Aortic stiffness
Retinal arteriolar caliber
Neural processing (facial expression)
Blood pressure measurement (cold pressor test)
Blood pressure measurement (high sodium and potassium intervention)
Blood pressure measurement (low sodium intervention)
Blood pressure measurement (high sodium intervention)
Malignant mesothelioma
Self-reported allergy
Meningococcal disease
Mitral annular calcification
Aortic-valve calcification
Amygdala reactivity
Fluorouracil treatment response in colorectal cancer
Waist-to-hip circumference ratio (ever vs never smoking interaction)
Body mass index (alcohol intake interaction)
Body mass index (dietary energy interaction)
Body mass index (recreational physical activity interaction)
Body mass index (ever vs never smoking interaction)
Body mass index (smoking years interaction)
Waist-to-hip circumference ratio (dietary energy interaction)
Waist-to-hip circumference ratio (smoking years interaction)
Waist-to-hip circumference ratio (recreational physical activity interaction)
Waist-to-hip circumference ratio (alcohol intake interaction)
Depression and alcohol dependence
Occipital cortical area (total cortical area interaction)
Schizophrenia (age at onset) (sex interaction)
Postoperative ventricular dysfunction
Chronic myeloid leukemia
Thyroid volume
Postoperative nausea and vomiting
Metabolite levels (Dihydroxy docosatrienoic acid)
Metabolite levels (Pyroglutamine)
Metabolite levels (X-11787)
Bulimia nervosa
Eating disorders (purging via substances)
Eating disorders
Erectile dysfunction in type 1 diabetes
Tetralogy of Fallot
Adverse response to lamotrigine and phenytoin
Liver enzyme levels (aspartate transaminase)
Hippocampal volume in schizophrenia
Acne (severe teenage)
Orthostatic hypotension
Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)
Response to antipsychotic therapy (extrapyramidal side effects)
Uric acid levels (SNP x SNP interaction)
Joint damage progression in ACPA-positive rheumatoid arthritis
Migraine - clinic-based
Word reading
Reading and spelling
Non-word repetition
Job-related exhaustion
Response to platinum-based chemotherapy (carboplatin)
Response to platinum-based chemotherapy (cisplatin)
Bipolar disorder (mania)
Ventricular fibrillation
Chemotherapeutic susceptibility
Odorant perception
Pancreatitis
Fat body mass
Lipoprotein diameter
Alzheimer's disease (SNP x SNP interaction)
Systolic blood pressure in sickle cell anemia
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)
Rate of change of FEV1 (time interaction)
Plasma cystastin c levels in acute coronary syndrome
End-stage renal disease or diabetic nephropathy in type 1 diabetes
Electrodermal activity
Urinary uromodulin levels
Fasting plasma glucose (childhood)
Bone properties (heel)
Esophageal squamous cell carcinoma
Urinary metabolites (H-NMR features)
Obstructive sleep apnea
Endothelial growth factor levels
Allergic rhinitis in asthma
Allergic rhinitis in non-asthmatics
Inflammatory skin disease
Superior frontal gyrus grey matter volume
Suicidal ideation in depression or bipolar disorder
Suicide attempts in depression or bipolar disorder
Body mass index (sex interaction)
Waist circumference (sex interaction)
Waist-to-hip ratio (sex interaction)
Receptive language ability
Renal function and chronic kidney disease
White matter microstructure (global fractional anisotropy)
Clubfoot
Conduct disorder (symptom count)
Conduct disorder
Asthma (corticosteroid response)
Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
Coronary artery calcification (smoking interaction)
Colorectal cancer (diet interaction)
Tooth agenesis (maxillary third molar)
Tooth agenesis (mandibular third molar)
Tooth agenesis (third molar)
Social communication problems
Substance dependence phenotypes
Seasonality
Contrast sensitivity
Response to antidepressant treatment (citalopram)
NHDL cholesterol levels
Liver disease in chronic hepatitis B virus infection
Congenital heart disease
Congenital left-sided heart lesions (maternal effect)
Response to Dalcetrapib treatment in acute coronary syndrome
Glycemic traits
Vaspin levels
Factor VII levels
Eosinophilic esophagitis (pediatric)
Hepatitis C induced liver fibrosis
Cleft lip
Plasminogen activator inhibitor type 1 levels (PAI-1)
Hereditary hemochromatosis-related traits (HFE mutation homozygotes)
Response to haloperidol in psychosis
Hashimoto thyroiditis versus Graves' disease
Marginal zone lymphoma
Migraine in bipolar disorder
Reading or mathematical ability
Phenytoin-induced severe cutaneous adverse reactions
Bronchodilator response in asthma
Substance dependence
Sick sinus syndrome
Thyrotoxic hypokalemic periodic paralysis
Anticoagulant levels
Multiple myeloma (hyperdiploidy)
Multiple myeloma (IgH translocation)
Callous-unemotional behaviour
Response to iloperidone treatment (PANSS-T score)
Parkinson's disease (coffee consumption interaction)
D-dimer levels
Temperament
Insomnia (caffeine-induced)
Wegener's granulomatosis
Pulmonary artery enlargement and chronic obstructive pulmonary disease
Pulmonary artery enlargement in chronic obstructive pulmonary disease
CD4:CD8 lymphocyte ratio
CD3-positive T-lymphocyte count
CD4-positive T-lymphocyte count
CD8-positive T-lymphocyte count
CD19-positive B-lymphocyte count
CD56-positive NK-lymphocyte cell count
Response to radiotherapy in cancer (late toxicity)
Longevity (90 years and older)
Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)
Age-related cataracts
Age-related cataracts (age at onset)
Vitamin B levels in ischemic stroke
Serum IgA levels
Autism spectrum disorder-related traits
Sepsis from pneumonia (survival)
Response to thiazide diuretic treatment (hypokalemia)
Laryngeal squamous cell carcinoma
Toenail selenium levels
Blood and toenail selenium levels
Osteoarthritis biomarkers
Thrombin generation potential phenotypes
Hemoglobin A2 levels in sickle cell anemia
Longevity (85 years and older)
Hearing function
Glycemic traits (pregnancy)
Smoking quantity
Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)
Pulse pressure (alcohol consumption interaction)
Systolic blood pressure (alcohol consumption interaction)
Diastolic blood pressure (alcohol consumption interaction)
Mean arterial pressure (alcohol consumption interaction)
Coronary heart disease in familial hypercholesterolemia
Anger
Nicotine use
Illicit drug use
Non-substance related behavioral disinhibition
Behavioural disinhibition (generation interaction)
Autoimmune hepatitis type-1
Birth length
Infant length
Mitochondrial DNA levels
Plasma homocysteine levels (post-methionine load test)
Morphine dose requirement in tonsillectomy and adenoidectomy surgery
Maternal genotype effects in autism spectrum disorder families
Preschool internalizing problems
Medication adherence in chronic diseases
Chronic obstructive pulmonary disease (moderate to severe)
Chronic obstructive pulmonary disease (severe)
Asthma (sex interaction)
Type 2 diabetes (young onset) and obesity
Breast cancer (early onset)
Chronic periodontitis
Urinary albumin excretion rate in type 1 diabetes
"Osteoarthritis (hand, severe)"
Blood pressure (anthropometric measures interaction)
Age-related hearing impairment (SNP x SNP interaction)
Sickle cell anemia (severity)
Arterial stiffness (carotid-femoral pulse wave velocity)
Arterial stiffness (brachial-femoral pulse wave velocity)
Arterial stiffness (brachial-ankle pulse wave velocity)
Alcohol use disorder
Problematic alcohol use (MTAG)
Alcohol consumption (drinks per week) (MTAG)
Problematic alcohol use
Total carotid plaque area (excess vs minimal atherosclerosis)
Pancreatic beta-cell glucose sensitivity
Early-onset ischemic stroke
Serum C-reactive protein concentration
Serum C-reactive protein concentration in non-obese individuals
Serum C-reactive protein concentration in obesity
Serum C-reactive protein concentration in inactive individuals
Serum C-reactive protein concentration in low fat diet
Serum C-reactive protein concentration in high fat diet
Serum C-reactive protein concentration in visceral obesity (waist-hip ratio)
Serum C-reactive protein concentration in visceral obesity (waist circumference)
Serum interleukin-6 concentration
Serum interleukin-6 concentration in non-visceral-obese individuals
Serum interleukin-6 concentration in high fat diet
Serum interleukin-6 concentration in active individuals
Shoulder impingement syndrome
Aspartate aminotransferase levels x alcohol consumption interaction
Gamma glutamyl transferase levels x alcohol consumption interaction
Alanine aminotransferase levels x alcohol consumption interaction
Aspartate aminotransferase to alanine aminotransferase ratio x alcohol consumption interaction
Multiple severe cisplatin-induced neurotixicitiies in testicular cancer survivors
White matter microstructure (mean diusivities)
White matter microstructure (axial diusivities)
White matter microstructure (radial diusivities)
White matter microstructure (mode of anisotropy)
White matter microstructure (fractional anisotropy)
N-acyl ethanolamine levels
Major depressive disorder (lifetime)
Major depressive disorder (lifetime with recurrence)
Help-seeking from a GP
Help-seeking from a psychiatrist
Major depressive disorder symptoms (low mood or anhedonia)
Help-seeking from a GP (without major depressive disorder symptoms)
Depression or depression symptoms
Distal/Left-sided colorectal cancer
Proximal colorectal cancer
Distal colorectal cancer
Percent liver fat
Tumor necrosis factor levels
Persistent chemotherapy-induced alopecia in breast cancer
Myocardial fractal dimension (slice 1)
Myocardial fractal dimension (slice 2)
Myocardial fractal dimension (slice 3)
Myocardial fractal dimension (slice 4)
Myocardial fractal dimension (slice 5)
Myocardial fractal dimension (slice 6)
Myocardial fractal dimension (slice 7)
Myocardial fractal dimension (slice 8)
Myocardial fractal dimension (slice 9)
Myocardial fractal dimension (slices 1-9)
Facial morphology traits (59 NSCL/P endophenotypic segments)
Septic shock (28-day mortality)
Septic shock (90-day mortality)
Septic shock resolution
Septic shock
Adverse response to chemotherapy (fluoropyrimidines)
Combined resilience (covariance of educational attainment with residual cognitive resilience)
Residual cognitive resilience
prednisolone sensitivity in B-cell precursor acute lymphoblastic leukaemia
dexamethasone sensitivity in B-cell precursor acute lymphoblastic leukaemia
Chronic back pain
Systemic mastocytosis
Cutaneous mastocytosis
Cutaneous mastocytosis (adult)
Mastocytosis
Cutaneous mastocytosis (childhood)
Vaginal microbiome composition (L. iners)
Vaginal microbiome composition (G. vaginalis)
Vaginal microbiome composition (Shannon diversity index)
Vaginal microbiome composition (community state type)
Vaginal microbiome composition (L. crispatus)
Hepatic steatosis in non-alcoholic fatty liver disease
Liver fibrosis in non-alcoholic fatty liver disease
Non-alcoholic steatohepatitis activity score in non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease activity score in non-alcoholic fatty liver disease
Nonalcoholic steatohepatitis
Severe liver fibrosis and non-alcoholic fatty liver disease
Neuroblastoma (pediatric)
Concussion
Restless legs syndrome in migraine without aura
Restless legs syndrome in migraine with aura
Restless legs syndrome in migraine
Migraine (chronic vs episodic)
Migraine (proposed chronic vs episodic)
Thrombosis in response to liver transplant
"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)"
Sporadic miscarriage
Multiple consecutive miscarriage
2-hydroxyisobutyrate levels
3-aminoisobutyrate levels
3-hydroxybutyrate + 3-aminoisobutyrate levels
3-hydroxyisobutyrate levels
3-hydroxyisovalerate levels
3-Indoxylsulfate levels
4-deoxyerythronic acid levels
4-deoxythreonic acid levels
5-oxoproline levels
Acetate levels
Acetone levels
Alanine levels
Carnitine levels
Citrate levels
Creatine levels
Dimethylamine levels
Formate levels
Glucose levels
Glutamine levels
Glycine levels
Hippurate levels
Isoleucine levels
Lactate levels
Leucine levels
Lysine levels
N-acetyl neuraminic acid levels
N-methyl-2-pyridone-5-carboxamide levels
N-methylnicotinic acid levels
N-methylpicolinic acid levels
N1-methyl-nicotinamide levels
P-cresol sulfate levels
P-hydroxyphenylacetate levels
Pantothenic acid levels
Proline betaine levels
Scyllo-inositol levels
Succinate levels
Sucrose levels
Taurine levels
Trimethylamine levels
Trimethylamine oxide levels
Tyrosine levels
Valine levels
White matter hyperintensity volume x hypertension interaction (2df)
White matter hyperintensity volume (adjusted for hypertension)
Severe COVID-19 infection with respiratory failure (analysis I)
Severe COVID-19 infection with respiratory failure (analysis II)
Liver fat content (MRI proton density fat fraction measure)
Liver fibrosis and steatohepatitis severity (MRI cT1 measure)
Benign childhood epilepsy with centro-temporal spikes
Urine 6-bromotryptophan levels in chronic kidney disease
Thrombin-induced platelet aggregation
Matrix metalloproteinase-10 levels
Neurotrophin-3 levels
Oncostatin-M levels
PD-L1 levels
Sirtuin-2 levels
SLAMF1 levels
Sulfotrasferase 1A1 levels
STAM binding protein levels
Transforming growth factor-alpha levels
Tumor necrosis factor receptor superfamily member 9 levels
Tumor necrosis factor ligand superfamily member 14 levels
Tumor necrosis factor ligand superfamily member 10 levels
Tumor necrosis factor ligand superfamily member 11 levels
Tumor necrosis factor ligand superfamily member 12 levels
Vascular endothelial growth factor A levels
Migraine and/or diastolic blood pressure
Migraine and/or systolic blood pressure
Migraine and/or pulse pressure
Migraine with aura and/or diastolic blood pressure
Migraine with aura and/or systolic blood pressure
Migraine with aura and/or pulse pressure
Migraine without aura and/or diastolic blood pressure
Migraine without aura and/or systolic blood pressure
Migraine without aura and/or pulse pressure
Leg fat mass (lean adjusted)
Leg lean mass (fat adjusted)
Leg fat mass and leg lean mass (pleiotropy)
FEV1/FVC ratio x pack-years of smoking interaction (2df test)
Plasma selenium concentration
Response to selenium supplementation (change in plasma selenium concentration)
Caffeine consumption from coffee
Caffeine consumption from tea
Caffeine consumption from coffee or tea
Triglyceride levels in HIV infection
LDL cholesterol levels in HIV infection
HDL cholesterol levels in HIV infection
Cardiovascular disease in systemic lupus erythematosus
First year height change in growth hormone-treated short stature
Tau burden
Preeclampsia (fetal genotype effect)
Preeclampsia (maternal genotype effect)
Cardiorespiratory fitness (800m run time)
Alzheimer's disease or posttraumatic stress syndrome (pleiotropy)
Attention deficit hyperactivity disorder (inattention symptoms)
Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
CXCL6 levels
CXCL9 levels
DNER levels
EN-RAGE levels
Fibroblast growth factor 19 levels
Fibroblast growth factor 5 levels
Flt3L levels
Interleukin-10 receptor B levels
Interleukin-12 subunit B levels
interleukin 15 receptor subunit alpha levels
interleukin-18 receptor 1 levels
Transforming growth factor-beta levels
Leukemia inhibitory factor receptor levels
Monocyte chemoattractant protein-2 levels
Monocyte chemoattractant protein-4 levels
4E-BP1 levels
Adenosine Deaminase levels
Axin-1 levels
Caspase 8 levels
CCL11 levels
CCL19 levels
CCL20 levels
CCL23 levels
CCL25 levels
CCL28 levels
CCL3 levels
CCL4 levels
CD244 levels
CD40 levels
CD5 levels
CD6 levels
CDCP1 levels
Colony stimulating factor levels
Cystatin D levels
CX3CL1 levels
CXCL1 levels
CXCL10 levels
CXCL11 levels
CXCL5 levels
Response to radiotherapy in nasopharyngeal carcinoma (acute oral mucositis)
Hip bone mineral content accrual during adolescent growth spurt
Peak hip bone mineral content
Essential hypertension (time to event)
Abdominal hernia (time to event)
Hyperlipidemia (time to event)
Osteoarthrosis (time to event)
Cardiac dysrhythmias (time to event)
Asthma (time to event)
Cataract (time to event)
Coronary atherosclerosis (time to event)
Type 2 diabetes (time to event)
Parkinson's disease (time to event)
Alzheimer's disease (time to event)
Schizophrenia (time to event)
Brain amyloid deposition (PET imaging)
Alzheimer's disease in depression
Cognitive function in depression
Cognitive impairment in depression
Cognitive decline in depression
Parent of origin effect on receptive language ability (paternal)
Parent of origin effect on receptive language ability (maternal)
Peginterferon alfa-2a treatment response in chronic hepatitis B infection
Nontraumatic osteonecrosis of the femoral head
Lung cancer (survival time) in never smokers
Lung adenocarcinoma (survival time) in never smokers
Rate of cognitive decline in Alzheimer's disease
"CV-A6-associated hand, foot, and mouth disease (severe vs mild)"
Autoimmune thyroid disease
Chronotype (sMEQ score)
Evening vs. morning chronotype (sMEQ score)
Evening vs. morning chronotype (self-assessed)
Response to antiepileptic mood-stabilizing treatment in bipolar disorder
"Gut microbiota (bacterial taxa, hurdle binary method)"
"Gut microbiota (bacterial taxa, rank normal transformation method)"
Antibody-deficiency-associated primary immunodeficiency
L-selectin levels
Cardiovascular death or myocardial infarction in response to clopidogrel treatment
"Cardiovascular death, myocardial infarction or stroke in response to clopidogrel treatment"
Stent thrombosis in response to clopidogrel treatment
Platelet reactivity in response to clopidogrel treatment
Diabetic neuropathy in type 2 diabetes
Macrovascular complications in type 2 diabetes
Ophthalmic complications in type 2 diabetes
Pulse rate
joint destruction in rheumatoid arthritis (rapid vs slow)
Disruptive behavior disorder in attention deficit hyperactivity disorder
Disruptive behavior disorder and attention deficit hyperactivity disorder
Declining hemoglobin trajectory in blood donors
Motor composite score
Mental composite score
Frontal fibrosing alopecia
Body size at age 10
Adult body size
Sodium levels in epilepsy
Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy
Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy
Carbamazepine-induced hyponatremia in epilepsy
Oxcarbazepine-induced hyponatremia in epilepsy
"Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy"
Autoimmune pulmonary alveolar proteinosis
Bronchodilator response x age interaction in asthma
Alzheimer's disease or cardiovascular risk factors (pleiotropy)
Coronary artery disease in type 1 diabetes
Diverticular disease
Diverticulitis
Keratoconus
Hypospadias (moderate to severe)
Metabolic coherence (transcriptomic)
Emotional lability
Lack of behavioral control
Type A behavior
Locus of control over disease
Psychoticism
Fasting plasma glycodeoxycholate 3-O-glucuronide concentration
Fasting plasma glycochenodeoxycholate 3-O-glucuronide concentration
Psychological resilience (outcome-based) in high deployment stress exposure
Psychological resilience (self-assessed)
Psychological resilience (outcome-based)
Glycosuria in pregnancy (maternal genotype effect)
Glycosuria in pregnancy (offspring genotype effect)
Glycosuria in pregnancy (maternal and offspring genotype effect)
Sphingolipid d18:1/d18:2 ratio
Anti-sp100 seropositivity in primary biliary cholangitis
Anti-gp210 seropositivity in primary biliary cholangitis
Microscopic colitis in proton-pump inhibitor treatment
Microscopic colitis
Academic attainment (English)
Academic attainment (maths)
Academic attainment (science)
Peptic ulcer disease
Gastroesophageal reflux disease
"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment"
Systolic blood pressure (baseline)
Diastolic blood pressure change trajectory
Diastolic blood pressure (baseline)
Serum galactose-deficient IgA1 levels in IgA nephropathy
Asthma-chronic obstructive pulmonary disease overlap syndrome in asthma
Asthma-chronic obstructive pulmonary disease overlap syndrome
Triiodothyronine levels and thyroxine levels
Hip bone mineral density and total body fat mass (bivariate analysis)
Change in HbA1c levels in response to metformin treatment in type 2 diabetes
Affective disorder and suicide attempts
Endometrial cancer (endometrioid histology)
Endometrial cancer (Non-endometrioid histology)
Major depressive disorder (probable)
Major depressive disorder (ICD-10 coded)
Depression (broad)
Response to hepatitis B vaccine
Facial wrinkles
Myopic maculopathy
Extremely high intelligence
Eye movement (horizontal position gain)
Eye movement in schizophrenia (scanpath length)
Eye movement (scanpath length)
Eye movement in schizophrenia (duration of fixations)
Eye movement (duration of fixations)
Eye movement in schizophrenia (integrated eye movement score)
Eye movement (integrated eye movement score)
Eye movement in schizophrenia (horizontal position gain)
Maternal chorioamnionitis
Metabolic syndrome (multivariate analysis)
Response to lurasidone in schizophrenia
Eudaimonic well-being
Hedonic well-being
Diffusing capacity of the lung for carbon monoxide traits
Socioeconomic status of place of residence
Population density of place of residence
Relative amplitude of rest-activity cycles
Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)
Upper eyelid sagging severity
Circulating fibroblast growth factor 23 levels
Guillain-Barré syndrome
Brain morphology (MOSTest)
Cortical thickness (MOSTest)
Subcortical volume (MOSTest)
Brain morphology (min-P)
Cortical surface area (MOSTest)
Subcortical volume (min-P)
Cortical surface area (min-P)
Cortical thickness (min-P)
Uterine fibroid size (maximum dimension)
Fish consumption
Falling risk
Immunoglobulin M against phosphorylcholine (IgM anti-PC) levels
Delirium
Anthropometric traits (multi-trait analysis)
Disorders of lipid metabolism
Skin pigmentation traits
Hair morphology traits
Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)
Initial alcohol sensitivity
Pulmonary tuberculosis
Biliary tract cancer
Hematological malignancy
Arrhythmia
Cataracts
Nephrotic syndrome
Periodontal disease
Urolithiasis
Drug eruption
Pollinosis
Cerebral aneurysm
Congestive heart failure
Interstitial lung diseases in rheumatoid arthritis
Cognitive function (kinship model)
Cognitive function (mixed linear model)
Cognitive function (generalized correlation coefficient)
First fracture in long-term childhood cancer survivors (time to event)
Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer
Self-harm ideation
Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG levels
Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG levels
Anti-Kaposi's sarcoma associated herpesvirus ORF73 IgG levels
Anti-Kaposi's sarcoma associated herpesvirus K10.5 IgG levels
Anti-Kaposi's sarcoma associated herpesvirus K8.1 IgG levels
Ceramide levels (C24:0)
Ceramide levels (C22:0)
Fractures (paediatric)
Simvastatin-induced myopathy
Atorvastatin-induced myopathy
Statin-induced myopathy (severe)
Statin-induced myopathy
Obsessive-compulsive traits
Childhood ALL/LBL (acute lymphoblastic leukemia/lymphoblastic lymphoma) treatment-related venous thromboembolism
Theta EEG coherence
Deep white matter hyperintensities
Periventricular white matter hyperintensities
Motor fluctuations in levodopa treated Parkinson's disease
Levodopa-induced dyskinesia in levodopa treated Parkinson's disease
spontaneous preterm birth x maternal stress interaction (1df)
Hypopharyngeal or laryngeal cancer
Bone mineral density or leg lean mass (pleiotropy)
Arm lean mass
Leg lean mass
Social deprivation
Anorectal malformation
Waldenström macroglobulinemia / lymphoplasmacytic lymphoma
Remission after SSRI treatment in major depression
Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)
Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)
Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)
Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)
Brain imaging measurements
Small subcortical brain infarct
Brain infarct
Healthspan
Pulmonary function (FEV1) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)
Pulmonary function (FVC) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)
Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)
Pulmonary function (FEV1) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)
Response to ranibizumab in age-related macular degeneration (exudative)
Anti-cytomegalovirus IgG seropositivity
Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG seropositivity
Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG seropositivity
Anti-Epstein-Barr virus early antigen (EA) IgG seropositivity
Anti-herpes simplex virus 1 IgG seropositivity
Anti-herpes simplex virus 2 IgG seropositivity
Anti-varicella zoster virus IgG seropositivity
Anti-influenza A virus IgG seropositivity
Anti-measles virus IgG seropositivity
Anti-mumps virus IgG seropositivity
Anti-rubella virus IgG seropositivity
Anti-hepatitis B virus surface antigen (HBs) IgG seropositivity
Anti-hepatitis B virus core antigen (HBc) IgG seropositivity
Anti-cytomegalovirus IgG levels
Anti-Epstein-Barr virus early antigen (EA) IgG levels
Anti-herpes simplex virus 1 IgG levels
Anti-herpes simplex virus 2 IgG levels
Anti-varicella zoster virus IgG levels
Anti-helicobacter pylori IgG levels
Anti-Toxoplasma gondii IgG levels
Anti-influenza A virus IgG levels
Anti-measles virus IgG levels
Anti-mumps virus IgG levels
Anti-rubella virus IgG levels
Anti-hepatitis B virus surface antigen (HBs) IgG levels
Anti-hepatitis B virus core antigen (HBc) IgG levels
Leukoderma in response to rhododendrol
Allergic march (atopic dermatitis to allergic rhinitis)
Allergic march (atopic dermatitis to asthma)
Gestational insulin sensitivity
Response to esketamine in treatment resistant depression
Response to esketamine (responder status) in treatment resistant depression
Response to esketamine (remission) in treatment resistant depression
Autoimmune traits
Autoimmune disease (without mental disorder)
Mental disorder (without autoimmune disease)
Autoimmune disease and mental disorder
Dietary fat liking
Invasive breast cancer
Tafenoquine efficacy in P. vivax malaria (recurrence by 6 months)
Tafenoquine efficacy in P. vivax malaria (recurrence by 4 months)
Tafenoquine efficacy in P. vivax malaria (time to recurrence up to 6 months)
"Allergic disease (asthma, hay fever and/or eczema) (age of onset)"
"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)"
Lean nonalcoholic fatty liver disease
Trigger finger
Sudden cardiac arrest in coronary artery disease
Body mass index and systolic blood pressure (bivariate analysis)
Body mass index and diastolic blood pressure (bivariate analysis)
Systolic blood pressure and diastolic blood pressure (bivariate analysis)
Carboplatin drug response (IC50)
Ara-C drug response (AUC)
Capecitabine drug response (AUC)
Cisplatin drug response (IC50)
Daunorubicin drug response (IC50)
Etoposide drug response (IC50)
Paclitaxel drug response (AUC)
Pemetrexed drug response (AUC)
Mortality in COVID-19
Response to opioid analgesics in cancer (pain decrease)
Type 2 diabetes or coronary artery disease (pleiotropy)
High IL-1beta levels in gingival crevicular fluid
Nicotine dependence and major depression (severity of comorbidity)
Serum erythropoietin levels
Total hippocampal volume
Presubiculum volume (corrected for total hippocampal volume)
Subiculum volume (corrected for total hippocampal volume)
Hippocampal subfield CA1 volume (corrected for total hippocampal volume)
Hippocampal subfield CA3 volume (corrected for total hippocampal volume)
Hippocampal subfield CA4 volume (corrected for total hippocampal volume)
Dentate gyrus granule cell layer volume (corrected for total hippocampal volume)
Dentate gyrus molecular layer volume (corrected for total hippocampal volume)
Hippocampal fissure volume (corrected for total hippocampal volume)
Hippocampal tail volume (corrected for total hippocampal volume)
Fimbria volume (corrected for total hippocampal volume)
HATA volume (corrected for total hippocampal volume)
Parasubiculum volume (corrected for total hippocampal volume)
Presubiculum volume
Subiculum volume
Hippocampal subfield CA1 volume
Hippocampal subfield CA3 volume
Hippocampal subfield CA4 volume
Dentate gyrus granule cell layer volume
Dentate gyrus molecular layer volume
Hippocampal fissure volume
Hippocampal tail volume
Fimbria volume
HATA volume
Parasubiculum volume
Vestibular neuritis
Major depressive disorder (MTAG)
Bipolar disorder (MTAG)
Left inferior frontal gyrus (orbital part) cortical thickness
Left parahippocampal gyrus cortical thickness
Human milk oligosaccharide concentration (2'-fucosyllactose)
Human milk oligosaccharide concentration (3'-fucosyllactose)
Human milk oligosaccharide concentration (3'-fucosyllactose) in secretors
Human milk oligosaccharide concentration (3'-sialyllactose)
Human milk oligosaccharide concentration (6'-sialyllactose)
Human milk oligosaccharide concentration (difucosyllacto-N-hexaose)
Human milk oligosaccharide concentration (difucosyllacto-N-hexaose) in non-secretors
Human milk oligosaccharide concentration (difucosyllacto-N-tetrose)
Human milk oligosaccharide concentration (difucosyllacto-N-tetrose) in secretors
Human milk oligosaccharide concentration (difucosyllactose)
Human milk oligosaccharide concentration (disialyllacto-N-hexaose)
Human milk oligosaccharide concentration (disialyllacto-N-tetraose)
Human milk oligosaccharide concentration (fucodisialyllacto-N-hexaose)
Human milk oligosaccharide concentration (fucosyllacto-N-hexaose)
Human milk oligosaccharide concentration (lacto-N-fucopentaose I)
Human milk oligosaccharide concentration (lacto-N-fucopentaose I) in secretors
Human milk oligosaccharide concentration (lacto-N-fucopentaose II)
Human milk oligosaccharide concentration (lacto-N-fucopentaose II) in secretors
Human milk oligosaccharide concentration (lacto-N-fucopentaose III)
Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors
Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in secretors
Human milk oligosaccharide concentration (lacto-N-hexaose)
Human milk oligosaccharide concentration (lacto-N-neotetraose)
Human milk oligosaccharide concentration (lacto-N-tetrose)
Human milk oligosaccharide concentration (sialyl-lacto-N-tetraose b)
Hypertrophic cardiomyopathy (sarcomere positive)
Hypertrophic cardiomyopathy (sarcomere negative)
Adverse response to chemotherapy in colorectal cancer (XELOX) (Peripheral Neuropathy)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Peripheral Neuropathy)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Peripheral Neuropathy)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Peripheral Neuropathy)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Stomatitis)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Stomatitis)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Stomatitis)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Stomatitis)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Nausea)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Nausea)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Nausea)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Nausea)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Vomiting)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Vomiting)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Vomiting)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Vomiting)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Diarrhoea)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Diarrhoea)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Diarrhoea)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Diarrhoea)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Lethargy)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Lethargy)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Lethargy)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Lethargy)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Neutropenia)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Neutropenia)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Neutropenia)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Neutropenia)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Hand foot syndrome)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Hand foot syndrome)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Hand foot syndrome)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Hand foot syndrome)"
Adverse response to chemotherapy in colorectal cancer (XELOX)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX, Cetuximab)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Sepsis)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Sepsis)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Rash)
"Adverse response to chemotherapy in colorectal cancer (XELOX, Cetuximab) (Rash)"
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Rash)"
Kidney injury 5 years post-surgery in obstructive uropathies
Hypoalbuminemia
Pernicious anemia
Polymyalgia rheumatica
Anti-BK polyomavirus IgG seropositivity
BK polyomavirus VP1 antibody levels
Anti-JC polyomavirus IgG seropositivity
JC polyomavirus VP1 antibody levels
Anti-Merkel cell polyomavirus IgG seropositivity
Merkel cell polyomavirus VP1 antibody levels
Low testosterone levels
Human milk oligosaccharide concentration (sialyl-lacto-N-tetraose c)
Human milk oligosaccharide concentration (sialyl-lacto-N-tetraose c) in non-secretors
Motor coordination
Cisplatin-induced hearing loss in childhood cancer
Executive function (trail making test B) x time interaction
Executive function (trail making test B)
Executive function (verbal digit span backwards test) x time interaction
Executive function (verbal digit span backwards test)
Brain functional connectivity measurement (global efficiency)
Brain functional connectivity measurement (characteristic path length)
Brain functional connectivity measurement (louvain modularity)
Brain functional connectivity measurement (transitivity)
Brain functional connectivity measurement (local efficiency default)
Brain functional connectivity measurement (local efficiency dorsal attention)
Brain functional connectivity measurement (local efficiency frontoparietal)
Brain functional connectivity measurement (local efficiency limbic)
Brain functional connectivity measurement (local efficiency salience)
Brain functional connectivity measurement (local efficiency somatomotor)
Brain functional connectivity measurement (local effieiency visual)
Brain functional connectivity measurement (strength default)
Brain functional connectivity measurement (strength dorsal attention)
Brain functional connectivity measurement (strength frontoparietal)
Brain functional connectivity measurement (strength limbic)
Brain functional connectivity measurement (strength salience)
Brain functional connectivity measurement (strength somatomotor)
Brain functional connectivity measurement (strength visual)
Frozen shoulder
COVID-19 (covid vs negative)
COVID-19 (hospitalized covid vs population)
COVID-19 (covid pneumonia vs population)
COVID-19 (covid respiratory support vs population)
COVID-19 (severe respiratory symptoms vs population)
Age at peak height velocity
Height at time of age with peak height velocity
Response to buprenorphine in opioid use disorder
Perceptual and visual search speed (trail making test A)
Disability level (impaired activities of daily living)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes)
Cognitive impairment level
Liver volume
Pancreas volume
Visceral adipose tissue volume
Abdominal subcutaneous adipose tissue volume
Liver iron content
Pancreas fat
Pancreas iron content
Hypertension in type 2 diabetes
Tinnitus in cranial radiation therapy-treated pediatric cancer survivors
Hearing loss in cranial radiation therapy-treated pediatric cancer survivors
Sarcoidosis (non-Lofgren's syndrome) (smoking status interaction)
Sarcoidosis (Lofgren's syndrome) (smoking status interaction)
Cleft lip with or without cleft palate or cleft palate (pleiotropy)
Cleft lip or cleft palate (pleiotropy)
Cleft lip with cleft palate or cleft palate (pleiotropy)
Cleft lip or cleft lip with cleft palate (pleiotropy)
Lung cancer prognosis in former smokers
Estimated glomerular filtration rate (creatinine)
Stroke (hemorhagic)
Response to levetiracetam in focal epilepsy
Response to sodium channel-Active anticonvulsant in focal epilepsy
Response to lamotrigine in focal epilepsy
Response to carbamazepine in focal epilepsy
Response to oxcarbazepine in focal epilepsy
Response to phenytoin in focal epilepsy
Response to calcium-channel-Active anticonvulsants in focal epilepsy
Response to valproic acid in focal epilepsy
Response to levetiracetam in epilepsy
Response to lamotrigine in epilepsy
Response to calcium-channel-Active anticonvulsants in epilepsy
Response to valproic acid in epilepsy
Response to sodium channel-Active anticonvulsants in focal epilepsy
Stimulant dependence
Aerodigestive squamous cell cancer (pleiotropy)
Frequent insomnia symptoms
Peptic ulcers
Neuropsychiatric disorders
Peripheral vascular disease
Acute reaction to stress
Varicose veins
Age at menopause
Age at menarche
Degenerative rotator cuff disease surgery
Extrahepatic cholangiocarcinoma
sarcopenia
Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel
Progression free survival in epithelial ovarian cancer
Progression free survival in serous epithelial ovarian cancer
Overall survival in epithelial ovarian cancer treated with carboplatin and paclitaxel
Overall survival in epithelial ovarian cancer
Overall survival in serous epithelial ovarian cancer
Amyloid beta positivity
Asthma and eczema
Hand osteoarthritis severity (hand Klsum)
Finger osteoarthritis severity (hand Klsum)
Thumb osteoarthritis severity (hand Klsum)
Cardiovascular disease
Dermatophytosis
Dyslipidemia
Hemorrhoids
Hernia abdominopelvic cavity
Severe autoimmune type 2 diabetes
Severe insulin-deficient type 2 diabetes
Severe insulin-resistant type 2 diabetes
Mild obesity-related type 2 diabetes
Mild age-related type 2 diabetes
Parkinson's disease motor subtype (tremor dominant vs postural instability/gait difficulty)
Parkinson's disease motor subtype (tremor to postural instability/gait difficulty score ratio)
Anxious temperament
Cyclothymic temperament
Depressive temperament
Irritable temperament
Hyperthymic temperament
Conotruncal heart defects with normally related great vessels (without 22q.11.2 deletion syndrome)
Conotruncal heart defects with normally related great vessels
Left atrial active emptying fraction
Left atrial passive emptying fraction
Left atrial total emptying fraction
COVID-19
Longevity (100 years and older)
Relative brain age
DNA methylation-estimated granulocyte proportions
DNA methylation GrimAge acceleration
DNA methylation Hannum age acceleration
DNA methylation-estimated plasminogen activator inhibitor-1 levels
DNA methylation PhenoAge acceleration
Carotid artery intima-media thickness in type 2 diabetes
Coronary artery calcification in type 2 diabetes
Coronary artery calcification in type 2 diabetes (excluding prevalent cardiovascular disease)
Age related hearing loss-related regional glucose metabolism (Bilateral Heschl’s gyrus)
Age related hearing loss-related regional glucose metabolism (Inferior colliculus)
Age related hearing loss-related regional glucose metabolism (Cochlear nucleus)
Sociability score
Frequency of friend / family visits
Attending social / leisure activities
Alcohol drinking status (current drinker vs non-current drinker)
Fibrinogen gamma chain measurement
Galectin-3-binding protein measurement
Interleukin-7 receptor subunit alpha measurement
Coagulation factor IXab measurement
Prothrombin measurement
Interleukin-1 receptor antagonist protein measurement
GDP-fucose protein O-fucosyltransferase 1 measurement
Procollagen galactosyltransferase 1 measurement
Coagulation factor XIII B chain measurement
von Willebrand factor A domain-containing protein 1 measurement
Protein FAM162A measurement
"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 measurement"
"GrpE protein homolog 1, mitochondrial measurement"
von Willebrand factor A domain-containing protein 2 measurement
Inter-alpha-trypsin inhibitor heavy chain H3 measurement
Haptoglobin measurement
ERO1-like protein beta measurement
KDEL motif-containing protein 2 measurement
Sulfhydryl oxidase 2 measurement
Complement C1s subcomponent measurement
Endoplasmic reticulum lectin 1 measurement
Monocyte differentiation antigen CD14 measurement
Palmitoyl-protein thioesterase 1 measurement
Neuronal pentraxin-1 measurement
Peptidyl-prolyl cis-trans isomerase FKBP7 measurement
Coagulation factor Xa measurement
Interleukin-2 receptor subunit alpha measurement
Coagulation factor VII measurement
Complement C2 measurement
Insulin-degrading enzyme measurement
Complement C1r subcomponent measurement
Antithrombin-III measurement
Angiostatin measurement
Creatine kinase M-type:Creatine kinase B-type heterodimer measurement
Complement factor B measurement
Plasminogen measurement
Thrombin measurement
Complement factor H measurement
Serotransferrin measurement
Interleukin-1 receptor-like 1 measurement
dCTP pyrophosphatase 1 measurement
C-reactive protein measurement
Growth/differentiation factor 15 measurement
Lactadherin measurement
Gelsolin measurement
Inter-alpha-trypsin inhibitor heavy chain H4 measurement
Coagulation factor IX measurement
Coagulation Factor X measurement
Coagulation Factor V measurement
D-dimer measurement
Interleukin-2 receptor subunit beta measurement
Complement C1r subcomponent-like protein measurement
Gamma-glutamyl hydrolase measurement
Vesicular integral-membrane protein VIP36 measurement
Eukaryotic translation initiation factor 4E type 2 measurement
MAP/microtubule affinity-regulating kinase 3 measurement
Severe COVID-19 infection
Asymptomatic COVID-19 infection
Thoracic aortic aneurysms
Idiopathic central precocious puberty
Two-hour glucose
Unilateral cleft lip (left vs right)
Unilateral cleft lip and palate (left vs right)
Right unilateral cleft lip
Left unilateral cleft lip and palate
Left unilateral cleft lip
Right unilateral cleft lip and palate
Cleft lip with or without cleft palate (bilateral vs unilateral)
Nausea incidence in varenicline-treated smokers
Plasma p-tau181 levels
Pulmonary mycobacterium avium complex disease
Type 1 diabetes with low genetic risk score
Psoriasis or type 2 diabetes (trans-disease meta-analysis)
